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Summary 
As a chronic inflammatory disease of the arterial wall, atherosclerosis is a leading 
cause of death and morbidity worldwide. However, current treatments, statins, causing 
strong adverse drug reaction lead to unsatisfactory tolerance in patients experiencing 
coronary event. Hydrogen sulfide (H2S), as the novel identified gaseous mediator in 
mammals, has emerged its protective effect on oxidative stress, inflammation, 
cardiovascular disease and neurodegenerative disease. In this study, the therapeutic 
potentials of H2S and an analog of sulfide-containing garlic extraction, SPRC on 
atherosclerosis in vitro and in vivo were investigated. 
 
In pilot study - experiment I, human umbilical vein endothelial cells (HUVECs), as 
the major cells evolved in the initial process of atherosclerosis, were protected by 
exogenous H2S (NaHS) against hydrogen peroxide (H2O2) induced oxidative stress 
and mitochondrial dysfunction. H2S showed no toxic to HUVECs at μM level. The 
results obtained from MTT, LDH releasing and Sulforhodomine B indicated that H2S 
increased cell viability damaged by H2O2. For unveiling the mechanisms hidden 
behind, the mitochondria, redox status and program cell death were the three targets 
focused on. By observed by the staining of Hochest, PI and Annexin V/PI, H2S 
reduced apoptotic cells, which may be mediated by increased anti-apoptotic proteins 
(Bcl-2 and Bcl-XL) and decreased pro-apoptotic proteins (cleaved caspase-3 and Bax). 
Mitochondrial function was reserved by H2S through increasing ATP synthesis. H2S 
also maintained the intact mitochondrial membrane by attenuating the dissipation of 
mitochondrial electrochemical potential (ΔΨm) and inhibiting cytochrome c releasing. 
The production of ROS detected by H2DCFDA and DHE was inhibited by H2S which 
elevated GSH, SOD, catalase, GST and GPx. The effects of H2S can be reversed by 
inhibitor of CSE, PAG. The antioxidative and mitochondrial protective effects of H2S 
may be through CSE/ H2S pathway. 
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In experiment II, the mitochondrial protective effect of H2S was further demonstrated 
on New Zealand White (NZW) rabbit aortas. After the rabbits aortas were collected, 
mitochondria were isolated and accepted the injury from H2O2. H2O2 treatment 
resulted in oxidative stress to the aortic mitochondria, which showed a greater extent 
of ROS generation by the staining of H2DCFDA and DHE. Under such circumstance, 
exogenous H2S (NaHS) not only inhibited ROS generation, but also increased ATP 
synthesis. As the main location of producing ROS and ATP, mitochondrial respiration 
chain became the investigated target. Oxygen consumption by the respiration chain 
was suppressed by H2O2 and rescued by H2S. The activities of mitochondrial 
respiration chain complex I, II/III, IV and matrix enzyme α-KGDHC was restored by 
H2S. ΔΨm and Δ540 for testing mitochondrial swelling showed H2S prevented the 
mitochondria rupture and maintained mitochondrial membrane. PAG showed the 
adverse effects of H2S. 
 
In experiment III, H2S showed the inhibition of atherogenesis on NZW rabbit 
hyperlipidemic model. The serum were collected to test the cholesterol level, LDL 
level and ox-LDL level, which significantly increased by high cholesterol feeding 
(HCD). Administration of H2S leaded to a decrease of LDL level and ox-LDL level, 
which may be mediated by the activation of HO-1. Aortic lesions detected by H&E 
and carotid arterial lesions detected by high resolution ultrasonographic (HRUS) 
imaging, showed that the atherosclerotic lesions in arteries were inhibited by H2S 
from the decreased intima-media thickness (IMT) and plaques sizes. The diminished 
plaques may be due to the suppression of free radicals, activation of antioxidants and 
inhibition of cell adhesive and inflammatory molecules. PAG showed the more severe 
atherosclerotic lesions. The cardiovascular protection of H2S may be through CSE/ 
H2S pathway. 
 
In experiment IV, S-Propargyl-cysteine (SPRC), a sulfide-containing molecule and the 
structural analog of a garlic extraction - S-allylcysteine (SAC), inhibited early 
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atherogenesis on NZW rabbit hyperlipidemic model. HCD treatment not only leaded 
to significantly increased body weight, serum cholesterol level and LDL level, but 
also formed the early atherosclerotic plaques. SPRC decreased LDL level and 
inhibited the plaques formation by the observation of aortas by H&E and carotids by 
HRUS. The mechanisms of anti-atherogenesis by SPRC may be through the 
regulation of redox status and suppression of inflammatory cell adhesion. The 
cardiovascular protective effect of SPRC was inhibited by PAG, showing greater 
atherosclerotic lesions. This anti-atherogenesis effect of SPRC may be through CSE/ 
H2S pathway. 
 
In summary, H2S and SPRC carry potential effects on atherosclerotic therapy, through 
the endothelial protection, modulation of mitochondrial function, antioxidant effects 
and anti-inflammatory cell adhesion. 
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Chapter 1 
General Overview
 Chapter 1 
2 
 
1.1 Overview 
Atherosclerosis is a chronic inflammatory disease occurring hand-in-hand with 
incipient accumulation of serum lipid in arterial blood vessels[1]. This high morbidity 
cardiovascular disease can silence for years, even though the atherosclerotic plaques 
formation in patience vasculature, called “stable plaques”. As the atherosclerotic 
conditions slowly grow and cumulate, the stable plaques become unstable and rupture 
to thrombus, which rapidly stop blood flow and result in death of tissues in the block 
areas[2]. The catastrophic ischemic symptoms can be myocardial infarction, stroke 
and claudication[3]. These complications can be lethal and disable, which are 
recognized as a leading cause to death in worldwide[3]. The patients carrying 
atherosclerotic unstable plaques and experienced the complications endure 
devastating impacts that may be chest pain, loss of vision, speech, paralysis and 
confusion, physical and mental disabilities. Therefore, atherosclerosis brings a 
substantial economical burden on individuals and society. 
 
Although the mechanisms of atherogenesis are not fully understood, this vascular 
disease is highly related to the increased serum lipid, especially LDL[4]. Under this 
stimulation, the free radical species are dramatically generated, in turn, react with 
LDL to oxidized lipid molecules, which trigger a cascade of immune responses, like 
monocyte – endothelial cells adhesion, inflammation, fatty steak information and 
plaque core hardening[5]. There are also various anatomic, physiological and 
behavioral risk factors influencing atherosclerosis, including diabetes, 
dyslipoproteinemia, tobacco smoking, hypertension, vitamin B6 deficiency and raised 
serum C-reactive protein levels [6]. Therefore, reducing risk factors and developing 
therapies targeting the atherogenesis are the efficient solution for this cardiovascular 
disease. 
 
Reducing risk factors can be done by doing regular exercise, eating healthily, 
maintaining an ideal body weight, avoiding excessive alcohol intake, doing physical 
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examination regally, preventing stress and giving up smoking. When these non-drug 
approaches become work little, the drugs turn to be main force. Current medications 
for atherosclerosis are usually the family “Statin”, which can lower serum cholesterol 
levels and stable plaques effectively. However, the Prove-It Trials found that intensive 
statin therapy for two years did not prevent 22.4% of patients from the coronary 
events occurred[7]. Moreover, liver dysfunction, rhabdomyolysis and elevated risk of 
cancer cause some patients to withdraw from statin treatments [8]. Therefore, it is 
high interest to investigate alternative therapies for atherosclerosis to extend patients 
treatments choices.  
 
H2S may have the potential to treat this ancient disease. H2S, the novel 
gasotransmitter, is a hot research issue in recent years, due to its cardioprotective and 
anti-inflammatory characteristics [9]. The studies on myocardial infarction[10], 
ischemia/reperfusion[11, 12] and colitis [13] have been proven that H2S regulates 
cellular adhesive molecular expression, expresses antioxidative abilities, suppresses 
inflammatory cytokines and antagonizes tissue program cell death. Atherosclerosis, an 
age-dependent and a multi-factorial disease with an important inﬂammatory 
component, is associated with oxidative stress and cell adhesion and program cell 
death[14], which can be triggered by H2S, according to its novel features in previous 
peer studies. Additionally, some in vitro studies by using smooth muscle cells and in 
vivo studies focused on ICAM-1[15, 16] have already collected several inspiring 
results. Therefore, it is an interesting and encouraging attempt to link H2S to 
atherosclerotic therapy that may provide a novel avenue to the treatments of this high 
prevalent disease. 
 
Moreover, considering mitochondria is the main source of cellular energy plant[17], 
and mitochondria contribute to cardiac dysfunction and myocytes injury[18], this 
organelle functions were investigated for unveiling the protective effects of H2S as 
one mechanism. There are several studies reported that H2S can induce suspended 
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animation and create hypothermia by reducing metabolism in order to improve organ 
preservation [19]. Also, in wild nature, some bacteria and archaea produce and utility 
H2S as their energy supply for survival and proliferation [20]. Under these 
considerations, we hypothesize that H2S may modulate the cellular energy supply 
through mitochondrial functions. Therefore, whether mitochondrial ultrastructure and 
function can be reserved by H2S or not is an investigated direction we elucidate in this 
thesis. 
 
In these studies, we found that administration of H2S and the sulfide-containing 
chemical (SPRC) could attenuate the atherogenesis from cellular and animal levels 
that protect mitochondria, exhibited antioxidative abilities, suppression of lipid 
oxidation, inhibition of inflammatory cell adhesion. Therefore, our studies provided 
the new avenue for exploring novel therapeutic strategies for combating 
atherosclerosis and extended our understanding of the pathways of cardiovascular 
effects of H2S. 
 
This thesis focuses on the effects of H2S and the sulfide-containing chemical (SPRC) 
on atherosclerosis and the mechanisms involved in protective effects on vasculature. 
Animal studies and cell studies were carried out for the general functional 
observations and specific mechanisms investigations in early stage of atherosclerotic 
process. Advanced stage of atherosclerosis and related complications are very 
complicated and involve many systemic issues. Therefore, investigations of advanced 
atherosclerosis are not central to this study and hence are beyond the scope of this 
thesis. 
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1.2 Objectives 
The main objectives of this work are fourfold: 
1. Verify the possible therapeutic potential of exogenous H2S on HUVECs against 
H2O2-induced mitochondrial dysfunction, oxidative stress and apoptosis.  
In experiment I, the H2S toxicity level and cell viability recovered by H2S were tested. 
The underlying mechanisms of protective effects of H2S were investigated in 
mitochondrial function (ATP production and ΔΨm), anti-oxidation (ROS production, 
MDA and antioxidative enzymes) and anti-apoptosis (apoptotic related proteins 
expressions and Akt pathway). These mechanisms of cardioprotective effects of H2S 
were demonstrated through CSE/H2S pathway. 
2. Elucidate the effects of exogenous H2S on modulation of mitochondrial 
function in rabbit aortas mitochondria.  
Since mitochondria are the primary source of determining the cellular oxidative stress, 
in experiment II, the reserved mitochondrial functions by H2S were assessed in terms 
of mitochondrial respiration chain, ATP biosynthesis, ROS production and 
mitochondrial membrane permeability (ΔΨm and mitochondrial swelling). 
3. Address the effects of exogenous H2S on atherogenesis in New Zealand White 
rabbit hyperlipidemic model.  
In experiment III, H2S was target to identify the anti-atherogenesis in several 
parameters: cholesterol level, ox-LDL level, MDA level and HO-1 expressions to 
identify the effects of H2S on lipid oxidation; aortic ultrastructure, thoracic aorta H& 
E and carotid imaging to identify the effects of H2S on aortic plaque sizes; 
antioxidative enzymes activities and proteins and genes expressions to identify the 
effects of H2S on oxidative stress; inflammatory cellular adhesive molecules 
expressions to identify the effects of H2S on atherosclerotic inflammatory procedure. 
These mechanisms of cardioprotective effects of H2S were also demonstrated through 
CSE/H2S pathway. 
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4. Illustrate the effects of the sulfide-containing chemical, SPRC, on 
atherogenesis in New Zealand White rabbit hyperlipidemic model. 
In experiment IV, a novel sulfide-containing chemical, SPRC, was target to identify 
the anti-atherogenesis in several parameters: serum lipid levels and MDA level to 
identify the effects of SPRC on lowering serum cholesterol; aortic ultrastructure, 
thoracic aorta H& E and carotid imaging to identify the effects of SPRC on aortic 
plaque sizes; antioxidative enzymes activities and proteins and genes expressions to 
identify the effects of SPRC on oxidative stress; inflammatory cellular adhesive 
molecules expressions to identify the effects of SPRC on atherosclerotic inflammatory 
procedure. These mechanisms of cardioprotective effects of H2S were also 
demonstrated through CSE/H2S pathway. 
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2.1 The Novel Gasotransmitter, Hydrogen 
Sulfide 
2.1.1 Introduction 
In an evolutionary perspective, the synthesis and catabolism of hydrogen sulfide 
(H2S) by living organisms antedates the evolution of vertebrate. Bacteria and archaea 
produce and utilise the stinking gas as one of the essential sources for their survival 
and proliferation. For many decades, H2S, the colorless gas with a strong odour of 
rotten gas, is recognized as a toxic gas and an environmental pollutant. The 
mechanism of its toxicity is a potent inhibition of mitochondrial cytochrome c 
oxidase, which is the important enzyme that is closely related with chemical energy 
in the form of adenosine triphosphate (ATP). Sulfide, together with cyanide, azide 
and carbon monoxide (CO), all can inhibit cytochrome c oxidase which leads to 
chemical asphyxiation of cells.  
 
In the last two decades, the perception of H2S has been changed from that of a 
noxious gas to a gasotransmitter with vast potential in pharmacotherapy. At the end 
of 1980s, endogenous H2S is found in the brain [21]. Then, its enzymatic mechanism, 
physiological concentrations, specific cellular targets were described in the year of 
1996 [22]. Subsequently, the physiological and pharmacological characters of H2S 
were unveiled. Recently, H2S, followed with NO and CO, is identified as the third 
gasotransmitter by Rui Wang [23]. The three gases share some common features. 
They are all colorless and poisonous gases. With the exception of gas pressure in 
atmosphere, they can dissolve in water at different solubility. All these small 
signaling molecules possess significant physiological importance, like 
anti-inflammation, anti-apoptosis, etc. The similarities and differences of the features 
of NO, CO and H2S are summarized in Table 2-1. 
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Table 2- 1 Comparison of nitric oxide, carbon monoxide and hydrogen sulfide 
 nitric oxide carbon monoxide hydrogen sulfide 
Formula NO CO H2S 
Color and odor 
Colorless; a mild, 
sweet odor 
Colorless; odorless 
Colorless; smell 
like rotten egg 
Free radical Yes No No 
Flammable No No Yes 
Toxicity and dose Yes Yes Yes 
Inhibition of 
mitochondrial 
cytochrome c 
oxidase 
Yes Yes Yes 
Resources L-arginine or nitrite Protohaem IX L-cysteine  
Intermediate 
Products 
L-NG 
hydroxyarginine, 
citrulline 
Biliverdin IX-α 
Cystathionine, 
L-cysteine, 
αketobutyrate, 
pyruvate 
Enzymes 
calmodulin-dependent 
nitric oxide synthase 
(NOS) (types 1, 2 and 
3) 
heme oxygenase 
(HO)( HO-1, HO-2 
and HO-3) 
Cystathionine 
β-synthase (CBS), 
Cysthathionine 
γ-lyase (CSE), 3 
mercaptopyruvate 
sulfide transferase 
(3-MST) 
Vascular effect vasodilation vasodilation vasodilation 
Inhibition 
inflammation 
Yes Yes Yes 
Anti-apoptosis Yes Yes Yes 
Haem effect Yes Yes Yes 
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Molecular targets 
soluble guanylate 
cyclase (sGC) 
soluble guanylate 
cyclase (sGC) 
KATP (ATP-gated 
potassium) channel 
Targeting 
outcome 
Stimulation of soluble guanylate cyclase 
and increase of intracellular cGMP 
concentration. But CO is a much weaker 
activator than NO. 
Increase of cAMP, 
relaxation of 
smooth muscle 
Application on 
human 
pulmonary 
hypertension, lung 
transplantation, ARDS 
not available not available 
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2.1.2 Physical and biological characteristics  
H2S, a colorless and flammable gas with the characteristic foul odor of rotten eggs, is 
known for decades as a toxic gas and an environmental hazard. It is soluble in water 
(1 g in 242 ml at 20°C). In water or plasma, H2S is a weak acid which hydrolyzes to 
hydrogen ion, hydrosulfide and sulfide ions as followings: H2S ↔ H+ + HS- ↔ 2H+ 
+ S2-. The pKa at 37°C is 6.76. When H2S is dissolved in physiological solution 
(pH7.4, 37°C), it yields approximately 18.5% H2S and 81.5% hydrosulﬁde anion 
(HS-), as predicted by the Henderson–Hasselbach equation [24]. H2S could be 
oxidized to sulfur oxide, sulfate, persufide and sulfite. H2S is permeable to plasma 
membranes as its solubility in lipophilic solvents is five-fold greater than in water. In 
other words, it is able to freely penetrate cells of all types. 
 
The toxic effect of H2S on living organisms has been recognized for nearly 300 years 
and until recently it was believed to be a poisonous environmental pollutant with 
minimal physiological significance. H2S is more toxic than hydrogen cyanide and 
exposure to as little as 300 ppm in air for just 30 min is fatal to human. The level of 
odor detection of sulfide by the human nose is at a concentration of 0.02-0.1ppm, 
400-fold lower than the toxic level. As a broad spectrum toxicant, H2S affects many 
organ systems including lung, brain, kidney etc.  . 
 
H2S is often produced through the anaerobic bacterial breakdown of organic 
substrates in the absence of oxygen, such as in swamps and sewers (anaerobic 
digestion). It also results from inorganic reactions in volcanic gases, natural gas and 
some well waters. Digestion of algae, mushrooms, garlic and onions, are believed to 
release H2S by chemical transformation and enzymatic reactions [25]. Structures of 
nature food releasing H2S on digestion are shown in Fig. 2-1. Consuming 
mushrooms, garlic and onions, which contain chemicals and enzymes responsible for 
the transformation of the sulfur compounds, are responsible for H2S production in 
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human gut [26]. Human body produces small amounts of H2S and uses it as a 
signaling molecule. In different species and organs, the concentration of H2S varies 
in different levels. In Wistar rats, the normal blood level of H2S is 10 µM [27]; while 
in Sprague–Dawley rats, the plasma level of H2S increase to 46 µM [28]; In human, 
10–100 µM H2S in blood was reported [29]. The tissue level of H2S is known to be 
higher than its circulating level. The concentration of endogenous H2S has been 
reported up to 50–160 µM in brains of rat, human and bovine [21, 30, 31]. 
Significant amounts of H2S are generated from vascular tissues, and this production 
varies among different types of vascular tissues. For instance, the homogenates of 
thoracic aorta yielded more H2S than that of portal vein of rats [28]. 
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Fig.2- 1 Synthesis and catabolism of H2S 
AAT: aspartate aminotransferase CBS: cystathionine β-synthase 
CDO: cysteine dioxygenase CSD: sulfinate decarboxylase 
CSE: cystathionine γ-lyase HDH: hypotaurine dehydrogenase 
H2S: hydrogen sulfide GCS: γ-glutamyl cysteine synthase 
GNMT: glycine N-methyltransferase GS: glutathione synthase 
GSH: glutathione MAT: methionine adenosyltransferase 
3-MST: 3-mercaptopyruvate sulfide transferase MS: methionine synthase 
MTHFR: methylenetetrahydrofolate reductase S0: elemental sulfur 
SAH: S-adenosylhomocysteine SAM: S-adenosylmethionine 
SO: sulfite oxidase THF: tetrahydrofolate 
TSR: thiosulfate reductase TSST: thiosulfate sulfurtransferase 
TSMT: thiol-S-methyltransferase  
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2.1.3 Synthesis and catabolism of H2S; 
H2S is endogenously formed by both enzymatic and non-enzymatic pathways [23]. 
The enzymatic procedure of synthesizing H2S, in mammalian tissues, is involved in 
two pyridoxal 5’-phosphate-dependent enzymes: cystathionine γ-lyase (CSE) and 
cystathionine β-synthase (CBS) [32-34]. As shown in figure 1, H2S is catalyzed from 
the desulfhydration of L-cysteine, a sulfur containing amino acid derived from 
alimentary sources, produced by the trans-sulfuration pathway of L-methionine to 
homocysteine, or liberated from other endogenous proteins [35, 36]. As the 
intermediate, CBS catalyzes homocysteine together with serine to yield 
cystathionine, which get converted to cysteine, α-ketobutyrate and NH4+ by CSE. 
The two pyridoxal 5’-phosphate-dependent enzymes both or either catalyze the 
conversion of cysteine to H2S, pyruvate, NH4
+. CSE also could catalyze a 
β‑disulfide elimination reaction that results in the production of thiocysteine, 
pyruvate and NH4
+. Thiocysteine is associated with cysteine or other thiols to form 
H2S [37]. 
 
The two enzymes are widespread in mammalian tissues and cells and also in many 
invertebrates and bacteria [38]. The activity of CSE is chiefly concentrated in liver, 
heart, vessels, kidney, brain, small intestine, stomach, uterus, placenta and pancreatic 
islets; whereas the amounts of CBS is mainly located in brain, liver, kidney and 
ileum, uterus, placenta and pancreatic islets [39]. The locations of H2S-producing 
enzymes are seen in Table 2-2. In several species, the liver is the common organ 
containing the two enzymes in abundance. According to Zhao’s research, the 
intensity rank of biosynthesis of H2S by origin of exogenous cysteine in different rat 
blood vessels was tail artery > aorta > mesenteric artery [40].  
 
 
                                                                                                         
Chapter 2 
15 
 
 
Table 2- 2 Characteristics of H2S-producing Enzymes 
 
 Cysthathionine γ-lyase (CSE) 
Cystathionine β-synthase 
(CBS) 
Localization 
liver, heart, vessels, kidney, 
brain, small intestine, stomach, 
uterus, placenta and pancreatic 
islets 
brain, liver, kidney and ileum, 
uterus, placenta and 
pancreatic islets 
Activators Pyridoxal 5′-phosphate 
Pyridoxal 5′-phosphate, 
S-adenosyl-L-methionine, 
Ca2+/calmodulin 
Inhibitors 
D,L-propargylglycine, 
β-cyano-L-alanine 
Hydroxylamine, 
Amino-oxyacetate 
Functional 
roles 
H2S production in liver and 
smooth muscle 
H2S production in the brain 
and nervous system 
 
 
A third enzymatic reaction contributing to H2S production has recently been 
identified in brain and vascular endothelium, i.e. 3-mercaptopyruvate 
sulfurtransferase (3-MST) in combination with aspartate aminotransferase (AAT) 
(also called cysteine aminotransferase) [41, 42], seen in Fig. 2-1. In mitochondria, 
L-cysteine and α-ketoglutarate as substrates, can be converted to 3-mercaptopyruvate 
by AAT; then the intermediate product is converted to H2S by 3-MST [42]. In brain, 
3-MST is found almost in neurons, while CBS in astrocytes [43]. It could speculate 
that the two enzymes of catalyzing H2S play different roles in nervous system. In 
vascular tissues, 3-MST could be detected in both endothelial cells and vascular 
smooth muscle cells (SMCs), while AAT just occurs in endothelial cells. From 
another perspective, only vascular endothelial cells in vessel could utilize the two 
 Chapter 2 
16 
 
enzymes to produce H2S, whereas vascular SMCs likely absorb 3-mercaptopyruvate 
or other sources to generate H2S which exerts as a vasodilator. 
 
The non-enzymatic route of yielding H2S is the conversion of elemental sulfur and 
transformation of oxidation of glucose. The non-enzymatic route is presented in vivo, 
involving phosphogluconate (<10%), glycolysis (>90%), glutathione (<5%) [23]. 
 
In the pathway of H2S production, there are some important amino acids: 
homocysteine and L-cysteine. Besides generation of H2S pathway, homocysteine is 
related to folate cycle and methionine cycle [44], the latter of which is participated in 
methionine, SAM and SAH, as previously stated. As the bridge of the two cycles, 
homocysteine could be remethylated to methionine by interacting with 
methyltetrahydrofolated (methyl-THF) and vitamin B12 as cofactor under the 
synthesis of methionine synthase (MS). Methyl-THF is transformed from 
methylenetrahydrofolate (methylene-THF) by methylenetetrahydrofolate reductase 
(MTHFR). Tetrahydrofolate (THF) is generated by remethylation and converted to 
methylene-THF, thus integrated the folate cycle. In another cycle, methionine, is 
transformed to S-adenosylmethionine (SAM) by methionine adenosyltransferase 
(MAT), then is converted to S-adenosylhomocysteine (SAH), which is subsequently 
hydrolyzed to homocysteine by glycine N‑methyltransferase (GNMT).  
 
Cysteine metabolism is engaged in three major routes. Apart from the conversion of 
H2S, one path is oxidation of –SH group by cysteine dioxygenase (CDO) to cysteine 
sulfinate, which is decarboxylated to hypotaurine by cysteine sulfinate 
decarboxylase (CSD), then further transformed to taurine by a non-enzymatic 
reaction or by hypotaurine dehydrogenase (HDH); or which is converted to sulfinyl 
pyruvate, subsequently to sulfite and further sulfate. Another path from cysteine is 
synthesis GSH by glutathione synthase (GS) from γ-Glutamyl cysteine, which is 
originated from cysteine and glutamate catalyzed by γ-Glutamyl cysteine synthase 
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(GCS). 
 
The concentration of H2S is not only determined by the rate of formation but also by 
degradation of H2S. Dissolved gaseous H2S is in a pH-dependent equilibrium, with 
hydrosulfide anions (HS-) and sulfide anions (S2-), which can be catabolized to any 
sulfur-containing molecule. Sulfide, via non-enzymatic route, is catabolized to 
thiosulfate, which could be catalyzed to sulfite by thiosulfate reductase (TSR) in 
livers, brains or kidneys, or by thiosulfate sulfurtransferase (TSST) in livers, 
sequentially oxidized to sulfate via sulfite oxidase (SO) by a glutathione 
(GSH)-dependent reaction. The last product is excreted in urine [45]. H2S could be 
breakdowned by rhodanese, methylated to CH3SH, sequestrated by methemoglobin, 
interacted with superoxide or NO and scavenged by metallo- or disulﬁde-containing 
molecules such as oxidized glutathione [37],[38]. The major routes of degradation of 
H2S through non-enzymatic oxidation of sulfide also yield elemental sulfur, 
polysulfides, dithionate, polythionates. The whole schematic version of synthesis 
and catabolism of H2S is depicted in Fig. 2-1. 
 
2.1.4 Donors and inhibitors of H2S 
2.1.4.1 The donors of H2S 
2.1.4.1.1 Sulfide-containing salts 
Sodium hydrogen sulfide (NaHS) and disodium sulfide (Na2S) are the common 
H2S-releasing chemicals in research of hydrogen sulfide. These sodium salts 
purchased from pharmaceutical companies are usually aquo-compound, like 
NaHS·12H2O, Na2S·9H2O, or anhydrous forms. The products of sodium hydrogen 
sulfide and disodium sulfide should be white. The pills with yellow color predicates 
the anhydrous forms have been converted to hygroscopic blocks and should not be 
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purchased. White sulfide products are likely to have greater purity, but may contain 
sodium salts of thiosulfate or higher oxidation state sulfur oxyanions [46]. 
Contamination by trace metal ions may also be important, as these catalyze oxidation 
processes. The sulfides should therefore be reserved in a vacuum dessicator to 
minimize oxidation. 
 
The solution of NaHS, at physical pH and room temperature, hydrolyzes to sodium 
ion, hydrosulfide as followings: NaHS ↔ Na+ + HS-. Solutions of HS- are sensitive 
to oxygen, converting mainly to polysulfides, indicated by the appearance of yellow 
color. Hence, solutions of fresh prepared NaHS should be clear and put to use 
immediately. The purity of sulfides could be measured by determining the sulfide 
content either by titration with bromate, as described in standard analytical chemistry 
texts, or by UV spectroscopy in the case of sodium hydrogen sulfide, at pH 9, which 
has an absorption maximum at 230 nm with a molar absorptivity of 7200 L/mol/cm 
[47].  
 
Considering the unstable chemical properties of NaHS and Na2S, some researchers 
introduce another donor of H2S, calcium sulfide (CaS), which is more steady [48]. 
CaS can be found as one of the effective components in a traditional herb, named 
“hepar sulfuris calcareum”, usually applied to homeopathic remedy. Oral 
administration of CaS will be decomposed to more H2S in stomach acid environment. 
This review postulates CaS may carry out hypotension, arguing from its catabolism, 
relationship of calcium supplementation and blood pressure, dosage design and 
traditional application of homeopathic remedy on infection. 
 
2.1.4.1.2 H2S releasing molecules:  
Thioacetamide is an organosulfur compound with the formula C2H5NS. This white 
crystalline solid is soluble in water and serves as a source of sulfide ions in the 
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synthesis of organic and inorganic compounds [49]. For lab safety, thioacetamide is 
carcinogen class 2B and has hepatotoxicity. Thioacetamide was widely used in 
classical qualitative inorganic analysis as an in situ source for sulfide ions. 
 
Some research laboratories developed H2S releasers. Lawesson’s reagent is a chemical 
compound used in organic synthesis as a thiation agent, is also a H2S releaser. 
Lawesson's reagent is first synthesized in 1956 during a systematic study of the 
reactions of arenes with P4S10 [50]. After much time, it is first made popular by 
Sven-Olov Lawesson for introducing a thiation procedure as an example of a general 
synthetic method for   the conversion of carbonyl to thiocarbonyl groups [50]. 
2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane2,4-disulfide, Lawesson’s 
reagent, has a four-membered ring of alternating sulfur and phosphorus atoms. 
Normally in higher temperatures, the central phosphorus/sulfur four-membered ring 
can open to form two reactive dithiophosphine ylides (R-PS2), which decompose to 
release H2S. As its strong and unpleasant smell, it is best to prepare Lawesson's 
reagent within a fume hood and treat all glassware used with a decontamination 
solution before taking the glassware outside the fume hood. 
 
Based on Lawesson’s compound, a series of compounds are synthesized. Professor 
Moore’s lab reports that morpholin-4-ium-4-methoxyphenyl (morpholino) 
phosphinodithioate (GYY4137) releases H2S slowly both in vitro and in vivo. It has 
been proved that GYY4137 has vasodilator and antihypertensive activities and a 
useful H2S-releasing chemical in the study of biological effects of H2S [51]. In a later 
experiment, administration of GYY4137 to lipopolysaccharide(LPS) induced rats 
displays its anti-inflammatory effect by increasing plasma anti-inflammatory cytokine 
IL-10 and reducing plasma proinflammatory cytokines ((TNF-α, IL-1β, IL-6) and 
nitrite/nitrate, C-reactive protein, and L-selectin [52]. Structures of H2S releasing 
molecules are shown in Fig. 2-2. 
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Fig.2- 2 Structures of H2S releasing molecules 
 
Considering pharmacological effects and adverse effects of H2S, some pharmaceutical 
factories join in working on H2S donors which is made up well-established parent 
compounds and H2S-releasing moieties. CTG Pharma developed ACS series 
H2S-releasing compounds to meet their interests on the aspects of hypertension, 
metabolic syndrome, thrombosis and arthritis (www.ctgpharma.com). Antibe 
Therapeutics synthesizes several ATB series H2S-releasing derivatives for the 
treatments of inflammatory bowel disease, joint pain, and irritable bowel syndrome 
(www.antibe-therapeutics.com). The compound, IK-1001, from the company Ikaria, is 
an injectable form of Na2S, which is pure, PH neutral and stable. IK-1001 has been 
used several basic studies and processed into clinical trials. One is a phase I safety 
trial for assessing pharmacokinetics of intravenous IK-1001(ClinicalTrials.gov ID: 
NCT00879645). Another is a phase II efficacy trial which administer IK-1001 in 
patients undergoing surgery for a coronary artery bypass graft (ClinicalTrials.gov ID: 
NCT00858936). The effects of some H2S-releasing compounds are shown in Table 
2-3. 
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Table 2- 3 H2S-releasing compounds used in basic scientific researches  
 
Compounds Constituents Effects on Research fields 
SAC S-allylcysteine 
Protection on cardiovascular 
and neural systems 
SPRC S-propargyl-cysteine 
Anti-cancer, 
anti-inflammation, 
anti-hypoxic/ ischemia, 
impair cognition and 
Aβ-induced neuronal 
damage 
GYY4137 
morpholin-4-ium-4-methoxyphenyl 
(morpholino) phosphinodithioate 
Antagonize endotoxic shock 
though anti-inflammatory 
effects 
ACS-6 a H2S-donating sildenafil 
Inhibits superoxide 
formation and gp91phox 
expression in porcine 
PAECs 
ACS-14 a H2S-releasing aspirin 
Regulate redox imbalance, 
such as GSH formation, 
HO-1 promoter activity, and 
isoprostane suppression 
ACS-15 
a H2S-releasing derivative of 
diclofenac 
Arthritis 
ACS-67 
a H2S-releasing derivative of 
latanoprost acid 
Glaucoma; retinal ischemia 
ATB-284 a H2S-releasing derivative of Irritable bowel Syndrome 
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trimebutine 
ATB-337 
a H2S-releasing derivative of 
diclofenac 
Gastrointestinal damage 
induced by NSAIDs 
ATB-346 
a H2S-releasing derivative of 
naproxen 
Acute and chronic joint pain 
ATB-429 
a H2S-releasing derivative of 
mesalamine 
Inflammatory bowel disease. 
antinociceptive and 
anti-inflammatory effects 
IK 1001 
calcium-crosslinked alginate 
polymer 
Suspended animation, 
multiple hypoxic/ ischemic 
conditions, cardiac 
remodeling and congestive 
heart failure. 
 
2.1.4.1.3 Nature products containing sulfur  
Digestion of algae, mushrooms, garlic and onions, are believed to form H2S by 
chemical transformation and enzymatic reactions [25]. Structures of nature food 
releasing H2S on digestion are shown in Fig. 2-3. Nearly all the allium families are 
sulfur rich containing. Several publications reports enumerated functional activities of 
garlic. It exhibits hypolipidemic, anti-microbial, anti-platelet and pro-circulatory 
effects [53-55]. It also demonstrates immune enhancement and provides anticancer, 
anti-mutagenic and anti-proliferative that are interesting in chemopreventive 
interventions. Additionally, aged garlic extract possesses hepatoprotective, 
neuroprotective, anti-oxidative activities [56]. The major sulfur-containing 
compounds in intact garlic are γ-glutamyl-S-allyl-L-cysteines and S-allyl-L-cysteine 
sulfoxides (alliin). Both are abundant as sulfur compounds, and alliin is the primary 
odorless, sulfur-containing amino acid, a precursor of allicin, methiin, 
(+)-S-(trans-1-propenyl)-L-cysteine sulfoxide, and cycloalliin [57].  
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S-allylcysteine (SAC), a major transformed product from 
γ-glutamyl-S-allyl-L-cysteine, is a sulfur amino acid detected in the blood that is 
verified as both biologically active and bioavailable [58], seen in Fig. 2-3. SAC has 
been enumerated in several research investigations mediating protective effects in 
neural system and cardiovascular system by the inhibition of cell damage in neuron, 
heart and endothelium. In neural system, it is reported that SAC may attenuate 
Aβ-induced apoptosis [59], destabilize Alzheimer’s Aβ fibrils in vitro [60]. SAC 
prohibits cerebral amyloid, cerebral inflammation, and tau phosphorylation in 
Alzheimer’s transgenic mouse model harboring Swedish double mutation [61]. In 
stroke-prone spontaneously hypertensive rats, intaking SAC diminishes incidence of 
stroke, impairs behavioral syndroms, abates mortality induced by stroke [62]. SAC 
inhibits free radical production, lipid peroxidation and neuronal damage in rat brain 
ischemia [63]. In cardiovascular system, SAC can help the acute myocardial 
infarction rats survived by significantly lowering mortality and reducing infarct size 
[10]. 
 
SPC and SPRC are structural analogues of SAC, differing only in the propargyl and 
allyl moiety respectively while containing the same cysteine structure as shown in Fig. 
2-3. Wang et al., from our lab, reported that SPRC exhibited stronger cardioprotective 
effects than SAC in reducing mortality, increasing cell viability, reducing heart infarct 
size, lowering LDH and CK levels and activities, and having antioxidant properties 
[64]. These data suggest that the propargyl group of SPRC further increases the 
affinity and/or activity of SPRC towards the enzyme CSE as compared to SAC, where 
SPRC treatment is shown to have an increased CSE expression and activity to 
produce H2S for coping with ischemic damage. This observation suggests that the 
cardioprotective effects involving the CSE/H2S pathway were more effective using 
SPRC compared to SAC. Recently, our lab reported that SPRC showed 
neuroprotective effects of cognitive impairment and inhibition of neuronal 
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ultrastructure damage in Aβ-induced rats, affords a beneficial action on 
anti-inflammatory pathways [65]. SPRC has been demonstrated the anti-cancer effect 
on gastric cancer at high dose-50 mg/kg/d and 100mg/kg/d [66].The effects of SAC 
and SPRC are shown in Table 2-3. 
 
 
Fig.2- 3 The chemical structures of SAC, SPC and SPRC 
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2.1.4.2 The inhibitors and regulator of H2S 
The production of H2S from cysteine by tissue/cell homogenate is decreased by the 
presence of inhibitors of H2S-producing enzymes, which are mainly attributed to CSE 
and CBS. CSE is also named cysteine desulfhydrase [67]. The CBS locus is mapped 
to chromosome 21 (21q22.3) [68]. Several specific blockers for CSE and CBS are 
currently available. D,L-Propargylglycine (PAG) and  b-cyano-L-alanine  
selectively  inhibit CSE [28]. L-Cysteine metabolites, including ammonia, H2S, and 
pyruvate, cannot inhibit CSE activity [69]. CBS is inhibited by hydroxylamine (HA) 
and aminooxyacetate (AOAA) albeit these chemicals are not selective inhibitors of 
CBS [22]. The relationships between H2S-producing enzymes and their inhibitors are 
summarized in Table 2-2. 
 
The currently known regulations of H2S-producing enzymes are glutamate and its 
receptors, S-adenosyl-methionine (SAM), hormones, other gasotransmitters- NO and 
CO, etc. In the brain, electrical stimulation and excitatory neurotransmitter, glutamate, 
rapidly increase CBS activity in Ca2+/ calmodulin-dependent manner [70, 71]. Both 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) glutamate receptors and 
N-methyl-D-aspartate (NMDA) are involved in this effect. SAM is an intermediate 
product of methionine metabolism and a major donor of methyl groups. This allosteric 
regulator can activate CBS by approximately two-fold [22, 35]. Sex hormones seem 
to regulate brain H2S since CBS activity and H2S level are higher in male than in 
female mice and castration of male mice decreases H2S formation [35]. Sodium 
nitroprusside, a nitric oxide donor, increases the activity of brain CBS in vitro; 
however, this effect is NO-independent and results from chemical modification of the 
enzyme’s cysteine groups [72]. In contrast, NO itself may bind to and inactivate the 
CBS. Interestingly, CO is a much more potent CBS inhibitor than NO and it is 
suggested that CBS may be one of the molecular targets for CO in the brain [73, 74]. 
In homogenates of the rat aorta, NO donors acutely increase CSE-dependent H2S 
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generation in a cGMP-dependent manner [40]. Moreover, prolonged incubation of 
cultured vascular smooth muscle cells in the presence of NO donors increases CSE 
mRNA and protein levels [28]. The physiological significance of NO in the regulation 
of H2S production is also supported by the observation that circulating H2S level as 
well as CSE gene expression and enzymatic activity in the cardiovascular system are 
reduced in rats chronically treated with NOS inhibitor. Thus, NO is probably a 
physiological regulator of H2S production in the cardiovascular system. 
 
2.1.5 H2S measurements 
2.1.5.1 Spectrophotometric method 
The principle of spectrophotometric method of H2S is depended on the formation of 
methylene blue. H2S is chemiadsorbed by zinc acetate and transformed into stable 
zinc sulfide. The sulfide is recovered by extraction with water. In contact with an 
oxidizing agent such as ferric chloride in a strongly acid solution, it reacts with the 
N,N-dimethyl-p-phenylenediammonium (NNDPD) ion to yield methylene blue 
(C16H18N3SCl). The equation is shown in Fig. 2-4:  
 
 
Fig.2- 4 The equation of spectrophotometric method of H2S 
 
The methylene blue method has been designed to different protocol. A common 
method is adding NNDPD and ferric chloride to the plasma or homogenized tissue, 
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then developing color and colorimetric estimating immediately. Owing to the volatile 
character of H2S, researchers modify the protocol, like using a filter paper to 
augment the contact surface and prolong the contact time [75, 76]. Based on 
published papers and previous experience, our lab revised the assay for H2S by 
placing a sample in an airtight vessel with a central tube. The central tube contains a 
filter paper wick saturated with zinc acetate. The purpose of the filter paper wick is 
for trapping H2S to zinc sulfide. The reactions are initiated by mixing of strong acid 
with the sample, which sulfide is driven out and adsorbed onto the wick. The driving 
time is usually 30-120 minutes which is modified based on lab condition and 
optimization in the sorts of samples. Reactions are stopped by injecting 0.5% 
tricholroacetic acid (TCA). After gas evolution and wick absorption, the sulfide in 
the central tube reacts with NNDPD in present of Fe2+ ion. The absorbance of the 
resulting solution at 670nm was measured with a micro plate reader. 
 
This colorimetric method is not only widely used on the determination of H2S on 
serum in animal experiment, but also the activity of CSE/CBS enzyme on tissues or 
cells. The concentrations of H2S are reflected on the different shades of color of 
methylene blue and calculated by the plotting H2S standard curve.  
 
Two points need to be made. Firstly, most researchers assay H2S using the 
spectrophotometric assay which involves acidifying zinc acetate-treated (to ‘trap’ 
free H2S) biological samples in the presence of a dye and observing a colour change. 
This assay actually measures total sulﬁde and not the gas H2S. Secondly, H2S is 
either broken down rapidly in the body by enzymes, sequestered by binding to 
haemoglobin, or can react chemically with a number of species abundant in tissues, 
including superoxide radical [77], hydrogen peroxide [75], peroxynitrite [78] and/or 
hypochlorite [79]. All in all, making reasonably accurate measurements of such an 
evanescent and reactive gas in biological tissues is difficult. Indeed, the chemical 
nature of gases such as H2S, NO and CO might render it nonsensical even to try and 
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measure them in body fluids or tissues. 
 
2.1.5.2 Sulfide ion-selective electrode 
A sulfide ion-selective electrode (SISE) is immersed in an aqueous solution 
containing the ions to be measured, together with a separate, external reference 
electrode. The electrochemical circuit is completed by connecting the electrodes to a 
sensitive milli-volt meter using special low-noise cables and connectors. A potential 
difference is developed across the SISE membrane when the sulfide ions diffuse 
through from the high concentration side to the lower concentration side. 
 
At equilibrium, the membrane potential is mainly dependent on the concentration of 
the target ion outside the membrane and is described by the Nernst equation. Briefly, 
the measured voltage is proportional to the Logarithm of the concentration, and the 
sensitivity of the electrode is expressed as the electrode slope - in millivolts per 
decade of concentration. Thus the electrodes can be calibrated by measuring the 
voltage in sulfide standard solution. Testing samples can then be determined by 
measuring the voltage and plotting the result on the calibration graph. The use of 
sulfide ion-selective electrode suffers from precipitation of metal sulfide, for 
example sliver sulfide (Ag2S) from the filling solution on the electrodes.  
 
Reproducibility is limited by factors such as temperature fluctuations, drift and noise. 
The electrode can be used at temperatures from 0 to 100 ℃, and only used 
intermittently at temperatures above 80 ℃. Interfering ions, like mercury, must be 
absent from all sulfide sample. In aqueous solution, H2S is dissolved into HS
- and S2-. 
In acid solution, sulfide is chiefly in the form of H2S, while in the intermediate pH 
range (up to approximately pH 12) almost all the sulfide is in the form HS-. Only in 
very basic does the sulfide exist primarily as free ion (S2-). The SISE from Thermo 
Scientific supplies sulfide anti-oxidant buffer could maintain a fixed level of H2S. 
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Nevertheless, the alkaline condition of anti-oxidant buffer is regarded as an 
influencing factor to SISE measurements in plasma. Initially mixing samples to 
anti-oxidant buffer is reported to generate protein desulfuration and artificially 
increased sulfide values [80]. It is also observed that placing 5% bovine serum 
albumin into anti-oxidant buffer leads to a surging reading of total sulfide measured 
by SISE in first 20 minutes and following slow accumulation in 3 hours [81]. 
 
2.1.5.3 Other analyzing methods 
Carbon nanotube (CNT) was introduced by Wu et al. for measuring low 
concentration and nano-quantity H2S [82, 83]. One of the benefits of unfuctionalized 
CNT in analyzing H2S is due to the special bond with H2S but other proteins kept in 
serum. H2S concentrations are reflected by the intensity of the fluorescence of the 
unfuctionalized CNT, due to the two values in a linear relationship. The lowest H2S 
concentration can be tested is 20μM and smallest quantity of H2S is 0.5μg. The 
series of experiments are trying to establish a new sensor to measure micro or nano 
quantity H2S, comprising unfuctionalized CNT as a transducer and LSM 
fluorescence as a signal acquisition modality. 
 
Polarography is a voltammetric measurement which makes use of the dropping 
mercury electrode or the static mercury drop electrode. The value of diffusion 
current is depended on the speed of electroactive material (samples) diffusing to 
dropping mercury electrode. This principle contributes to the measurement of the 
concentration of analytes. Polarography is well known for the application of 
quantitative measurements of O2 (polarographic oxygen sensor, POS) and NO 
(polarographic nitric oxide sensor, PNOS). By recent years of the appreciation of the 
third gasotransmitter, H2S, several analytical methods are utilized, including 
polarography. A novel polarographic hydrogen sulfide sensor (PHSS) has been 
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developed for the study of H2S producing rates and consumption in mammalian 
tissues, with resolution of 10 nM [84]. The polarographic sulfide sensor is also 
applied to the investigation of kinetics of sulfide metabolism in organisms living in 
sulfide-rich environment [85]. PHSS permits direct and simultaneous measurement 
of H2S gas in biological fluids without sample preparation. PHSS has provided an 
alternative method for sulfide measurement. 
 
Gas chromatography is a recent method describes by Levitt et al. as a unique 
chemiluminescence-based technique to measure free and acid-labile H2S in multiple 
tissues from mouse [86]. The tissues were first submerged in 50mM glycine-NaOH 
buffer (pH 9.3) and homogenized. The homogenate were then transferred to 
syringes,which were sealed and flushed with N2. The homogenate in alkaline 
extraction turns to acidification to pH 5.8 by adding sodium hydrogen phosphate 
solution (pH 5.5). After vigorous mixture, the gas space was removed to gas 
chromatography to analyze free H2S concentration. Next, adding 50% trichloroacetic 
acid to the syringe, the gas was collected to test the acid-labile H2S concentration. 
The flow rate of N2 was 25 ml/min. The concentration of H2S was calculated by the 
plotting H2S standard curve. 
 
High-performance liquid chromatography (HPLC) is used to separate the sulfide 
mixture. Togawa et al. reported that using monobromobimane (MBB) with 
dithiothreitol (DTT) reacted with bound sulfide to produce sulfide dibimane, which 
is separated from MBB by HPLC and detected by its fluorescent probes [87]. 
Recently, MBB assay without DTT was used to measure available H2S in rat blood 
[88] and mouse plasma [89]. The rangs or limits of H2S measurements are in Fig. 
2-5. 
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Fig.2- 5 The ranges or limits of H2S measurements 
2.1.6 H2S in inflammation 
Inflammation is an immune response to an injury or harmful stimuli, in order to 
self-protect body from avoiding pathogens assaults and initiating healing process. 
However, the adaptive immune system fails to counter invading agents, will turn to 
target host tissues, making deeply more serious damage. H2S regulating 
inflammation and injury was initially contradictory, but in recent years more studies 
supported that H2S inhibited the process of inflammation, except at high 
concentration [90]. This mediator possibly exerts its anti-inflammatory effects 
through reduction of leukocyte-endothelial cell adhesion [91], action on 
ATP-sensitive K+ channels [92], scavenging of toxic free radicals [93], elevation of 
cyclic AMP and/ or cyclic GMP [78, 79], inhibition of nuclear factor- κ B (NF-κB) 
and pro-inflammatory cytokines (e.g., COX-2 [94], iNOS [13] and interleukin 
(IL)-1β, IL-6 [95]).  
 
Various diseases could be found inflammatory response, like atherosclerosis, 
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ischemia-reperfusion and colitis. Contributing to anti-inflammatory molecular 
mechanisms of this novel gasotransmitter, it is not surprising that H2S may 
participate in the process of resolution of a variety of inflammatory diseases. In 
atherosclerosis, H2S exerts its potent inhibitor of leukocyte adherence to vascular 
endothelium [15]. Meanwhile, the generation of reactive oxygen species (ROS), 
activation of NF-κB, increased expressions of cell adhesion cytokines and induction 
of apoptosis, which were all regarded as the key promoters of pathology, were all 
found suppressed by H2S [15, 96]. These mechanisms of action described for H2S 
may explain that H2S can diminish the plaques in arteries and attenuate the 
atherosclerotic injury, suggesting the character of anti-inflammation of H2S is benefit 
for the vascular protection. 
 
Ischemia-reperfusion (I/R) is identified as an acute endogenous inflammatory 
response that characterizes release of toxic free radicals, leucocyte-endothelial cell 
adhesion and platelet-leucocyte aggregation [97]. In porcine myocardial I/R model, 
therapeutic sulfide improved myocardial function and diminished infarct size though 
decreased levels of inflammatory cytokines (IL-6, IL-8 and TNF-α), reduced left 
ventricular pressure and improved coronary microvascular reactivity, [11]. A similar 
tissue protection of H2S also found in hepatic I/R injury by inhibition of 
inflammation (lipid peroxidation, IL-10, ICAM-1 and TNF-α) and apoptosis 
(caspase-3, Fas and Fas ligand) [98]. Another study suggested that the 
cardioprotective effects of H2S may be mediated by opening the mitochondrial KATP 
channel and second window of protection caused by endotoxin [99].  
 
Colitis is one form of gastrointestinal inflammation and ulceration. Administration of 
H2S-generating agents or precursor for H2S synthesis, L-cysteine, has been show to 
significantly accelerate ulcer healing [100, 101]. This ability of H2S to enhance 
gastrointestinal resistance attracts investigators to exploit novel treatments of 
gastrointestinal injury and inflammation, like H2S-releasing derivative of NSAIDs to 
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reduce the adverse drug reaction of NASIDs, retarding gastrointestinal ulcer healing 
[102]. Evidence of H2S in resolution of colitis in rats or mice studies showed that 
administration of H2S donor significantly inhibited the severity of colitis with 
marked reduction of granulocyte infiltration into colonic tissue. In inflamed colon, 
H2S production was highly increase via CSE, CBS or other enzymatic pathways 
[103, 104]. Once H2S synthesis was inhibited, the colitis tended to worsen the 
inflammation with thickening of the smooth muscle, perforation of bowel wall, even 
death [13]. 
 
2.1.7 H2S in redox status 
In a weak acid, H2S dissociates in equilibrium with hydrosulfide anion (HS
−) and 
sulfide anion (S2−). Under physiological conditions the amounts of H2S and HS
− are 
early equal within the cell, whereas extracellular fluid and plasma exist 
approximately the ratio of 20% H2S, 80% HS
− and 0% S2−. HS− is a potent 
one-electron reductant that eliminates free radicals by donating single electron. 
Hydrogen disulfide (H2S2), also known as disulfane, is the production of oxidation of 
HS− by two-electron oxidants, like hypochlorous acid [105] and hydrogen peroxide 
[106]. H2S2, a highly reactive oxidizing chemical, can generate H2S by reacting with 
thiol [107] or disproportionation [105, 108]. 
 
H2S is considered as an endogenous reducing agent which is produced in response to 
oxidative stress [109, 110]. Evidence showed that H2S is a highly reactive molecule 
and may easily react with other compounds, especially with reactive oxygen and 
nitrogen species. H2S reacts with at least four different ROS: superoxide radical 
anion [77], hydrogen peroxide [75], peroxynitrite [78] and hypochlorite [79]. All 
these compounds are highly reactive and their reactions with H2S result in the 
protection of proteins and lipids against RNS/RNS-mediated damage [78, 79]. 
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Mitochondrial injury is an important source of reactive oxygen species (ROS), which 
is involved in a range of pathologies, such as ischemia/reperfusion, atherosclerosis 
and toxin exposure [111]. Under oxidative stress conditions, mitochondria will show 
unstable mitochondrial membrane potential (ΔΨm), redox transitions, and negative 
changes in the mitochondrial permeability transition (MPT) pore and the inner 
membrane anion channel (IMAC) [112]. Our lab found that H2S can reduced the 
H2O2-induced injury in HUVECs via increasing ATP production, saving 
mitochondrial ultrastructure, stabilizing mitochondrial membrane intact, decreasing 
ROS and MDA, and rising anti-oxidants, The same situation was also unveiled in 
H2O2-stimulated isolated rabbits aorta that H2S ameliorated mitochondrial 
dysfunction through improving O2 consumption and ATP production, protecting 
mitochondrial respiration chain complexes activities and matrix enzymes, decreasing 
mitochondrial membrane permeability and inhibiting mitochondrial ROS levels. 
These effects of H2S indicated that the antioxidative ability of H2S is through 
increasing antioxidants and prohibiting ROS levels, and also preserving 
mitochondrial function to reduce the production of toxic free radicals. 
 
2.1.8 H2S in cardiovascular system 
2.1.8.1 Hypertension 
Before identified as the third gasotransmitter, together with NO and CO, H2S has 
been speculated to regulate an array of physiological processes in regulating 
cardiovascular functions, distinctive from its toxicological effect. A great number of 
studies have been carried on investigation of the modulating of blood pressure by 
exogenous and endogenous H2S. Early at the end of last century, it is first reported 
that H2S relaxes the contracted smooth muscles (SM) induced by 1 μM 
norepinephrinein in rat thoracic aorta and portal vein [113]. The relaxations in these 
tested aortas and veins present a NaHS dose dependent manner, but the potency of 
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relaxation by exogenous H2S in the thoracic aorta is less than the portal vein, even 
by 10-3 M NaHS, which are around 25% and 90%, respectively. The data also 
showed that the relaxation effects of H2S and NO can be enhanced by each other. 30 
μM NaHS can augment the loosening effect of NO by up to 13 fold. Thus, 
endogenous cysteine and glutathione do not have synergistic effect with NO. 
Subsequently, the vasorelaxant effect of H2S is found in vivo of SD rats, ex vivo of 
aortic rings and in vitro at rat aortic smooth muscle cells [34]. This is a literature that 
first demonstrated the underlying mechanism of vasorelaxation which is a 
consequence of opening KATP
+ channels. The endogenous production of H2S is 
generated by CSE which is identified in vascular SMCs, not in endothelium. 
Nonetheless, this paper does not mention the third enzymatic pathway of 
synthesizing H2S by the enzymes MPST and AAT. Therefore, it does not mean 
endothelium cannot produce H2S. Additionally, this paper also refers to the 
association of and NO on elevated H2S production from vascular tissues. Above 
experiments are implemented on normal animals, while more functions of H2S are 
indicated in spontaneous hypertensive rats (SHRs) and CSE gene knockout mice 
(SMCs-KO) [28] [76, 114, 115].  
 
Different from NO and CO, the relaxed effect of vascular tissues by H2S is not 
through the activation of cGMP pathway. 1H-[1,2,4] oxadiazolo 
[4,3,-a]quinoxalin-1-one (ODQ), a specific inhibitor of soluble guanylyl cyclase, 
could abolish the vasorelaxation induced by NO, but not by H2S [116, 117]. One 
possible mechanism involved in the hypotensive effect of H2S is KATP
+ channels is 
opened by H2S that increasing K
+ currents result in hyperpolarizing membrane of 
smooth muscle cells in vascular tissue. The vasodilation effect of H2S is inhibited 
significantly by either using a calcium-free bath solution or with the normal bath 
solution but in the presence of nifedipine, a voltage-gated Ca2+ channel inhibitor, on 
aortic rings [28]. This indicates that the vascular effects of H2S are also likely 
mediated by the attenuation of intracellular inward Ca2+ currents. H2S not only 
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influences blood pressure, but also exerts cardioprotective effect by relieving 
vascular structural remodeling observed during hypertension, including and 
suppression of VSMC proliferation via the activation of cardiac 
extracellular-signal-regulated kinase (ERK) and/ or Akt pathway [118] and 
attenuation of collagen accumulation through reduction of collagen type I level, [3H] 
thymidine and [3H] proline incorporation and [3H] hydroxyproline secretion in the 
SHRs [114] and through  mitrogen-activated  protein  kinase  (MAPK) pathway 
[16]. In CSE-KO mice, other mechanisms were found that due to the feature of CSE 
activated by calcium-calmodulin, the H2S formation may be involved in vascular 
activation to reduce blood pressure [115]. 
 
2.1.8.2 Atherosclerosis 
Atherosclerosis is a chronic and slowly progressive cardiovascular disease that 
affects arterial blood vessels by thickening and hardening as consequences of the 
high plasma cholesterol concentrations, especially cholesterol in low density 
lipoprotein [119]. Cholesterol deposition, lipid oxidization, cell adhesion, vascular 
inflammation, foam cell accumulation, smooth muscle cell migration and plaque 
calcification are involved in different stages of the pathological process [120]. The 
cumulative plaques consequentially narrow the arterial lumen and restrict blood 
supply. Severe atherosclerotic lesions are the high risk factors of ischemic diseases 
such as stroke and heart attack [121]. 
 
Recent years, H2S draws attentions from researchers by its cardiovascular protective 
effects, while there are not many studies on its effects on the progress of 
atherosclerosis. Fortunately, increasing evidence has indicated that H2S plays a 
potentially significant role in number of biological processes and potential 
cardiovascular protections, which suggest that H2S may contribute to the inhibition 
of pathogenesis of atherosclerosis. First, H2S shows inhibitory effects on the 
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development of atherogenesis, such as oxidative stress, modificated oxidation of 
LDL, cell adhesion and calcification. In vascular smooth muscle cells (SMCs), low 
levels of NaHS (30 or 50 μM), a donor of H2S, decrease toxic reactive oxygen 
species, including H2O2
-, ONOO-, and O2
- [122]. At the same time, NaHS also 
enhances the functions of antioxidative enzymes. In addition, H2S inhibits 
atherogenic modification of LDL (such as oxidized LDL, shorted as oxLDL) induced 
HOCl in vitro. As a potent atherogenic agent, oxLDL particle is a important product 
of atherogenic oxidation, that stimulate endothelial cells to express various adhesion 
molecules for consequent inflammatory reactions and formation of foam cells. 
Therefore, inhibition of oxLDL by potential treatments of H2S implies that H2S may 
interfere atherosclerotic progress [123]. Furthermore, H2S attenuates atherosclerotic 
lesions by reducing cell adhesion molecules, such as ICAM-1, involving the NF-κB 
pathway in vivo and in vitro [15]. Adhesion molecules are the significant causes to 
promote bindings between monocytes and T-lymphocytes to endothelial cells, which 
will lead to sequential inflammation and advanced process. Reduced expressions of 
adhesion molecules prohibit monocytes migration and later inflammation, which 
may also benefit in ameliorate atherosclerotic lesions. Lastly, calcification, presented 
in the advanced process of atherosclerosis, is a potent factor of plaque stability. 
There was a study found that the link between H2S with plaque calcification [124]. 
In calcified arteries, H2S level, CSE activity and CSE mRNA were down-regulated, 
while after administration of H2S a dose response was shown in decreasing vascular 
calcium content, Ca2+ accumulation, ALP activity, and aortic OPN mRNA. These 
changes speculated the effect on atherogenesis of H2S might be induced by 
suppressing vessel calcification.  
 
Second, H2S possesses vascular protective capacities from inhibition of proliferation 
of vascular cells, such as intima and SMCs, and angiosteosis. It has been 
demonstrated that H2S suppresses neointima hyperplasia on rat carotid after balloon 
injury [125]. In another balloon-injured arteries experiment, NaHS (30 μmol/kg 
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bodyweight) enhances methacholine induced vasorelaxation and significantly 
ameliorates neointimal lesion formation. Additionally, evidences are also pointing to 
the fact that H2S relieves apoptosis and proliferation of SMCs [126]. SMCs migrate 
from the medial layer into the sub-endothelial space where they may proliferate, 
ingest modified lipoproteins, secrete extracellular matrix proteins and contribute to 
lesion development. The suppression of proliferation of SMCs by H2S can restrict 
atherosclerotic damages. Moreover, H2S prevents the process of angiosteosis [16, 
127, 128]. Angiosteosis, ossification or calcification of a vessel, is an advanced 
change in the pathology of atherosclerosis. Its development leads to the narrowing of 
the caliber of an artery, stimulates thrombosis, or even worse, generates the 
abruption of unstable plaques. Vascular calcifications induced by vitamin D3 and 
nicotine in rats are ameliorated by exogenous H2S. The responses after 
administration of H2S show the decreased calcium concentration in vessels, reduced 
expressions of angiosteosis accompanied acidic phosphatese and osteopontin.  
 
Third, H2S alleviates the vascular damage induced by an established risk factor, for 
instance homocysteine. Homocysteine is an amino acid, biosynthesized from 
methionine and converted into cysteine and sulfur. Augmented levels of 
homocysteine in plasma, termed hyperhomocysteinemia, are considered as a high 
risk factor of atherogenesis. Early plaque development in apolipoprotein E deficient 
mice, a knock out genetic model of atherosclerosis by 8 weeks high cholesterol diet 
intake, could be enhanced by dietary supplementation with methionine or 
homocysteine [129]. A research shows that low concentrations of NaHS (30 or 50 
μM), a H2S donor, potentiates cell viability of rat aortic SMCs by abating 
cytotoxicity and reactive oxygen species stimulated by hyperhomocysteinemia [130].  
 
Although atherosclerosis is chronic, systemic disease with multi-factor involved in 
its initiation and progression, previous studies have shown that the specific 
characteristics and functions of H2S may contribute to the inhibition of atherogenesis. 
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The multiaspect recognitions of cardiovascular protective effects of H2S provide a 
new avenue of antagonism towards the complicated cardiovascular disease. 
 
2.1.8.3 Myocardial injury 
Plenty of work have documented that the CSE/H2S pathway participates in the 
regulation of cardioprotective effects [122]. Administration of exogenous H2S 
reduces “infarct-like” myocardial necrosis induced by isoproterenol in the rat [75, 
131, 132]. This protection is accompanied with the reduced concentrations of H2S in 
myocardium and plasma, decreased CSE protein activity and up-regulated CSE gene 
expression in myocardium [75]. NaHS attenuates the myocardial ischemic injury by 
evidences of reduced mortality and shrinked infarct size in vivo of rat and recovered 
SMCs viability induced by hypoxia [75]. Further study discovers that 14μmol/kg/d 
NaHS improves ECG and blood pressure, diminishes infarct size, as well as the 
greater survivin expression [132]. 
 
Oxidative stress injury is an important mechanism of myocardial injury. Direct or 
indirect antioxidative effects will lead to cardioprotection from myocardial ischemia. 
The data in above literature reveal that NaHS may antagonize MDA production in 
vitro of myocytes by oxygen-free radicals or directly react with hydrogen peroxide 
and superoxide anions [133]. Another experiment also proves that H2S provided 
profound protection against ischemic injury by significant decreases in infarct size, 
circulating troponin I levels, and oxidative stress [75]. The protections by Na2S in 
early and late preconditioning are all though stimulating the increased antioxidants, 
which could be itemized to the elevated Nrf2 in early stage and increased 
expressions of heme oxygenase-1 and thioredoxin 1 in late preconditioning. The 
antioxidant effect of H2S is also embodied in the preservation of mitochondrial 
functions and ultrastructure by Na2S after myocardial ischemia-reperfusion (MI-R) 
injury [134]. These observations have been recently confirmed by cysteine analogues, 
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SAC, SPC and SPRC [135, 136]. The activities of superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx), as well as glutathione redox status are 
preserved by cysteine analogues. The mitochondrial ultrastructure of cysteine 
analogues treatments appeared more normal than MI vehicle group. These evidences 
demonstrate the CSE/H2S pathway is involved in reducing the deleterious effects of 
oxidative stress. 
 
Furthermore, recent discoveries indicate the observed protection of H2S is related to 
regulate leukocyte adhesion and leukocyte-mediated inflammation, increase 
anti-inflammatory cytokines and reduce several pro-inflammatory cytokines [136]. 
The anti-inflammatory effect of H2S is reflected in amplification of heat shock 
protein (HSP) 70, HSP 90 and cyclooxygenase-2 [11], and reduction of MPO 
activity [134], nuclear factor- κ B (NF-κB), interleukin (IL)-6, IL-8, and tumor 
necrosis factor-alpha (TNF-α) [134]. The cardioprotection of H2S is associated with 
inhibition of cardiomyocyte apoptosis after myocardial injury. H2S amplifies 
anti-apoptosis proteins (Bcl-2, Bcl-xL) and inactivates pro-apoptogen (Bad) [11]. It 
is also suggested that H2S ameliorates cardiomyocyte apoptosis after MI-R injury in 
vitro and in vivo, significant abatement of caspase-3 activity and declining of the 
number of TUNEL positive nuclei, respectively [134].  
 
Finally, multiple studies have elucidated that a protective effect of KATP channel 
activators in myocardial MI-R injury [135]. By virtue of the relaxant effect of H2S as 
an opener of KATP channels, it is easy to hypothesize that H2S protects myocardial 
cells against ischemic injury. In the isolated Langendorff-perfused rat hearts, 
administrations of NaHS result in a dose-dependent limitation of infarct size induced 
by left coronary artery ligation and reperfusion, while this protective effect is 
abolished by KATP channel blockers [137]. There is a report that H2S preconditioning 
presents cardioprotective effects against ischemia though signaling pathways of 
KATP/PKC/ERK1/2 and PI3K/Akt [12]. 
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2.2 Pathophysiology of atherosclerosis 
2.2.1 The structure of vessel wall and functions 
There are three layers in healthy arteries and veins: 
1. Tunica intima, a single layer of squamous endothelial cells sticked with their 
matrix and connective tissue; 
2. Tunica media, the thickest layer in arteries, which is rich in vascular smooth 
muscle cells (SMCs), elastic fiber and polysaccharide substances and controls 
vascular tone; 
3. Tunica adventitia, the thickest layer in veins, which constitutes by connective 
tissue and nerves [1]. 
Endothelial cells comprise the lumen of blood vessels. Importantly, the vascular 
endothelium maintains vascular tone, balances the vasodilation and vasoconstriction, 
and regulates growth, thrombosis, inflammation and oxidation [138]. Endothelium is a 
bridge of blood flow and vascular wall that can inhibit platelets activation and 
aggregation, suppress monocyte adhesion and migration, and regulate vascular 
smooth muscle contraction and proliferation [1]. Endothelium is also a biggest 
endocrine organ in human body that nitric oxide (NO), prostacyclin and 
endothelium-derived hyperpolarizing factor (EDHF) are released as vasodilators, and 
vasoconstrictors endothelin-1, angiotensin II (AngII) and thromboxane A2 as 
vasoconstrictors [139]. SMCs relax or contract to control the volume of blood flow 
and blood pressure. Three type receptors, α1, α2, β2, are the adrenoceptors in 
sympathetic nervous system to innervate vascular smooth muscle. Activation of α1 
receptors leads to vasoconstriction, while agonists of α2 and β2 receptors cause 
vasodilation and hypotension in clinic practice [140]. The main cells involved in the 
progression of atherosclerosis are endothelial cells and SMCs in vessel, and platelets 
and monocytes from blood.  
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2.2.2 Modification of oxidized lipoproteins 
Atherosclerotic plaques consist of subendothelial foam cells which are identified as 
macrophages derived from monocytes circulating in the blood and scavenged lipid 
supplied by blood lipoproteins and modified by free radicals [141]. The oxidative 
modification of lipoprotein, especially low density lipoprotein (LDL) is a principal 
inducer for the progression of atherosclerosis [142]. Oxidized LDL has been 
demonstrated its proatherogenic potentials that stimulate the cell adhesion between 
endothelial cells and monocytes, stimulate endothelial cells to generate inflammatory 
cytokines, chemokines and adhesion molecules, and induce monocyte/macrophages to 
attach scavenger receptors and matrix metalloproteinase, eventually leading to the 
formation of foam cells, the hallmark of arterial fatty steak [143, 144]. 
 
Oxidized modification of LDL is assumed to change in two major stages [4, 145-147]. 
In the first stage of LDL oxidation, the LDL lipids are oxidized in the absence or little 
changes in apoliproprotein B 100, which called minimally oxidized LDL[145]. Such 
modified LDL still retains its affinity to the LDL receptors, has a little negative charge, 
but activates anti-apoptotic signaling, and stimulates more inflammatory chemokines 
and cytokines expressions[148, 149]. The changes to induction of inflammatory 
molecules may lead to large more variety of enhanced cytokines and process the 
oxidized modification of LDL. During second stage of LDL oxidation, the LDL lipids 
are further oxidized, including the modification of LDL lipoprotein[145, 147]. The 
advanced oxidized LDL gradually loses the recognition of LDL receptor and shifts to 
the attachment of scavenger receptors, also called oxidized LDL receptors. This 
change results in the accumulation of foam cells lesion development. The LDL 
diversity degrees of oxidation provide different biological effects to arterial walls. 
Mildly oxidized LDL could induced endothelial cell expressing tissue factors, while 
highly oxidized LDL is cytotoxic and pro-apoptotic, and stimulates the proliferation 
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of smooth muscle cells[149].  
 
The mechanisms of oxidized modification of LDL may be through the transition metal 
ions and oxidation by free radicals[147]. Without tissue or cells circumstances, high 
concentrations of free metal ions can oxidize LDL, which reactions were established 
and used for monitoring the extent of oxidized modification of human LDL[150]. In 
vitro, most of cells exist in the arterial intima can induce oxidized modification of 
LDL thorough the catalysis by lipoxygenase, myeloperoxidase and/ or metal ions, like 
microconcentration of iron or copper[147]. The oxidized modification of LDL 
mediated by macrophage forms enhanced cholesteryl ester-core aldehydes of 
LDL[151]. This type of cell-mediated oxidation of LDL can be blocked by metal 
chelators[4]. There is also found that the metal ions are increased in the advanced 
human atherosclerotic lesions[152]. The study using electron paramagnetic resonance 
(EPR) spectroscopy and inductively coupled plasma mass spectrometry (ICPMS) 
showed a relationship between elevated iron levels and cholesterol accumulation in 
the human carotid samples[152]. Others studies indicated that thiols may play a vital 
role in oxidation of LDL[153, 154]. Incubated with iron at acidic environment, LDL is 
oxidized to hydroperoxides and aldehydes and enhanced by increased levels of 
cysteine through transferring Fe3+ to Fe2+ and α-tocopherol radicals of oxidized LDL 
to α-tocopherol[155]. 
 
2.2.3 Monocyte-endothelial adhesion 
Early phase of atherosclerosis involves the interaction of monocytes with the vascular 
endothelium [156]. Some cell-surface proteins control these interactions, including 
integrins, selectins, and members of the immunoglobulin gene superfamily [157]. 
First, the accumulated ox-LDL particles activate endothelial cells to express adhesive 
molecules for recruiting blood cells [158]. After recruitment and contact, the next step 
is tethering and rolling of blood cells to the surfaces of activated endothelial 
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monlayers, which is mediated by selectins family. Then, the further attachment is 
firmed by the interaction of integrins with immunoglobulin superfamily, especially 
intercellular adhesion molecule-1 (ICAM-1) and VCAM-1 [159]. Furthermore, 
intergrins and platelet endothelial cellular adhesion molecule 1 (PECAM-1) help 
leucocytes transformation and transmigration to subendothelial layers for advanced 
inflammatory reactions [160]. 
 
2.2.3.1 Selectins 
Selectins include three members and named according to their main expression site: 
L-selectin in leukocytes, E-selectin specifically in endothelial cells, and P-selectin 
mainly in platelets but also in endothelial cells [161]. The three molecules have their 
own specific pattern of expression. L-selectin is present on some T cells, B cells and 
NK cells depending on the activated state. E-selectin cannot be tested in resting 
endothelial cells but is transcriptionally induced by inflammatory cytokines. 
P-selectin is just stored in resting cells of Weibel-Palade bodies of endothelial cells 
and α-granules of platelets and moves to cell surfaces after activation [161, 162]. 
After inflammatory stimuli, selectin family molecules are internalized, lysosomal 
targeted or shed/proteolytic cleaved to their activated states and rapidly recruited to 
the cell surface [162, 163]. Selectins and their ligands (mainly P-selectin glycoprotein 
ligand, PSGL-1) participate in the early stage of leukocyte recruitment: rolling and 
tethering of leukocytes on the vascular wall [159, 164]. Besides that, selectins are also 
involved in the recruitment of bonds between platelets and leukocytes, or between 
platelets, or between leukocytes [162]. P-selectin/PSGL-1 binding not only creates 
weak bonds between activated endothelium and leukocytes, also activates more 
leukocytes, mobilizes integrins, stimulates advanced inflammatory reactions and 
thrombosis [165]. Leukocytes traffic and homing is controlled by L-selectin [166, 
167].  
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2.2.3.2 Integrins 
Integrins belong to the group of heterodimeric transmembrane glycoproteins consisted 
by an α chain and a β chain with a non-covalent bond [168, 169]. Integrins are usually 
non-adhesive and present low affinity for ligands in resting cells, while develop 
higher affinity to ligands when activation by modifing their conformation [170, 171]. 
Integrins are expressed in various cells with different functions. In white blood cells 
can be found the class of β-2 integrins, which activated conformation interact with 
ICAM subfamily and lead to leucocytes transformation and migration at the surfaces 
of endothelial cells with firm arrests [170, 172, 173]. Integrins α4/β1 distributed in 
endothelial cells and binded with VCAM-1 can also firm adhesion in arresting step 
[170, 172]. The large class of β1 integrins is expressed in SMCs and help SMCs 
attaching to extracellular matrix[174, 175]. The β3 family integrins are distributed in 
platelets that control the fibrin formation, cell survival, migration and proliferation 
[174, 176, 177]. Until now, there is no soluble form of either integrin been found [169, 
178].  
 
2.2.3.3 Immunoglobulin family 
The adhesion molecules in immunoglobulin (Ig) superfamily are transmembrane 
glycoprotein receptors containing various extracellular Ig domains and participate in 
the antigen recognition. VCAM-1 is upregulated by TNF-α and IL-1, expressed on 
early dysfunctional endothelial surfaces [179, 180]. The attachment assisted by 
VCAM-1 is exclusively to monocytes and lymphocytes [181]. The ligands of 
VCAM-1 include integrins α4/β1 and α4/β7 in monocytes and lymphocytes to firm 
the adhesion. ICAM-1 is activated and expressed in endothelial cells by IFN-γ, TNF-α, 
IL-1β, and bacterial endotoxin [182]. The ligands of ICAM-1 is comprised of 
integrins αL/β2 and αM/β2 located on the surfaces of leukocytes, monocytes and 
lymphocytes [183]. Owing to interactions between leukocytes and endothelial cells 
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reflecting the inflammatory-immune response, the upregulation of ICAM-1 is also a 
characteristic feature of atherosclerosis [184]. Lastly, PECAM-1 is adhesive molecule 
in the Ig family distributed on platelets, leukocytes and endothelial cells [185]. 
PECAM-1 is particularly located at the junctions between endothelial cells where 
influence the homophilic bindings among adjacent endothelial cells [186]. Therefore, 
PECAM-1 is involved in endothelial integrity, leukocyte extravasation which helps 
leukocyte transmigration to media layer [160]. 
 
2.2.4 Endothelial dysfunction in atherosclerosis 
Endothelial dysfunction is a systemic disorder and an important viable in the 
pathogenesis of atherosclerosis and its complications. Enhanced NO inactivation is a 
hallmark of endothelial dysfunction in vascular disease [139]. Several studies have 
investigated that impairment of endothelium-dependent vasodilation is found in 
coronary, renal vasculature in patients with cardiovascular disease [187, 188]. In 
addition to the increase of endothelium-derived contracting factors, endothelial 
dysfunction also includes a distinct state of endothelial activation, which is 
represented by a pro-coagulatory, proliferative, and pro-inflammatory milieu that can 
be found at all stages of atherogenesis [189].  
 
ROS is generated at sites where the cell layers has been damaged or under metabolic 
stress. Endothelial dysfunction is also strong relationship with production of ROS, 
including superoxide anion (O2
–
), hydrogen peroxide (H2O2), hydroxyl radical (OH), 
hypochlorous acid (HOCl), NO, and peroxynitrite (ONOO–) [138]. The decreased 
bioavailability of NO, a feature of endothelial dysfunction, can be induced by the 
reaction with the increased generated ROS that form ONOO– which binds to 
guanylate cyclase, leads to lipid peroxidation, protein oxidation, and DNA 
fragmentation [1]. The vicious interaction between oxidative stress and endothelia 
dysfunction promotes the development of atherosclerosis. 
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Endothelial dysfunction can be treated as the “ultimate risk of the risk factors” 
presenting a specific atherogenic vascular milieu [190]. Many risk factors, including 
hyperlipidemia, hypertension, diabetes and smoking, are associated to atherosclerosis, 
complications and cardiovascular events. These risk factors found to be related to 
endothelial dysfunction may be due to the overproduction of ROS and oxidative stress 
[191]. In turn, the increased oxidative stress will lead to the reduction of vascular NO 
bioavailability. Therefore, the ROS generation may serve as a major mechanism 
involved in atherogenesis and enhance the risk of endothelial dysfunction on the 
progression of atherosclerosis. Moreover, some studies also found that the variable 
endothelial susceptibility of individual patients to different cardiovascular risk factors, 
prevented or promoted the endothelial dysfunction[192-194], indicating the genetic 
predisposition is a factor that may vary the impact of risk factor observed in 
cardiovascular and metabolic diseases on endothelial dysfunction.  
 
2.2.5 Pathogenesis of atherosclerosis 
Atherosclerosis is no longer considered as a disorder rather than an inflammatory 
insult due to its bridge role of linking hyperlipidemia with atherosclerosis[195]. 
Amounting evidences suggest that high plasma cholesterol levels result in 
atherosclerotic lesion formation [196]. The other risk factors, like diabetes, 
hypertension, male gender and smoking, appear to accelerate a disease driven by 
atherogenic lipoproteins, the first of which being LDL [5]. Inflammation in 
atherogenesis is likely initiated when endothelial cell over-expresses various adhesion 
molecules in response to turbulent flow in the setting of an unfavorable serum lipid 
profile, which leads to the attachment of leucocytes to endothelial cells [195]. It has 
been demonstrated vascular cell adhesion molecules-1(VCAM-1), an early and 
necessary step in the pathogenesis of atherosclerosis, induces the binding of 
monocytes and T-lymphocytes to endothelium [161]. Subsequently, leukocytes 
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express monocyte chemoattractant protein-1 (MCP-1) to recruit more leukocytes and 
magnify the inflammatory cascade [197]. After the attachment to endothelial cells, 
monocytes migrate to subendothelial layer and differentiate to macrophages. 
Macrophages produce scavenger receptors which bind ox-LDL, with no any feedback 
by intracellular cholesterol levels [120]. Continued scavenging lipid droplets, 
macrophages are full of cholesterol esters in their cytoplasm and gradually change to 
foam cells, which accumulate to fatty steaks. Fatty steak is the earliest observable 
pathological change in the arterial walls [14]. Subsequently, foam cells release 
inflammatory cytokines and ROS, which promote the inflammatory process [198]. In 
response to cytokines and growth factors, atherosclerotic plaques may accumulate 
vascular smooth muscle cells (VSMCs) migration and proliferation, which contribute 
to the narrowing of blood lumen. VSMCs also secrete extracellular matrix proteins, 
such as collagen and elastin, which may progress to the formation of fibrous cap [199]. 
At the advanced stage, the death of macrophages leads to the necrotic lipid core and 
finally the plaque ruptures, which yield blood components contact with plaque lipids 
and tissue factors, generating the thrombus and related clinical complications [200, 
201].  
 
2.2.6 Mitochondria and vascular disease 
2.2.6.1 Endothelial mitochondria 
Mitochondria are estimated to account for 5% of endothelial cell volume[202]. 
Mitochondrion is not only an organelle generating ATP, also plays a vital role in 
regulating the homeostatic triangle of ROS, NO, and Ca2+ [202]. Whether 
mitochondrion is the major source of ATP production is a debating issue. Recently, 
some observations showed that the data of mitochondria respiratory flux in primary 
endothelial cells of bovine aortas suggested mitochondria respiration was greatly 
coupled to ATP production[203]. There were evidences showed that under oxidative 
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stress, the reliance of endothelial cells upon oxidative phosphorylation increased, 
indicating the mitochondrial reserve capacity was involved in the protective effect to 
endothelial cells response to oxidative stimulation[203, 204]. Therefore, the more 
important role of endothelial mitochondria is the generation of ROS and NO, and 
regulation of intracellular Ca2+ signaling. 
 
 
Fig. 2-6 Oxidative phosphorylation, superoxide production and scavenging 
pathways in mitochondria [205].  
 
Mitochondria ETC located at mitochondria inner membrane, consists of complex I, 
II, III, IV and V, seen Fig 2-6 [205]. Electrons (e-) from nicotine adenine 
dinucleotide (NADH) and FADH2 pass thorough complex I and II, respectively, then 
via ubiquinol (coenzyme Q) transfer to complex III. Through cytochrome c, 
electrons are transferred from complex III to IV, reducing O2 to H2O. In the 
meantime, the protons (H+) are pumped from the mitochondrial matrix to 
intermembrane space by complex I, III and IV and reenter to the mitochondrial 
matrix through complex V by proton-motive force (Δp) to produce ATP [205]. 
Among these protein complexes, complex I leaks electrons to produce to matrix and 
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complex III produces both matrix and intermembrane space [205]. Superoxide is 
dismutaed to hydrogen peroxide (H2O2) by Mn-SOD (SOD-2) in the mitochondrial 
matrix and Cu,Zn-SOD (SOD-1) in the mitochondrial intermembrane space. 
Hydrogen peroxide (H2O2) is degraded to H2O through glutathione peroxidase (GPx) 
by using glutathione (GSH) as the hydrogen donor [206]. 
 
2.2.6.2 Mitochondria and ROS 
Mitochondria are the major source of ROS within most mammalian cells, generating 
superoxide then dismutated to hydrogen peroxide [111, 207]. In tranquil status, 
mitochondria produce ROS as the natural byproduct of the normal metabolism of 
oxygen; while in the cardiovascular diseases, ROS increase dramatically and 
overwhelm antioxidant defenses, resulting in damage to cell structures, known as 
oxidative stress [208].  
 
There are several potential sites of ROS generation in mitochondria. The majority of 
superoxide produced from mitochondria is on the complexes of the 
electron-transport chain (ETC) [209]. Others sources of ROS comprise Krebs cycle 
enzymes participating in redox reactions, like monoamine oxidase A and B [210, 
211], a-ketoglutarate dehydrogenase[212], tricarboxylic acid cycle enzymes 
aconitase [213], cytochrome b5 reductase and glycerol-3-phosphate dehydrogenase 
from the glycerol phosphate shuttle [214]. The production of ROS by these proteins 
relies on the proteins to be abundantly charged with electrons [215]. Therefore, when 
available electrons are relatively small, the ROS generation is reduced. 
 
From the way of transferring electrons on ETC, the major sites of mitochondrial 
ROS are complexes I and III. In physiologic conditions prone to ATP generation, 
complexes I accept electrons donated from NADH, then through iron-sulfur centers, 
pass electrons to ubiquinone-biding sites[216]. Through ubiquinol and cytochrome c, 
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complex I pass electrons to complex III, which release O2
.- to mitochondrial matrix 
and intermembranous space[217]. Under oxidative stress, the high ratios of 
NADH/NAD+, low electron flow, low oxygen consumption, and low ATP production 
need, electrons can be transferred from the fully reduced flavin mononucleotide 
(FMN) sites on complexes I and Q cycle in complex III to oxygen to yield 
superoxide[212]. ROS generation could also be enhanced together with the release 
of cytochrome c during apoptosis as absence of cytochrome c results in the block of 
electron flow to complex III and a rise in reverse flow of electron to complex I with 
a subsequent rise in ROS generation at this site[218]. 
 
ROS, the natural byproduct in the metabolism, can also damage to cellular 
macromolecules, such as nucleic acids, phospholipids and proteins[213]. Oxidative 
stress inflicts to DNA leading to the modification of the bases (purine and 
pyrimidine), the backbone (deoxyribose), and single and double strand-breaks[219]. 
These modifications of DNA structures are mutagenic and have close relationship 
with cancer, aging and neurodegenerative disease[220]. Polyunsaturated fatty acid 
(PUFA) located in phospholipids is highly sensitive to ROS. One potent inducers of 
lipid peroxidation is hydroxyl radical generated by the Fenton reaction[221]. 
Another powerful catalyst of lipid peroxidation is Fe2+, which has been demonstrated 
to increase the mitochondrial PUFA oxidation and the lysosomal fragility[222]. 
Proteins assaulted by ROS have been demonstrated several types of damage, such as 
protein-protein cross-linking, oxidation of sulfhydryl groups, reaction with 
aldehydes, alteration of tertiary structure of proteins and protein fragmentation[223]. 
The outcome of protein oxidation is the loss of proteins normal functions, like 
channel forming properties, enzymatic activities, etc. and the increasing of the 
tendency to proteolytic degradation[224]. 
 
In addition to being the primary source of intracellular ROS in aerobic cells, 
mitochondria are also the targets of oxidative stress. Mitochondrial DNA (mtDNA) 
 Chapter 2 
52 
 
is a target of oxygen radicals, because mtDNA is more sensitive to free radicals than 
nuclear DNA due to the close proximity to ETC where ROS is generated. 
Additionally, mtDNA is deficiency in protective histone and has limited base 
excision repair mechanisms[225]. A mechanism of superoxide toxicity leading to 
oxidative stress is oxidation and inactivation of iron-sulfur (Fe-S) proteins, like 
aconitases, and association of leaking iron[226-228]. The consequences are the 
simultaneous release of Fe2+ and H2O2 and generation of potent hydroxyl radicals, 
which amply the oxidative damage[229]. Other deleterious effects of ROS 
generation in mitochondria are suppression of mitochondrial metabolism [207] and 
opening of Ca2+-dependent mitochondrial permeability transition (MPT) [230, 231]. 
These effects will change mitochondrial functions and lead to apoptosis which 
contribute to vascular diseases. 
 
2.2.6.3 Mitochondria and apoptosis 
Apoptosis is a form of cell death that is an evolutionarily conserved and genetically 
regulated procedure which plays a crucial role in morphogenesis, embryonic 
development, and for the maintaining homeostasis in mature cells[232]. Apoptosis is 
characterized by plasma membrane blebbing, cell shrinkage, condensation of 
chromatin, nuclear fragmentation, and chromosomal DNA fragmentation [233]. 
 
All mammalian cells posses contain two major apoptotic signaling pathways, known 
as intrinsic pathway and extrinsic pathway. The extrinsic pathway initiates apoptosis 
through the gathering of plasma membrane death receptors, tumor necrosis factor 
receptor (TNFR) family, which transmit the apoptotic signaling through binding with 
their death ligands. Fas/FasL, the TNFR/ligand binding, is reported to involve in 
apoptosis of endothelial cells and smooth muscle cells [234-236].  
 
Another important apoptotic protein is caspase family, a group of proteases with low 
                                                                                                         
Chapter 2 
53 
 
intrinsic activity and activation by proteolytic maturation or interaction with an 
allosteric activator [237]. Fas-associated death domain protein (FADD), Fas, FasL 
and procaspase-8 or -10 combine to a death-inducing signaling complex (DISC), 
which switch off the positions of death effector domain (DED) with initiator caspase 
(procaspase-8) [238]. Therefore, the initiator caspases activate caspase-3 that 
generates the execution of apoptotic program by cleavage of downstream signaling 
[239]. Moreover, caspase-8 first cleaves Bid, a protein leading to apoptosis in Bcl-2 
family[240], which, results in translocation, oligomerization and insertion of other 
apoptotic Bcl-2 proteins, like Bax or Bak, into the mitochondrial outer membrane 
(OMM) [241]. The permeabilization of OMM leads to the release of cytochrome c, 
which forms a cytosolic apoptosome complex that activate caspase-9, then in turn 
cleaves and activates caspase-3 and downstream caspase cascade[242].  
 
 
Fig.2- 7 Role of the mitochondria in apoptosis and necrosis [243]. 
 
The intrinsic pathway includes mitochondria swelling, causing the mitochondrial 
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outer membrane rupture and various pro-apoptotic proteins from the mitochondrial 
intermembrane space to the cytoplasm, including cytochrome c, apoptosis inducing 
factor (AIF), Smac/Diablo, HtrA/Omi, and DNaseG [244], seen in Fig. 2-7. This 
pathway can be regulated by Bcl-2 family proteins to control cytochrome c release, 
Smac to activate mitochondrial apoptosis [245], inhibitor of apoptosis proteins (IAPs) 
to prevent caspase [246] and HtrA/Omi to suppress IAPs[247, 248]. Meanwhile, the 
swollen or ruptured mitochondria can generate and release high toxic ROS, which 
promotes the progress of apoptosis and cell death. These factors are all important for 
the mitochondrial regulation of apoptosis. 
 
An important protein family governing mitochondrial outer membrane 
permeabilization in apoptotic program is the Bcl-2 family, including pro- and 
anti-apoptotic proteins[249]. The group of anti-apoptotic proteins contains Bcl-2 and 
Bcl-XL, which inhibit permeabilization of OMM and release of pro-apoptotic 
proteins from the mitochondrial intermembrane space[250]. The other group of 
pro-apoptotic proteins includes Bax, Bak, BAD and Bok, which are activated by 
their oligomerization and insertion into OMM, leading to release of pro-apoptotic 
proteins from mitochondria, then cell death [251].  
 
In the intrinsic pathway, the generated ROS in mitochondrial ETC can be withstood 
by mitochondrial antioxidant defense systems. Within the mitochondrial matrix, O2
.− 
is converted to H2O2 by Mn-SOD (SOD-2). In the mitochondrial intermembrane 
space, O2
.− is catalyzed by Cu,Zn-SOD (SOD-1). Then, H2O2 can be readily 
metabolized to H2O by GPx-1 and peroxiredoxin (Prx III) which oxidize reduced 
GSH to oxidized glutathione (GSSG). GSSG can be converted back to GSH by 
glutathione reductase [206]. The formation, effects and inactivation of ROS in 
mitochondria are shown in Fig. 2-8. In addition to GSH, multiple GSH-linked 
antioxidant enzymes are involved in mitochondrial antioxidant defense, like GPx-1, 
GPx-4 and glutaredoxin (Grx) [252], seen in Fig. 2-8. Small fractions of GPx-1 
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present at mitochondrial matrix to show its biological effect. GPx-4 catalyzes lipid 
hydroperoxides and is considered as the primary enzymatic defense mechanism 
against oxidative stress to cellular membranes. Glutaredoxins catalyze 
glutathione-dependent dithiol reaction mechanisms [253], supply intramolecular 
disulfide bond to two cysteines[254], and carry electrons in the 
glutathione-dependent synthesis of deoxyribonucleotides [255].  
 
 
Fig.2- 8 Formation, effects and inactivation of ROS in mitochondria [206]. 
 
Besides glutathione antioxidative system, there are several mitochondrial enzymatic 
antioxidants, such as peroxiredoxin (Prx), thioredoxin (Trx) and thioredoxin 
reductase (TrxR), seen in Fig.2-8. Thioredoxins show higher reduction of protein 
GSH: reduced glutathione GSSG: glutathione disulﬁde 
Gpx: glutathione peroxidase Grx: glutaredoxin 
IDHm: mitochondrial isocitrate dehydrogenase NADP: nicotinamide adenine dinucleotide phosphate 
Prx: peroxiredoxin SOD: superoxide dismutase 
TH: transhydrogenase Trx: thioredoxin 
TrxR: thioredoxin reductase  
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disulfides than Grx and interact with Prx, which in turn utilize Trx to detoxify H2O2 
[256, 257]. Nonenzymatic antioxidants include coenzyme Q10, cytochrome c, 
α-tocopherol, and glutathione.  
 
In structurally and functionally intact mitochondria, the abundant antioxidant 
defense network balances with physiological ROS generation, therefore there is little 
net ROS generation for cellular apoptosis. Nevertheless, the affliction of 
mitochondria causes largely increase of ROS generation outweighing the capability 
of mitochondrial antioxidant defense systems. Once this happens, a vicious cycle 
will ensue that more generation of toxic free radicals and loss of antioxidants 
capacities [258]. 
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3.1 Drug preparation 
3.1.1 Materials 
Cysteine, D, L-Propargylglycine (PAG), DHE and LDH assay kit were purchased 
from Sigma, USA. Sodium hydrosulfide (NaHS) was purchased from Aldrich, USA.  
H2DCFDA and Annexin V/PI kit were purchased from Invitrogen, USA. MDA levels 
kit, JC-1 assay kit were purchased from Beyotime, China. DPPP, kits for antioxidant 
enzyme assays, SOD, catalase, GPx and GST assay were purchased from Cayman 
Chemicals, USA. 
 
3.2 Synthesis of SPRC 
SPRC (also named as ZYZ-802) was synthesized from the reaction of l -cysteine with 
propargyl bromide and purified by recrystallization from an ethanol-water mixture 
(96.1%). The final product was verified with 1H nuclear magnetic resonance 
spectroscopy. 
 
3.2 Animals and cells 
3.2.1 Animals 
NZW rabbits were provided by the Centre for Animal Resource (CARE) of National 
University of Singapore (NUS). The experimental protocol for animal study was 
approved by NUS Institutional Animal Care and Use Committee (IACUC). New 
Zealand White rabbits weighing around 2.5 kg were caged individually in the Animal 
Holding Unit (24 ± 1°C and 55 ± 5% humidity) with dark-light cycles of 12 hours. 
Water and feeds were available to the animal ad libitum with standard rabbit chow 
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(with or without 1% cholesterol). Rabbits were randomly divided into different 
experimental groups of 6 animals each. The rabbits in the normal control (sham) 
group were fed a chow diet for 8 weeks. The other rabbits fed 1% cholesterol diet 
were treated with either saline (0.5 ml/kg/day, vehicle group) with or without 
treatments of NaHS (1, 10 and 30 μmol/kg/d) or SPRC (10 μmol/kg/d) or PAG (10 
mg/kg/d) administered daily through subcutaneous injection for 8 weeks. These diets 
were high-cholesterol diet (HCD) SF00-221 (modified guinea pig and rabbit + 1% 
cholesterol) and purchased from Glen Forrest Stockfeeders, Western Australia. Rabbit 
health and weight were monitored throughout the study. 
 
3.2.2 Cell culture 
HUVECs (Lonza, Singapore) were grown in EGM-2 (Lonza, Singapore) containing 
vascular endothelial growth factor (VEGF), basic ﬁbroblast growth factor (bFGF), 
insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), hydrocortisone, 
heparin, gentamicin sulfate amphotericin, 1‰ ascorbic acid and 2% fetal bovine 
serum (FBS) at 37 °C in a humidified atmosphere with 5% CO2. HUVECs were 
passaged every three days. The 4th to 8th passages of HUVECs were used for this 
study.  
 
3.3 Hyperlipidemic rabbit model 
New Zealand white (NZW) male rabbits weighing on average 2.5 kg were obtained 
from the Laboratory Animal Centre (Sembawang, Singapore). The NZW rabbits were 
caged individually in the Animal Holding Unit (24 ± 1°C and 55 ± 5% humidity) with 
dark-light cycles of 12 hours. Water and feeds were available to the animal ad libitum 
with high-cholesterol diet (HCD) SF00-221 (modified guinea pig and rabbit + 1% 
cholesterol) for eight weeks. The food intake and animal body weights were 
monitored, and all rabbits gained weight during the experimental period of 8 weeks. 
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3.4 Experimental protocols 
3.4.1 Experimental protocol I 
3.4.1.1 Objectives 
Hydrogen sulfide (H2S) has been shown to have cytoprotective effects in models of 
hypertension, ischemia/reperfusion and Alzheimer’s disease. However, little is known 
about its effects or mechanisms of action in atherosclerosis. Therefore, in this part 
studies we have examined the protective effects of H2S in endothelial cells against 
H2O2 induced cellular stress.  
 
Our major focus is to determine whether H2S,  
i) executes it protective effects through CSE/ H2S pathway,  
ii) preserves mitochondrial functions and ultrastructure,  
iii) promotes the induction of cytoprotective antioxidant enzymes that can detoxify 
toxic free radicals.  
 
The current findings provide further evidences for a functional role of H2S in 
endothelial cells in relation to the prevention of atherosclerosis. 
 
3.4.1.2 Experimental design 
The experimental design is illustrated in Fig. 3-1. For all experiments, HUVECs were 
grown to confluence in 96-well plates, 35 mm2 dishes or 100 mm2 dishes. Cells were 
pre-incubated with NaHS (10, 30, 100, 300, 500 or only 300 µM) or PAG (10 mM) 
for 6 hours before exposure to H2O2 (600 μM). Following exposure to H2O2, cells 
were harvested for further analysis. Normal control cells are in “control group” 
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without H2O2 stimulation; cells accepted H2O2 (600 μM) only are in “vehicle +H2O2 
group”; treatment groups are included NaHS (10, 30, 100, 300, 500µM) groups or 
only NaHS group (300 µM) and PAG group (10 mM), seen in Table 3-1. First, we 
evaluated the cytotoxicity of H2S by MTT assay. Then, the cellular protective effects 
of exogenous H2S were tested by MTT assay, LDH assay and apoptosis – Annexin 
V/PI staning. In order to investigate the cardioprotective effects by H2S though the 
CSE/ H2S pathways, we measured the H2S concentrations in the medium, CSE 
activity, and CSE protein and gene expressions in cells. For the mitochondrial studies, 
mitochondrial membrane potential-JC-1 staining, ΔΨm assay, ROS production and 
Transmission Electron Microscopy (TEM) were used to detect the mitochondrial 
healthy status in HUVECs. More specific measurements were needed for detect 
mitochondrial dysfunction in HUVECs. Therefore, cells were isolated mitochondrial 
suspension for subsequent experiments. ATP biosynthesis assay and cytochrome c 
release measurement were done to evaluate the effects of H2S in isolated 
mitochondria. Moreover, the effects of antioxidants activities and antioxidants 
enzymes protein expressions were evaluated. Furthermore, the protective mechanism 
of H2S was also investigated by detecting apoptotic protein expressions. 
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Table 3- 1 Grouping for studies of effects of H2S on HUVECs 
 
Group #-1. Cytotoxicity study Treatments 
1 Control – no drug 
2 NaHS (10 µM) + H2O2 
3 NaHS (30 µM) + H2O2 
4 NaHS (100 µM) + H2O2 
5 NaHS (300 µM) + H2O2 
6 NaHS (500 µM) + H2O2 
Group #-2. Cellular protection study Treatments 
1 Control – no drug 
2 Vehicle + H2O2 (600µM) 
3 NaHS (30 µM) + H2O2 
4 NaHS (100 µM) + H2O2 
5 NaHS (300 µM) + H2O2 
6 NaHS (500 µM) + H2O2 
Group #-3. Mechanisms study Treatments 
1 Control – no drug 
2 Vehicle + H2O2 (600µM) 
3 NaHS (300 µM) + H2O2 
4 PAG (10 mM) + H2O2 
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Fig.3- 1 A flow chart represents the general outline of the experiment I. 
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3.4.2 Experimental protocol II 
3.4.2.1 Objectives 
Hydrogen sulfide (H2S) has been shown to have cardioprotective effects in models of 
hypertension, ischemia/reperfusion and Alzheimer’s disease. However, few evidence 
is provided to show its effects or mechanisms of action mitochondrion, especially in 
vascular system. Therefore, in this part studies we have examined the protective 
effects of H2S on isolated rabbit aortas mitochondria against H2O2 induced 
mitochondrial dysfunction.  
 
Our major focus is to determine whether H2S,  
(i) prevents oxidative stress (ROS production), 
(ii) protects mitochondrial functions (mitochondrial respiration-oxygen consumption, 
ATP biosynthesis, and mitochondrial respiratory chain and matrix enzyme activity); 
(iii) preserves mitochondrial membrane intact (mitochondrial membrane potential and 
cytochrome c release) 
 
The current findings provide further evidences for a functional role of H2S in isolated 
rabbit aortas mitochondria in relation to the prevention of vascular mitochondrial 
dysfunction. 
 
3.4.2.2 Experimental design 
The experimental design is illustrated in Fig. 3-2. New Zealand White rabbits were 
anaesthetized with 2 ml/kg ketamin/xylazine (i.p) and killed by 1ml phenobarbitone in 
order to collect the aorta samples. Aortas were fasted collected, immediately peeled 
the surrounding fats and muscles, and then processed for isolation mitochondria. 
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Before the experiments were to be carried out, quality of aortic mitochondrial 
preparations was assessed by JC-1 assay to ensure the quality of mitochondria suitable 
for bioenergetics studies. Isolated mitochondria suspension was divided into groups as 
listed in Table 3-2 for subsequent experiments. ROS production, mitochondrial 
respiration, ATP biosynthesis, mitochondrial respiratory chain and matrix enzyme 
activity, mitochondrial membrane potential and cytochrome c release were used to 
detect the effects of H2S on isolated aortic mitochondria. 
Table 3- 2 Grouping for studies of effects of H2S on isolated mitochondria 
Group # Treatments 
1 Control – no drug 
2 Vehicle + H2O2 (1mM) 
3 NaHS (10 µM) + H2O2 
4 NaHS (100 µM) + H2O2 
5 NaHS (300 µM) + H2O2 
6 PAG (10 mM) + H2O2 
 
 
Fig. 3-2 A flow chart represents the general outline of the experiment II. 
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3.4.3 Experimental protocol III 
3.4.3.1 Objectives 
Due to the limited knowledge of effects of H2S on atherosclerosis, in this part study 
we have examined the vascular protective effects of H2S in the high cholesterol-fed 
rabbit model.  
 
Our major focus is to determine whether, in the hyperlipidemic rabbits, H2S  
(i) executes its cardioprotective effects via the CSE/ H2S pathway;  
(ii) inhibits the development of atherosclerotic plaques;  
(iii) inhibits atherogenic oxidized LDL;  
(iv) reduces toxic free radicals and improves activities of antioxidant enzymes, 
thereby improving the redox status; 
(v) suppresses inflammatory cell adhesion molecules in the atherogenesis. 
 
The results of this study will provide a better understanding of the biological 
properties of H2S vis-à-vis atherosclerosis, and unveil a potential therapeutic avenue 
for this challenging and ubiquitous disorder. 
 
3.4.3.2 Experimental design 
The experimental design is illustrated in Fig. 3-3. Thirty-six New Zealand White male 
rabbits weighing around 2.5 kg were caged individually in the Animal Holding Unit 
(24 ± 1°C and 55 ± 5% humidity) with dark-light cycles of 12 hours. Water and feeds 
were available to the animal ad libitum with standard rabbit chow (with or without 1% 
cholesterol). Rabbits were randomly divided into 6 experimental groups of 6 animals 
each. The rabbits in the normal control (sham) group were fed a chow diet for 8 weeks. 
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The other rabbits fed 1% cholesterol diet were treated with either saline (0.5 
ml/kg/day, vehicle group), NaHS (1, 10 and 30 μmol/kg/d) or PAG (10 mg/kg/d) 
administered daily through subcutaneous injection for 8 weeks, seen in Table 3-3. 
Rabbit health and weight were monitored throughout the study. First, in order to 
investigate the effects of H2S though CSE/H2S pathway, we detected the H2S levels in 
plasma, aortic CSE activities, and aortic CSE gene expressions. Then, the lipid files 
were tested for veiling the cholesterol-lowing effects of H2S. H & E staining and 
HRUS were used to detect the plaques in thoracic and carotid aortas. TEM were 
shown the vascular ultrastructure of thoracic aorta in different treatment groups. The 
mechanisms of protective effects of H2S were investigated on oxidative modification 
of LDL and antioxidative effects. 
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Table 3- 3 Grouping for studies of effects of H2S on hyperlipidemic NZW rabbits 
Group # Treatments 
1 Sham – no drug 
2 Vehicle + high cholesterol diet (HCD) 
3 NaHS (1 μmol/kg/d) + HCD 
4 NaHS (10 μmol/kg/d) + HCD 
5 NaHS (30 μmol/kg/d) + HCD 
6 PAG (10 mg/kg/d) + HCD 
 
 
Fig.3- 3 A flow chart represents the general outline of the experiment III 
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3.4.4 Experimental protocol IV 
3.4.4.1 Objectives 
SPRC, a structural analog of garlic extract - S-allylcysteine (SAC), plays 
cardioprotective roles in hypertension and ischemia/reperfusion. But no evidence was 
shown its effects on atherosclerosis. Therefore, in this part study we have examined 
the vascular protective effects of SPRC, in the high cholesterol-fed rabbit model.  
 
Our major focus is to determine whether, in the hyperlipidemic rabbits, SPRC  
(i) executes its cardioprotective effects via the CSE/ H2S pathway;  
(ii) inhibits the development of atherosclerotic plaques;  
(iii) inhibits toxic free radicals and enhances activities of antioxidant enzymes, 
thereby improving the redox status. 
(iv) suppresses the inflammatory cytokines and cell adhesive cytokines to play its 
anti-inflammatory effects. 
 
3.4.4.2 Experimental design 
The experimental design is illustrated in Fig. 3-4. Thirty New Zealand White male 
rabbits weighing around 2.5 kg were caged individually in the Animal Holding Unit 
(24 ± 1°C and 55 ± 5% humidity) with dark-light cycles of 12 hours. Water and feeds 
were available to the animal ad libitum with standard rabbit chow (with or without 1% 
cholesterol). Rabbits were randomly divided into 5 experimental groups of 6 animals 
each. The rabbits in the normal control (sham) group were fed a chow diet for 8 weeks. 
The other rabbits fed 1% cholesterol diet were treated with either saline (0.5 
ml/kg/day, vehicle group), SPRC (1, 10 μmol/kg/d) or PAG (10 mg/kg/d) 
administered daily through subcutaneous injection for 8 weeks, seen in Table 3-4. 
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Rabbit health and weight were monitored throughout the study. First, in order to 
investigate the effects of SPRC though CSE/H2S pathway, we detected the H2S levels 
in plasma, aortic CSE activities, and aortic CSE gene expressions. Then, the lipid files 
were detected for analyzing the cholesterol-lowing effects of H2S. H & E staining and 
HRUS were used to detect the plaques in thoracic and carotid aortas. TEM were 
shown the vascular ultrastructure of thoracic aorta in different treatment groups. The 
mechanisms of protective effects of H2S were investigated on antioxidative and 
anti-inflammatory effects. 
Table 3- 4 Grouping for studies of effects of SPRC on hyperlipidemic NZW 
rabbits 
Group # Treatments 
1 Sham – no drug 
2 Vehicle – high cholesterol diet (HCD) 
3 SPRC (1 μmol/kg/d) + HCD 
4 SPRC (10 μmol/kg/d) + HCD 
5 PAG (10 mg/kg/d) + HCD 
 
 
Fig.3- 4 A flow chart represents the general outline of the experiment IV. 
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3.5 Experimental techniques 
3.5.1 Cytotoxicity assays 
The cell viability was determined by the colorimetric MTT assay. Briefly, HUVECs 
were seeded on 96-well plates in culture medium and maintained in regular growth 
medium for one day. Cells were pre-treated with different concentrations of NaHS (30, 
100, 300 µM) and PAG (10 mM) for 6 hours then exposed to 600 μM H2O2 for 4 
hours. Following H2O2 treatment, 10 µL of MTT (final concentration 0.5 mg/mL) was 
added to each well and cultures were incubated for 4 h at 37 °C. The medium was 
then removed and the cells were washed twice with phosphate-buffered saline (PBS). 
The metabolized MTT was solubilized with dimethylsulfoxide and the absorbance of 
the solubilized blue formazin dye was read at 530 nm, with 690 nm as reference. The 
reduction in optical density produced by NaHS treatment was considered to represent 
the decrease in cell viability. The cells incubated with control medium were 
considered to be 100% viable. Cell viability% = absorbance of each injured 
group/absorbance of normal group × 100. The effective concentration of H2O2 and 
NaHS chosen for further experiments was based on these MTT results. 
 
Cell death was determined by measuring LDH activity. At the end of incubation, the 
supernatant was collected, and the amount of LDH released from cells was 
determined using LDH assay kit according to the manufacturer’s instructions. The 
absorbance was measured on a microplate reader at 490 nm. The data in each 
treatment group is expressed as a percentage of control. 
 
Sulforhodomine B assay is an alternative method to measure total biomass (the 
number of cells) by staining cellular proteins with the dye, Sulforhodamine B. The 
result indicates the degree of cytotoxicity caused by the desired treatments. First, 
HUVECs were cultured in a 96-well plate. After drug treatments, add 25 µl of 50% 
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TCA in 100 µl medium in each well to fix the cells at 4 °C for 1 hour. The excess 
TCA was rinsed with distilled water. The plate was air dried, then added 50 µl of 0.4% 
Sulforhodamine B solution (in 1% acetic acid) to cover the culture surface area for 30 
minutes at room temperature. At the end of staining, the plate was washed with fresh 
1% acetic acid for 3 times. The incorporated dye was the solubilized in 100 µl 
Sulforhodamine B solubilization solution (10 mM Tris base solution) for 5 minutes at 
room temperature. The intense color was measured at 565 nm wavelength and 
background absorbance was subtracted at 690 nm wavelength. The data in each 
treatment group is expressed as a percentage of control. 
 
3.5.2 Fluorescent staining of nuclei 
HUVECs nuclei were stained with chromatin dye (Hoechst 33258). Briefly, cells were 
fixed with 3.7% paraformaldehyde for 10 min at room temperature, washed twice 
with phosphate buffered solution (PBS), and incubated with 10 µM Hoechst 33258 in 
PBS at room temperature for 30 min. After three washes, cells were observed under a 
fluorescence microscope (Olympus DP72). 
 
3.5.3 Cell apoptosis assay 
HUVECs were cultured in 35 mm2 disks. After treatments, cells were collected by 
trypsinization and centrifugation at 1500rpm for 5 minutes, followed by washing cell 
pellet twice with cold PBS and resuspending cell pellet in 1* Annexin-binding buffer. 
Then, cells were added 5 µL Annexin V and 1µL 100 µg/ml PI working solution in 
100 µL cell suspension, and incubated at room temperature for 15 minutes in the dark. 
After the incubation, 400 µL 1* Annexin-binding buffer was added. After mixing 
gently, the fluorescence intensity was detected with a flow cytometry (CyAn ADP, 
Beckman Coulter, USA) at emission at 530 nm and 575 nm and excitation at 488 nm. 
The percentage of cells stained by Annexin V/PI which indicates early apoptosis was 
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shown in bar chart. 
 
3.5.4 Measurement of H2S concentrations 
500 μl medium or plasma was mixed with 250 μl of zinc acetate (1% w/v) in 
duplicates. Subsequently, NNDPD (20 μM; 133 μl) in 7.2 mol/L HCl was added, 
followed by FeCl3 (30 μM; 133 μl) in 1.2 mol/L HCl. Thereafter, TCA (10% w/v; 250 
μl) was used to precipitate any protein. This final solution was then centrifuged at 
24000 g for 5 min at 4°C. The optical absorbance of the resulting solution was 
measured at 670 nm using a 96-well microplate reader (Tecan Systems Inc., 
Switzerland). H2S concentration for each sample was calculated against a calibration 
curve made using NaHS standard (3.125 μM-250 μM). Results are expressed as μM. 
 
3.5.5 Measurement of CSE activity 
Briefly, HUVECs were harvested by a cell lysis buffer and aortae were digested by a 
tissue lysis buffer, then centrifuged at 24000 g for 5 min at 4 °C. The supernatant was 
used for this assay. The reaction mixture contained 20 μl of 10 mM L-cysteine, 20 μl 
of 2 mM pyridoxal-5-phosphate, 30 μl of saline and 430 μl cell lysis supernatant. The 
catalytic reaction was initiated by transferring the reaction mixture contained in 
microtubes from ice to a 37 °C water bath for 30 min. Then 250 μl of 1% zinc acetate 
was added to the tubes using a syringe to trap any evolved H2S. 250 μl of 10 % 
trichloroacetic acid (TCA) was added next to quench the enzymatic reaction. Finally, 
133 μl N,N-dimethyl-pphenylenediamine sulphate (NNDPD) in 7.2 M HCl and 133 μl 
of FeCl3 in 1.2 M HCl were added. The absorbance of the final reaction mixture was 
measured at 670 nm using a 96-well microplate reader (Tecan Systems Inc., 
Switzerland). All samples were assayed in duplicates. H2S concentration for each 
sample was calculated against a calibration curve made using NaHS standard (3.125 
μM-250 μM). Results are expressed as μmol/h/g protein. Protein content was 
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determined using a BCA assay kit (BIO-RAD). 
 
3.5.6 Preparation of HUVECs Mitochondria 
Treated and untreated HUVECs were harvested by centrifugation at 1000g for 3 min 
at room temperature. Mitochondrial and cytosol extractions were carried out using a 
Mitochondrial Isolation Kit (Pierce Chemical) according to manufacturer’s 
instructions.  
 
3.5.7 Preparation of intact rabbit aorta mitochondria 
Briefly, New Zealand White rabbits weighed 2.8 – 3 kg were anaesthetized and aortas 
were collected. The aorta was immediately excised and transferred into ice-cold 
isolation buffer containing 20mM Tris-HCl, 250mM sucrose, 40mM KCl, 2mM 
EGTA, and 1mg/ml bovine serum albumin, pH7.2. All the isolation procedures were 
carried out at 4°C. The cortex was homogenized using hand-held glass dounce tissue 
grinder with 15 tight upward and downward strokes, in isolation buffer. The crude 
homogenate was centrifuged at 2000 × g for 3 minutes to remove cell debris and 
nuclei. The supernatant, containing the mitochondrial fraction was further centrifuged 
at 12000 × g for 11 minutes. Subsequently, the mitochondrial pellet was suspended in 
3.5ml of 15% (v/v) Percoll. This suspension was overlain on two preformed percoll 
layers consisting of 3.5ml 40% and 3.5ml 23% (v/v) Percoll. The percoll gradient was 
established by centrifugation at 30700 × g for 5 minutes. The distinct creamy layer 
in between 15% and 23% percoll was collected and resuspended in 500μl isolation 
buffer. The suspension was again subjected to centrifugation at 12000 × g for 11 
minutes. Mitochondrial pellet was washed by resuspending the pellet with isolation 
buffer (without EGTA) and centrifugation at 12000 × g for 11 minutes. The 
resulting mitochondrial pellet was suspended in 200μl of isolation buffer to give the 
protein concentration of 25-35mg/ml as measured by nanodrop (Thermo Scientific). 
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The mitochondrial suspension was kept on ice before the subsequent experiments. 
 
3.5.8 ATP Synthesis Recording 
1 mg/ml of mitochondria were collected for ATP synthesis analysis. The rate of ATP 
production was measured using a bioluminescence assay kit (Beyotime, China). 
Briefly, isolated mitochondria were immediately incubated with 2.5 mM ADP, 1 mM 
pyruvic acid and 1 mM malic acid. The ATP synthesis was kinetically recorded every 
30s for 2 minutes. Then, lyciferin substrate and luciferase enzyme were added and 
bioluminescence was measured by Luminometer (Varioskan Flash Multimode Reader, 
Thermo). Standardization was performed with known quantities of standard ATP 
provided in the kit and measured in the same conditions. The rate of ATP synthesis 
was calculated using a linear regression. Results were expressed in µmol ATP/min/g 
of mitochondrial protein.  
 
3.5.9 Mitochondrial respiration measurement  
Mitochondrial respiration was measured polarographically by monitoring the rate of 
oxygen consumption in an airtight chamber, equipped with a magnetic stirring device 
using a Clark type oxygen electrode (Hansatech, UK). Mitochondrial isolation was 
done for rabbit aortas from each treatment group. Subsequently, 1 mg  of  
mitochondria  was  added  into  the  2ml respiratory buffer consisting of 0.5mM 
EGTA, 3 mM MgCl2·6H2O, 60mM K-lactobionate, 20 mM Taurine, 10 mM KH2PO4, 
20mM HEPES, 110mM Sucrose and 1mg/ml bovine serum albumin, pH7.1 for 
oxygen consumption measurement. After the addition of mitochondria, the suspension 
was stirred with magnetic stirrer to ensure the equal distribution of oxygen and 
contents within the solution. Once the system had reached the equilibrium, state 2 
respiration was initiated by the addition of 10mM succinate. Subsequently, 125μM of 
ADP was added into the chamber for state 3 respiration, followed by state 4 
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respiration by adding 0.5μg/ml of oligomycin. Oligomycin is a F0F1 ATP synthase 
inhibitor. During the oxygen consumption measurement, oligomycin will return the 
mitochondrial respiration to the basal rates. Respiratory control ratio (RCR) was then 
calculated as ratio of mean of state 3 slope over state 4 respiration slopes.   
 
3.5.10 Mitochondrial respiratory chain and matrix enzyme 
activity assays 
After incubation with the indicated compounds, mitochondrial suspensions were 
subjected to three freeze–thaw cycles to disrupt membranes and expose enzymes. All 
enzyme assays were performed spectrophotometrically at 30°C using a 
thermostatically regulated UV/visible spectrophotometer (U-2550 spectrophotometer; 
Shimadzu Corp., Japan). Mitochondrial respiratory chain complex activities were 
measured by the following methods: complex I (NADH–ubiquinone oxidoreductase) 
[259], complex II/III (succinate–cytochrome c oxidoreductase) [260], and complex IV 
(cytochrome c oxidase) [261].  
 
The matrix enzyme citrate synthase was determined using the previously described 
method [262]. α-Ketoglutarate dehydrogenase complex (α-KGDHC) activity was 
measured as described previously [263]. Pyruvate dehydrogenase complex (PDHC) 
activity was measured using “method 3” of Elnageh and Gaitonde [264]. 
 
3.5.11 Mitochondrial membrane potential - JC-1 staining 
Loss of mitochondrial membrane potential (ΔΨm) was assessed by ﬂuorescence 
microscopy using the dye 5,5’,6,6’-tetrachloro-1,1’,3,3’- tetraethylbenzimidazole- 
carbocyanide  iodine  (JC-1assay kit, Beyotime, China). After each treatment, 
HUVECs were stained with JC-1 for 20 min at 37 °C. Cells on 8-chamber slides were 
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scanned with a ﬂuorescence microscope (Olympus DP72). Fluorescence was analyzed 
with a Texas red-FITC ﬁlter cube. Red emission of the dye represented a 
potential-dependent aggregation in the mitochondria, reﬂecting ΔΨm. Green 
ﬂuorescence represented the monomeric form of JC-1, appearing in the cytosol after 
mitochondrial membrane depolarization. Cells treated with 10 µM CCCP were used 
as positive control. CCCP is a protonophore which can cause dissipation of ΔΨm. 
 
3.5.12 ΔΨm measurement 
JC-1 was used to measure ΔΨm of HUVECs and aortic mitochondria. Total cells or 
mitochondria were collected into 2 ml tubes and incubated with JC-1 for 20 min at 
37 °C. The fluorescence intensity of cells was detected with a flow cytometry (BD 
FACSAria I cell sorter, Becton Dickinson Company). The fluorescence intensity of 
aorta mitochondria was detected with a fluorescent microplate reader (Molecular 
Devices, Gemini XS, USA). The wavelengths of excitation and emission were 514 nm 
and 529 nm for detection of monomeric form of JC-1. 585 nm and 590 nm were used 
to detect aggregation of JC-1. The ratio of aggregated JC-1 and monomeric JC-1 
represented ΔΨm of HUVECs or aortic mitochondria. 
 
3.5.13 Measurement of ROS 
The fluorescent probe, H2DCFDA, was used to measure the intracellular generation of 
ROS by H2O2. Briefly, confluent HUVECs in 96-well plates were pretreated with 300 
μM NaHS or 10 mM PAG for 6 hours and then stimulated with 600 μM H2O2 for 4 h. 
The reactions were stopped by removing medium, and washing with PBS followed by 
staining with 10 μM H2DCFDA for 20 min at 37 °C. DHE was also used to detect 
ROS production. After drug treatments, cells were incubated in 5 μM DHE for 30 min 
at 37 °C. The fluorescence intensities of H2DCFDA and DHE were kinetically 
measured at an excitation and emission wavelength of 485 nm and 530 nm for 
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H2DCFDA, and 520nm and 610nm for DHE, respectively, using a fluorescent 
microplate reader (Molecular Devices, Gemini XS, USA). The same methods were 
used to test the ROS production of aorta mitochondria.  
 
3.5.14 Lipid peroxidation assays 
For in vitro study, HUVECs were cultured in 35 mm2 disks. A cell lysis buffer (RIPA 
buffer) was used to the collect cell samples. For in vivo study, a tissue lysis buffer 
(RIPA buffer) was used to lyse liver samples. The tissue samples were then 
homogenized by Polytron homogenizer (Janke and Kunkel, Germany) followed by 
centrifugation at 3000rpm/minute for 15 min, supernatant was collected for 
malondialdehyde (MDA) measurement. MDA levels were determined by measuring 
the thiobarbituric acid-reactive substances using a commercial kit (Beyotime, China) 
according to the manufacturer's introduction. The kit is based on the MDA in the 
samples that forms 1:2 adduct with thiobarbituric acid (TBA). The MDA-TBA adduct 
formed from the reaction of MDA in samples with TBA can be measured 
spectrophotometrically at 532nm. MDA values are expressed as nmol/mg protein. 
 
Lipid peroxidation was further estimated using a fluorescent probe, DPPP. After 
treatments, cells were incubated with 100 μM DPPP for 60 min in the dark. The 
fluorescent intensities of DPPP fluorescence were analyzed with a fluorescent 
microplate reader (Molecular Devices, Gemini XS, USA) at an excitation of 351 nm 
and an emission of 380 nm. 
 
3.5.15 Cytochrome c Release Assay 
Cells were harvested by centrifugation at 1000g for 3 min at room temperature. 
Mitochondrial and cytosol extractions were separated using the Mitochondrial 
Isolation Kit (Pierce Chemical) according to manufacturer’s instructions. The 
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presence of cytochrome c was detected from mitochondrial and cytosol extractions by 
immunoblot analysis using anti-cytochrome c antibody (1:1000, Cell Signaling).  
 
3.5.16 Transmission Electron Microscopy (TEM) 
For in vitro study, HUVECs were harvested then prefixed in 2.5% glutaraldehyde 
solution overnight. Postﬁxation was in cold 1% aqueous osmium tetroxide for 1 h. 
After rinsing with PBS, the samples were dehydrated in a graded ethanol series of 25 
to 100% and then embedded in fresh resin and polymerized at 60 °C for 24 h. 
Ultra-thin sections were sliced with glass knives on a LKB-V ultramicrotome (Leica), 
stained with uranyl acetate and lead citrate, and examined under a transmission 
electron microscope CM120 Bio TWIN (Philips). 
 
For in vivo study, thoracic aortae sections were ﬁxed using 2.5% glutaraldehyde in 
0.01 M phosphate buffer at a pH 7.38. Subsequently, vessel sections were ﬁxed in 2% 
OsO4. Then after a process of dehydration, inﬁltration, embedment, and 
polymerization, the vessel tissues were cut into 50 nm sections with a vibratome and 
prepared for examination under TEM (CM120, Philips, Holland), following standard 
procedures. Ultrastructure of smooth muscle cell was observed. 
 
3.5.17 Antioxidant enzyme activities assay 
For in vitro study, HUVECs were cultured in 100 mm2 disks. Cells were harvested 
through centrifuging (1,500 g for 10 minutes at 4 °C). Then, cells were homogenized 
in cold buffer and centrifuged at 10,000 g for 15 min at 4 °C. The supernatants were 
used for all the assays. For in vivo study, livers were homogenized in cold buffer and 
centrifuged at 10,000 g for 15 min at 4 °C. The supernatants were used for all the 
assays. The antioxidants assays were performed using commercially available kits.  
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3.5.18 High resolution ultrasonographic (HRUS) imaging  
At the end of week 8, HRUS imaging was performed as described before. Rabbits 
under light anesthesia with intravenous sodium pentobarbital (30mg/kg) were 
examined by using a high resolution ultrasound system (Vevo 770, Visualsonics, 
Canada) equipped with a 30MHz mechanical transducer. The transverse section was 
first viewed on the B-mode to visualize the left common carotid arterial site, and after 
a clockwise 90° rotation, the longitudinal view of the artery at the site 0.5-1 mm 
proximal to the artery bifurcation was employed to depict the plaque length and 
thickness. After the transverse and longitudinal axis imagings of carotids were 
obtained, the maximal intima-media thickness (IMT) of the plaque, aortic end-diastole 
diameter (Dd) and end-systolic diameter (Ds) were measured from the imagings. 
Blood flow velocity was recorded by pulsed Doppler technique. The maximal systolic 
velocity of blood flow in the lumen of artery proximal to lesion is recorded to be 
carotid peak flow velocity (Vp) [265]. Relative-sectional change (RS) of the left 
common carotid arteries was calculated as: RS = （ Dd2-Ds2)/Dd2. All the 
measurements were repeated twice at the same site. 
 
3.5.19 H&E staining 
Sections from the thoracic aortae were fixed in 10% buffered formalin (Sigma, USA) 
for 1 week. 4 μm-thick tissue sections were stained with H&E for normal histological 
assessment, with the cytoplasm stained pink, and the nuclei deep purple. Hematoxylin, 
Eosin and Orange G stains were obtained from Merck, Germany while Light Green 
SF Yellowish and Pararosaniline hydrochloride were obtained from Sigma, USA. 
 
3.5.20 Measurement of serum lipid levels  
After overnight fasting, blood was drawn from the marginal ear vein at baseline and 
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the end of 8 weeks. Blood samples were put on ice and centrifuged (3000 rpm, 15 min, 
4 °C) to obtain serum. Serum TC and LDL levels were measured with an automatic 
analyzer (Au5600 OLYMPUS). 
 
3.5.21 Oxidized LDL (ox-LDL) in serum 
The level of ox-LDL in serum was measured using commercially available kits for 
rabbits (R&D systems), following the manufacturer’s instructions. Final results were 
expressed as μg/L. 
 
3.5.22 Inflammatory cytokines in serum 
The level of soluble vascular adhesion molecular-1 (sVCAM-1), soluble intercellular 
adhesion molecular-1 (sICAM-1), MCP-1, IL-6 and TNF-α in the serums were 
measured using commercially available kits for rabbits (R&D systems), following the 
manufacturer’s instructions. Final results were expressed as nanograms cytokine per 
milliliter serum. 
 
3.5.23 Immunoblotting 
Cultured HUVECs were harvested by scraping and centrifugation. The pellets of cells 
or aortas were washed twice with ice-cold PBS, and re-suspended in RIPA buffer. 
Soluble proteins were collected by centrifugation at 15,000 g for 15 min. Protein 
lysates were subjected to 10-12% SDS-PAGE and transferred onto a PVDF 
membrane (Millipore Corporation). After blocking with 5% skim milk, the 
membranes were incubated with the respective primary antibodies (SOD-1 1:800, 
SOD-2 1:400, catalase 1:500, GPx 1: 500, GST 1:500, cytochrome c 1:1000, CTH 1: 
1000, Santa Cruz; CBS 1:800 Abcam) in PBS 0.1% Tween-20 overnight at 4 °C. The 
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membranes were then incubated with the appropriate secondary horseradish 
peroxidase-conjugated IgG antibodies at a 1:10,000 dilution for 1 h at room 
temperature (Santa Cruz). Immunoreactive proteins were then visualized enhanced 
chemoluminescence (Pierce). The signals were quantiﬁed by densitometry using a 
Kodak Image Station 4000R (Kodak). β-actin served as the loading control. Protein 
content was determined using a BCA assay kit (BIO-RAD). 
 
3.5.24 Real-time Polymerase Chain Reaction (R-T PCR) 
Total RNA from HUVECs or aorta was isolated using Trizol reagent (Invitrogen, 
Carlsbad, CA). Real-time PCR was performed in triplicate on a Corbett RG6000 
5plex with HRM sequence detector, using 100ng RNA, 0.1 μl PCR master Mix 
(QuantiTect, QIAGEN), 5 μl SYBR (QuantiTect, QIAGEN), and 5 μM each of 
forward and reverse primers, in a final volume of 10 μl. Samples were incubated at 
50 °C for 30 min, then at 95 °C for 15 min; denaturation was performed for 45 cycles 
at 94 °C for 15 s, and followed by annealing and extension at 62 °C for 30s and 
72 °C for 30s. Amplifications were normalized by β-actin. The amount of the target 
gene, normalized to β-actin, is given as 2−ΔΔCT. Results were analyzed using the 
Rotor-Gene series software (1.7). Expressions of CSE and CBS SOD, CAT, GST, 
GPx, CSE and HO-1 mRNA were determined.  
The primers used for real-time PCR in experiment I are shown in Table 3-5 and 
The primers used for real-time PCR in experiment III and IV are shown in Table 
3-6. 
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Table 3- 5 The primers used for real-time PCR in experiment I. 
Gene Forward Reverse 
CSE  5’-ccatctcctattgattgttacctct-3’ 5’-cactgacgcttcaccaactc-3’ 
CBS  5’-tcaagagcaacgatgaggag-3’ 5’-atgtagttccgcactgagtc-3’ 
β-actin  5’-gagagggaaatcgtgcgtgac-3’ 5’-ctgctggaaggtggacagtgag-3’ 
 
Table 3- 6 The primers used for real-time PCR in experiment III and IV. 
Gene Forward Reverse 
Catalase 5`-tcttgtccaggatgtggtctt-3` 5`-gtcttcttcccaatatgctcaaac-3` 
SOD-1 5`-gacttgggcaaaggtggaaatg-3` 5`-caaccagcaggctaacagatgag-3` 
GPx 5`-tgtactccttctcagcgcacccg-3` 5`-tcagagcgacgccacattctcaat -3 
GST 5`-aaacgtctgctacagtcccg-3` 5`-acaaggaaatcggcgaaggt -3` 
VCAM-1  5`-gaaatggaatttgaacccaaac -3`  5`-ggcaacattgacaaaaagtgg -3`  
ICAM-1  5`-tatggcaacgactccttct-3`  5`-cattcagcgtcaccttgg-3`  
MMP-9  5`- agccctgcgagtttccgttcatc-3`  5`-tccttgtcgtagctggcggtggt -3`  
M-CSF  5`-tttgtggaccaggagcagttgaagg-3`  5`-ttggcgttgggcgtgctgtg-3`  
CSE 5`-cagtgcctaagaacgaccgagaa-3` 5`-gcccacagacaggcgaatga-3` 
β-actin 5`-agtgcgacgtggacatccg-3` 5`-tggctctaacagtccgcctag-3` 
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3.5.25  Statistical analysis 
Statistical analyses were performed using SPSS 13.0 for Windows software (SPSS Inc
, USA), with normality of data tested by Komogorov-Smirnov tests. Since the sample 
sizes of the groups were unequal, comparisons of normally distributed variables betwe
en control, SIVD and MIX were performed by one-way analyses of variance (ANOV
A) followed by post-hoc Tamhane’s T2 tests. Pearson’s product moment was used in 
correlations of neurochemical variables with dementia severity (defined as mean CA
MCOG and MMSE scores up to one year pre-death). Appropriate non-parametric test
s were used for ordinal or non-normally distributed variables. Results were considered
 statistically significant if p< 0.05. All values are represented as means ± SD. 
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4.1 Results of Experiment I: Hydrogen 
sulfide protects HUVECs against 
hydrogen peroxide induced 
mitochondrial dysfunction and 
oxidative stress 
 
4.1.1 NaHS is non-toxic to HUVECs 
Sodium hydrosulfide (NaHS) at concentrations of 10, 30, 100, 300 and 500 μM with 
incubation of 12, 24, 48 hours was found to be non-toxic to endothelial cells, as 
determined by the MTT viability assay (Fig. 4.1-1, n=9).  
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Fig. 4.1- 1 The cell viability of HUVECs subjected to different concentrations of 
NaHS. (A)-(C) MTT assay. (A) HUVECs were treated with 10-500 μM NaHS for 12 
hours. (B) HUVECs were treated with 10-500 μM NaHS for 24 hours. (C) HUVECs 
were treated with 10-500 μM NaHS for 48 hours. Cell viability in each treatment group 
is expressed as a percentage of control. The data shown are mean ± SEM (n=9).  
 
4.1.2 Protective effects of exogenous H2S on H2O2 induced 
cell death 
The dose response of H2O2 treatments on HUVECs cell viability is shown in Fig. 
4.1-2 (n=9). After incubating with H2O2 for 4 hours, cell viabilities were significantly 
decreased in 0.6-1.5 mM H2O2 treatment groups (P< 0.01). The less toxic 
concentration, 0.6 mM of H2O2 was chosen for later studies.  
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Fig. 4.1- 2. The Cell viability of HUVECs subjected to different concentrations of 
H2O2. HUVECs were treated with 0.2-1.5 mM H2O2 for 4 hours. Cell viability in each 
treatment group is expressed as a percentage of control. The data shown are mean ± 
SEM (n=9). ** p<0.01 vs control. 
 
 
Another MTT assay (Fig. 4.1-3 A) showed the cellular protective effect of NaHS on 
HUVECs damaged by H2O2. The cell viability fell to 57.71 ± 2.96% when exposed to 
H2O2 (600 µM) for 4 h (P< 0.01, vs. control). A dose response was observed in cell 
viabilities 62.38 ± 2.12%, 78.74 ± 4.23%, 89.26 ± 3.45% and 82.41 ± 1.78% for 30, 
100, 300 and 500 µM NaHS, respectively. The differences between the H2O2 group 
and NaHS (100, 300 and 500 µM) groups were statistically significant (P< 0.01). The 
MTT results were further supported by lactate dehydrogenase (LDH) release assay 
(Fig. 4.1-3 B). Compared with control, vehicle + H2O2 induced 252.23 ± 1.79% LDH 
release, while NaHS pretreatment significantly decreased LDH release to 180.63 ± 
3.13% and PAG increased to 297.26 ± 5.28% Pretreatment with different 
concentrations of NaHS could reverse H2O2-induced cell death dramatically, showing 
the ability of H2S to reduce H2O2 cytotoxicity. Sulforhodomine B assay showed the 
similar results of LDH data (Fig. 4.1-3 C). The higher absorbance of Sulforhodomine 
B solubilization solution means higher total biomass (equal to cell viability). Vehicle 
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+ H2O2 showed lower total biomass than control group, while NaHS had the denser 
total biomass and PAG showed much lower total biomass than Vehicle + H2O2 (P< 
0.01).  
 
 
Fig. 4.1- 3. Cell viability and death assay of HUVECs subjected to different 
concentrations of NaHS with or without H2O2. (A) MTT assay showed cell viability 
of HUVECs pretreated with vehicle or 30-500 μM NaHS for 6 hours, followed by 
exposure to 600 μM H2O2 for another 4 hours. (B) LDH release assay showed cell death 
of HUVECs pretreated with vehicle or 300 μM NaHS and 10mM PAG for 6 hours, 
followed by exposure to 600 μM H2O2 for another 4 hours. (C) Sulforhodomine B 
assay showed total biomass (the number of cells) of HUVECs pretreated with vehicle 
or 300 μM NaHS and 10mM PAG for 6 hours, followed by exposure to 600 μM H2O2 
for another 4 hours. Cell viability or LDH release in each treatment group is expressed 
as a percentage of control. The data shown are mean ± SEM (n=9). ** p<0.01 vs 
control. ## p<0.01 vs vehicle + H2O2. 
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Similar results were obtained using Hoechst staining (Fig. 4.1-4), in which apoptotic 
nuclei were brighter. There were fewer apoptotic cells in the NaHS pre-treated groups 
than in the H2O2 group, while much more apoptotic cells in the PAG pre-treated 
groups were observed than in H2O2 group.  
 
 
 
Fig. 4.1- 4 The cell viability of HUVECs by Hoechst staining. HUVECs were 
pretreated with vehicle, 300 μM NaHS or 10mM PAG for 6 hours, followed by 
exposure to 600 μM H2O2 for another 4 hours. Cells were observed under ×200 
microscopy. Scale bar is shown at 100μm. 
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The cell viability was also evaluated by propidium iodide (PI) staining, which a DNA 
dye to detect the nucleus and other DNA containing organelles. Under microscopy, 
we found the H2O2 group had more PI stained cells than that of control, while NaHS 
pretreated cells showed less bright and PAG increased the PI staining light, seen in 
Fig. 4.1-5. 
 
 
 
Fig. 4.1- 5 The cell viability of HUVECs by PI staining. HUVECs were pretreated 
with vehicle, 300 μM NaHS or 10mM PAG for 6 hours, followed by exposure to 600 
μM H2O2 for another 4 hours. Cells were observed under ×200 microscopy. Scale bar is 
shown at 50 μm.  
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The protective effects of H2S on cells in the stage of early apoptosis induced by H2O2 
were showed in Fig. 4.1-6. The percentage of cells stained by Annexin V/PI which 
indicated early apoptosis, was 11.5 ± 0.53% in control, and significantly increased to 
21.33 ± 0.89% in vehicle + H2O2, decreased to 13.59 ± 1.77% in NaHS and highly 
rocketed to 27.81 ± 3% in PAG (P< 0.01). H2S can protect endothelial cells against 
H2O2-induced apoptosis. 
 
 
 
Fig. 4.1- 6 The percentage of early apoptotic cells stained by Annexin V/PI by flow 
cytometry. HUVECs were pretreated with vehicle or 300 μM NaHS and 10mM PAG 
for 6 hours, followed by exposure to 600 μM H2O2 for another 4 hours. The data shown 
are mean ± SEM (n=3). ** p<0.01 vs control. ## p<0.01 vs vehicle + H2O2. 
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4.1.3 CSE protein and gene expression, CSE activity and 
H2S concentration after H2O2-induced injury 
H2O2 treatment was found to decrease of H2S concentration in the medium, Fig. 4.1-7 
(n=6) (P< 0.05, vs. control). In contrast, the H2S donor - NaHS elevated H2S 
concentrations in the medium (P< 0.05, vs. vehicle + H2O2). These effects were 
significantly reduced by PAG treatment (P< 0.05, vs. control).  
 
 
Fig. 4.1- 7 The H2S concentration (μM) in medium for each treatment group. The 
data shown are mean ± SEM (n=6). * p<0.05 vs control. # p<0.05 vs vehicle + H2O2 
group. 
 
 
Similarly, cellular CSE activities were analyzed in the cell lysates from all treatment 
groups, as shown in Fig. 4.1-8 (n=6). CSE activity in the control group was 28.73 ± 
0.69 (μmol/h/g) with this been decreased to 15.02 ± 0.91 (μmol/h/g) in the H2O2 
group (P< 0.05, vs. control). NaHS was found to preserve CSE activity in cells when 
exposed to H2O2 (21.07 ± 0.52 μmol/h/g; P< 0.05, vs. vehicle + H2O2), while PAG 
reduced CSE activity levels to 13.02± 0.97 (μmol/h/g) (P< 0.01, vs. control).  
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Fig. 4.1- 8 CSE activities (μmol/h/g) in HUVECs lysate of each group. The data 
shown are mean ± SEM (n=6). * p<0.05, ** p<0.01 vs control. # p<0.05 vs vehicle + 
H2O2 group. 
 
 
Using western blot and PCR analysis, we also determined the relative protein and 
mRNA levels of CSE in HUVECs (Fig 4.1-9). In the H2O2 treatment groups CSE 
protein and mRNA levels were reduced while in the NaHS pretreatment groups CSE 
protein and mRNA levels were increased and in the PAG pretreatment groups CSE 
protein levels were decreased and CSE mRNA levels were increased (P< 0.05). 
Interestingly, CBS protein and mRNA levels, an additional H2S synthesizing enzyme, 
remained unchanged in all treatments groups as shown in Fig. 4.1-9. Taken together, 
these results indicate that the cardioprotective effects by H2S might be though the 
CSE/ H2S pathways. 
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Fig. 4.1- 9 Effects of NaHS on H2S synthesizing enzyme protein and gene 
expressions. (A) CSE protein expressions levels as determined using western blot 
analysis. (B) CSE mRNA expression levels as determined by real-time PCR. (C) CBS 
protein expressions levels and (D) The CBS mRNA expression tested by real-time 
PCR. The values in (A)-(D) were normalized against the control values. The data 
shown are mean ± SEM (n=6). * p<0.05, ** p<0.01 vs control. # p<0.05 vs vehicle + 
H2O2 group. 
 
 
 
4.1.4 Effects of exogenous H2S on mitochondrial ATP 
synthesis 
In aerobic eukaryote cells the major site of adenosine triphosphate (ATP) production 
occurs in mitochondria. As shown in Fig. 4.1-10 (n=6) cellular ATP levels responded 
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to H2O2, the H2S donor (NaHS) and inhibitor (PAG). The ATP content of the control 
cells was 144.66 ± 21.13 (µmol/min/g). After incubation with H2O2, the rate of ATP 
production by mitochondria was greatly decreased to 54.16 ± 2.79 (µmol/min/g) (P< 
0.01, vs. control). Meanwhile, ATP production in the pretreated NaHS group 
significantly increased to 102.87± 22.34 (µmol/min/g) (P< 0.01, vs. vehicle + H2O2). 
A significantly decreased to 25.47 ± 8.90 (µmol/min/g) in the pretreated PAG group 
was also noted (P< 0.01, vs. control). These results indicated that H2S could attenuate 
H2O2 induced inhibition of ATP synthesis. 
 
 
 
Fig. 4.1- 10 Effect of NaHS on ATP synthesis. After pretreatment with vehicle, 300 
μM NaHS or 10mM PAG for 6 hours and followed by 600 μM H2O2 for another 4 
hours, HUVECs were harvested to collect mitochondria. The rate of ATP synthesis was 
expressed by µmol ATP/min/g of mitochondrial protein. 
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4.1.5 Effects of exogenous H2S on mitochondrial 
membrane permeability 
JC-1 aggregates in healthy mitochondria and has a red ﬂuorescence (Fig. 4.1-11 A). 
Exposure of HUVECs to H2O2 resulted in an increase in green ﬂuorescence, 
indicating a loss in mitochondrial membrane potential (ΔΨm) (Fig. 4.1-11 B). 
Pretreatment of NaHS reduced the effects of H2O2 on mitochondrial membrane 
potential, indicating a protective effect of NaHS (Fig. 4.1-11 C). Pretreatment with 
PAG also resulted in the dissipation of mitochondrial membrane potential (Fig. 4.1-11 
D). Carbonyl cyanide m-chlorophenylhydrazone (CCCP), the positive control of the 
JC-1 staining in mitochondria, promoted mitochondrial inner membrane permeable 
leading to the dissipation of the proton gradient across the inner mitochondrial 
membrane (Fig. 4.1-11 E). The ratio of red and green ﬂuorescence was also used to 
demonstrate the toxicity of H2O2 treatment to mitochondria and the protective effect 
of NaHS (Fig. 4.1-11 F). Moreover, the ratio of aggregated JC-1 and monomeric JC-1 
were measured by flow cytometry. In control cells, JC-1 aggregated in mitochondria 
with the strong PI intensity and light FITC intensity, presenting to the ratio of PI/FITC. 
In contrast, H2O2-treated cells was observed a lower ratio (P< 0.05, vs. control), 
because the monomeric form of JC-1 appeared in the cytosol indicating the 
dissipation of ΔΨm. Cells pre-treated with NaHS attenuated the dissipation of ΔΨm 
(P< 0.05, vs. vehicle + H2O2), while PAG further increased the loss of membrane 
potential (P< 0.05, vs. control). 
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Fig. 4.1- 11 Effects of NaHS on mitochondrial membrane potential (ΔΨm). (A)-(E) 
JC-1 staining. Red ﬂuorescence represents the mitochondrial aggregate form of JC-1, 
indicating intact ΔΨm. Green ﬂuorescence represents the monomeric form of JC-1, 
indicating dissipation of ΔΨm. (E) CCCP was the positive control. Cells were observed 
under ×200 microscopy. Scale bar is shown at 100μm. (F) Ratio of red to green 
fluorescence, indicating ratio of JC-1 polymer/monomer. The data shown are mean ± 
SEM (n=6). * p<0.05, vs control. # p<0.05, vs vehicle + H2O2 group.
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One possible mechanism by which oxidative stress may trigger cellular toxicity in 
HUVECs is the induction of the mitochondrial apoptotic pathway that is triggered 
through the release of cytochrome c into the cytosol. To verify this possibility, the 
protective effect of NaHS on H2O2-induced toxicity was measured by determining the 
release of cytochrome c from mitochondria using Western-Blot analysis (Fig. 4.1-12) 
(n=6). In the control group, the presence of relatively low levels of cytochrome c was 
released from the mitochondria to cytosol. After incubation with H2O2, the 
cytochrome c levels were signiﬁcantly increased in the cytosol and decreased in 
mitochondria (P< 0.01, vs. control). Pretreatment with NaHS inhibited the release of 
cytochrome c (P< 0.01, vs. vehicle + H2O2), while pretreatment of PAG potentiated 
the release of cytochrome c to the cytosol (P< 0.01, vs. control). 
 
Fig. 4.1- 12 Effects of NaHS on release of cytochrome c from mitochondria. After 
treatments as previous description, HUVECs were harvested to collect mitochondria 
and cytosol. The protein expression was tested by western blot. The bar chart showed 
the ratio of cytochrome c in cytosol to that in mitochondria, indicating the intensity of 
release of cytochrome c. The data shown are mean ± SEM (n=6). ** p<0.01vs control. 
## p<0.01 vs vehicle + H2O2 group. 
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4.1.6 Endothelial cell ultrastructure observation 
Fig. 4.1-13 shows ultrastructural changes in HUVECs exposed to H2O2. In control 
cells, the ultrastructure was normal with intact nuclei and healthy looking 
mitochondria, endoplasmic reticulum and lysosomes (Fig. 4.1-13 A, E). In contrast, 
H2O2-treated HUVECs displayed condensed chromatin, an irregular nuclear outline, 
dilated or fragmented endoplasmic reticulum, swollen, ruptured or engulfed 
mitochondria, and darkened and clumping lysosomes. In addition the cytoplasm had 
significant vacuolization and protrusions (Fig. 4.1-13 B, F). In the NaHS pretreated 
HUVECs, the cellular ultrastructure appeared similar to that of the control endothelial 
cells although some mitochondria had expanded cristas, and darkened lysosomes, 
vacuoles and engulfed organelles (Fig. 4.1-13 C, G). In the PAG pretreated cells a 
more severe ultrastructural change was observed including nuclear chromatin 
condensation, multiple cytoplasmic protrusions or blebs, and ruptured or fragmented 
organelles (Fig. 4.1-13 D, H). Essentially, the transmission electron microscopic 
observations indicated that exogenous H2S could preserve cellular ultrastructural 
changes induced by H2O2 damage. 
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Fig. 4.1- 13 Ultrastructural changes in HUVECs induced by H2O2 using 
transmission electron microscopy. (A)-(D) showed HUVECs with legible nucleus. 
Scale bar is shown at 1μm. (E)-(H) showed mitochondria. Scale bar is shown at 0.2 μm. 
(A) and (E) cell and mitochondria in the control group; (B) and (F) cell and 
mitochondria in vehicle + H2O2 group; (C) and (G) cell and mitochondria in NaHS + 
H2O2 group; (D) and (H) cell and mitochondria in PAG + H2O2 group. 
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4.1.7 Effects of exogenous H2S on MDA formation and ROS 
production 
MDA is a product of lipid peroxidation. The data for the levels of cellular MDA are 
shown in Fig. 4.1-14 A (n=6). MDA levels were low in the normal control cells. 
Treatment with H2O2 signiﬁcantly increased cellular MDA levels indicating the 
elevation of oxidative stress (P< 0.01, vs. control). Pretreatment with NaHS reduced 
the formation of MDA induced by H2O2 (P< 0.01, vs. vehicle + H2O2), while 
pretreated PAG reversed the inhibition caused by NaHS (P< 0.01, vs. control). The 
study of DPPP staining was in line with MDA result, which showed the increase in 
fluorescent intensity of DPPP induced by H2O2 was reduced by NaHS and enhanced 
by PAG (P< 0.01) (Fig. 4.1-14 B). 
 
 
 
Fig. 4.1- 14 Effects of NaHS on lipid peroxidation. HUVECs were pretreated with 
vehicle, 300 μM NaHS or 10mM PAG for 6 hours, then 600 μM H2O2 for 4 hours. (A) 
MDA changes in HUVECs mediated by H2O2. The data are expressed at nmol/mg. (B) 
Fluorescent intensity of DPPP in HUVECs mediated by H2O2. The data shown are 
mean ± SEM (n=6). ** p<0.01vs control. ## p<0.01 vs vehicle + H2O2 group.
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Redox status was observed in H2DCFDA study (Fig. 4.1-15 A) (n=6). Administration 
of H2O2 induced an increase in the fluorescence intensity of H2DCFDA, as compared to 
the control group (P< 0.05). Pre-incubation with NaHS inhibited the levels of ROS 
induced by H2O2 (P< 0.05). However, pretreatment with PAG intensified the 
fluorescence intensity of H2DCFDA induced by H2O2 (P< 0.05). DHE is another dye 
for ROS detection, especially superoxide. Similar results were found that cells 
stimulated by H2O2 expressed higher fluorescent intensity of DHE than that of control, 
which were suppressed by NaHS and strengthened by PAG (P< 0.05) (n=6) (Fig. 
4.1-15 B). Our results suggest that exogenous H2S can suppress the productions of toxic 
free radicals. 
 
 
 
Fig. 4.1- 15 Effects of NaHS on ROS production. (A) ROS production was stained by 
10 μM H2DCFDA for 20 min, whose oxidation product (DCF) fluorescence indicated 
ROS formation. (B) ROS production was stained by 5 μM DHE for 30 min, which 
fluorescence indicated ROS formation. The absorbance values in (D)-(F) of HUVECs 
were normalized against the values for normal controls and expressed as a percentage 
of control. The data shown are mean ± SEM (n=6). * p<0.05, vs control. # p<0.05, vs 
vehicle + H2O2 group. 
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4.1.8 Effects of exogenous H2S on antioxidants activities and 
antioxidants enzyme protein expressions 
The activities of tissue antioxidant enzymes are shown in Table 4.1-1. When cells 
were stimulated with H2O2 a significant decreases in the activities of superoxide 
dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione 
S-transferase (GST) were observed (P< 0.05, vs. control, n=6). However, 
pretreatment with NaHS significantly elevated the activities of SOD, catalase, GST 
and GPx (P< 0.05, vs. vehicle + H2O2), while PAG strongly reduced the activities of 
these antioxidative enzymes (P< 0.01, vs. control). In our study, exogenous H2S was 
found to increase the activities of antioxidant enzymes as compared with 
H2O2-stimulated group. 
 
Table 4.1- 1 Antioxidant enzyme activities in each study groups   
 
SOD  
(U/ g ) 
Catalase 
(nmol/min/g) 
GPx 
(nmol/min/g) 
GST 
(nmol/min/g) 
Control 4.32±0.84 12.39±1.75 68.85±5.63 45.66±4.8 
H2O2 1.24±0.14** 7.35±1.08** 48.11±6.21** 27.41±4.0** 
NaHS 3.98±0.53## 9.42±1.38# 55.39±13.67# 32.48±3.35## 
PAG 0.82±0.11** 6.09±1.34** 42.85±6.23** 19.41±1.62** 
The data shown are mean ± SEM (n=6). ** p<0.01 vs control. # p<0.05, ## p<0.01 vs 
vehicle + H2O2 group. 
 
To support these findings, we examined the protein expression levels of SOD, 
catalase, GPx and GST in HUVECs, as shown in Fig. 4.1-16 (n=6). Protein 
expression levels were all decreased in the H2O2 and PAG groups as compared to the 
control group (P< 0.05). In the NaHS group higher protein expressions levels of 
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antioxidant enzymes was observed as compared to the H2O2 group (P< 0.05). These 
results are in line with the corresponding enzymes activities in the above experiments. 
Combined these data indicates that H2S can enhance the antioxidative systems in cells 
under H2O2-stimulated stress and thus preserve cellular redox balance. These data 
correlating with the preservation of mitochondrial integrity, reduced oxidative stress 
levels and the maintenance of cell viability by H2S. 
 
Fig. 4.1- 16 Effects of NaHS on protein expressions of antioxidant enzymes. (A) 
Western-blot analysis showing the intensities of Catalase, SOD-1, SOD-2, GST and 
GPx in each group, (B)-(F) bar charts indicating the different intensities of antioxidant 
proteins between groups. Values were normalized against the control values. The data 
shown are mean ± SEM (n=6). * p<0.05, ** p<0.01 vs control. # p<0.05, ## p<0.01 vs 
vehicle + H2O2 group. 
 
4.1.9 Protective effects of exogenous H2S against 
H2O2-induced injury though the inhibition of program 
cell death pathway and elevation of Akt pathway 
Expression levels of apoptosis-related proteins were shown in Fig. 4.1-17 (n=6). 
Bcl-2 and Bcl-XL are known to promote cell survival as well as to suppress cell death 
by various apoptotic stimuli, while Bax is a pro-apoptotic protein. Caspase-3, a key 
protein in apoptosis, is activated by cleaved. In our study, H2O2-induced cytotoxicity 
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accompanying with decreased the expression of Bcl-2 and Bcl-XL, increased the Bax  
and cleaved caspase-3 expressions (P＜0.05, vs. control). Pretreatment with NaHS 
prevented the decrease in the expression of Bcl-2 protein and Bcl-XL protein whereas 
it suppressed the increase of Bax expression and cleaved caspase-3 (P＜0.05, vs. 
vehicle + H2O2). The PAG showed the reverse effects of NaHS in Bcl-2, Bcl-XL, Bax 
and cleaved caspase-3 protein expressions (P＜0.05, vs. control).  
 
It is also determined the relative expression levels of the serine/threonine kinase Akt, 
shown in Fig. 4.1-17 (n=6). NaHS increased the level of phosphor-Akt/total Akt as 
compared with H2O2 (P＜0.05, vs. vehicle + H2O2). However, PAG inhibited the 
increase in the level of phosphor-Akt/ total Akt induced by NaHS (P＜0.05, vs. 
control). These results strongly suggest that suppressing mitochondrial program cell 
death by H2S may be responsible for the cellular and mitochondrial protection against 
the oxidative stress. 
 
Fig. 4.1- 17 Effects of NaHS on protein expressions of proapoptotic and 
antiapoptotic proteins. (A) Western blot analysis showed intensities of Bcl-2, Bcl-XL, 
Bax, Cleaved Caspase 3, p-Akt and Akt in each group. (B)-(F) the bar charts showed 
the different intensities of apoptosis-related proteins between groups. The values were 
normalized against the control values. The data shown are mean ± SEM (n=6). * 
p<0.05, ** p<0.01 vs control. # p<0.05, ## p<0.01 vs vehicle + H2O2 group. 
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4.2 Results of experiment II: Hydrogen 
sulfide protects isolated rabbit aorta 
mitochondria against hydrogen 
peroxide 
4.2.1 Effects of H2S on mitochondrial ROS production in 
isolated rabbits aorta 
ROS is generated from mitochondrial respiration chain. Dramatic and overwhelm 
ROS production will lead to oxidative stress. In our study, redox status was first 
observed by a ROS dye, H2DCFDA (Fig. 4.2-1 A) (n=6). Administration of H2O2 
1mM for 30min induced an increase in the fluorescence intensity of H2DCFDA, as 
compared to the control group (P< 0.01). Pre-incubation with NaHS (10, 100 and 300 
μM) for 1 hour inhibited the levels of ROS induced by H2O2 (P< 0.05, vs. control). 
However, pretreatment with PAG (10 mM) for 1 hour intensified the fluorescence 
intensity of H2DCFDA induced by H2O2 (p<0.01, vs. vehicle + H2O2). Redox status 
was further evaluated by another ROS dye DHE, which can detect free radicals 
especially superoxide. Similar results were found that cells stimulated by H2O2 
expressed higher fluorescent intensity of DHE than that of control (P＜0.05, vs. 
control). The fluorescent intensity of DHE were suppressed by NaHS (P＜0.05, vs. 
vehicle + H2O2) and strengthened by PAG pretreatment (P＜0.05, vs. control) (n=6) 
(Fig. 4.2-1 B). Our results suggest that exogenous H2S can suppress the productions 
of toxic free radicals. 
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Fig.4.2- 1 Effects of H2S on mitochondrial ROS production. After treatments, 
isolated rabbits aorta mitochondria reacted with ROS detector dye (A) H2DCFDA or 
(B) DHE. The absorbance values of the mitochondria were normalized against the 
values of control and presented as a percentage of control, which was set as 100%. The 
data shown are mean ± SEM (n=9). ## p<0.01 vs control. * p<0.05 vs vehicle + H2O2 
group. 
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4.2.2 Effects of H2S on mitochondrial respiration in isolated 
rabbits aorta 
Mitochondrial respiration oxygen consumption is a prime readout of mitochondrial 
oxidative phosphorylation. The measurement of oxygen consumption at state 3 and 
respiratory control ratio (RCR) provide direct and indirect information of 
mitochondrial function. After incubation with indicated compounds in the respiration 
buffer, the state 3 and 4 respirations were analyzed. The addition of 1mM H2O2 lead 
to significant reductions of state 3 oxygen consumption and RCR (P＜0.05, vs. 
control), but not in state 4 oxygen consumption. Pretreatments of NaHS (100 and 300 
μM ) significantly attenuated H2O2–induced decreases in state 3 oxygen consumption 
and RCR  (P＜0.05, vs. vehicle + H2O2), however, this recovery effects did not show 
in state 4 oxygen consumption. Pretreatment of PAG (10 mM) showed stronger 
deduction of state 3 oxygen consumption and RCR (P＜0.05, vs. control) and no 
significant effect on state 4 of mitochondrial respiration. The effects of H2S on 
mitochondrial respiration were shown in Fig.4.2-2.  
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Fig.4.2- 2 Effects of H2S on mitochondrial respiration. Freshly isolated rabbit aorta 
mitochondria were pretreated with NaHS or PAG, then incubation with H2O2. (A) State 
3 and (B) State 4 respiratory rates were presented as nmol (O)/min/mg protein. (C) 
Respiratory control ratio (RCR) is defined as the ratio of state3 to state 4 oxygen 
consumption. The data shown are mean ± SEM (n=9). # p<0.05 vs control. * p<0.05 vs 
vehicle + H2O2 group. 
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4.2.3 Effects of H2S on mitochondrial ATP synthesis in 
isolated rabbits aorta 
ATP synthesis is a major function of mitochondria, which supply cell energy. The ATP 
production reflects the function and status of mitochondria. The ATP/O ratio can be 
calculated by mitochondrial ATP synthesis rate over mitochondrial respiratory state 3 
rate. The incubation of H2O2 resulted in a decrease in ATP synthesis and ATP/O ratio 
(P＜0.01, vs. control). Pretreated with NaHS (100 and 300 μM) for 1 hour, 
significantly reduced the H2O2–induced decrease of ATP synthesis and ATP/O ratio (P
＜0.05, vs. vehicle + H2O2). However, pre-incubation with PAG (10 mM) for 1 hour, 
caused a deeper decline in ATP synthesis and ATP/O ratio(P＜0.05, vs. control). The 
effects of H2S on ATP synthesis and ATP/O ratio were shown in Fig. 4.2-3. 
 
Fig.4.2- 3 Effects of H2S on ATP synthesis and ATP/O ratio. After treatments, 
isolated rabbits aorta mitochondria reacted with ADP, pyruvate and malate as 
substrates. (A) were presented as nmol ATP/min/mg protein. (B) was shown as the 
ratio of ATP/O .The data shown are mean ± SEM (n=6). # p<0.05 vs control. * p<0.05 
vs vehicle + H2O2 group. 
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4.2.4 Effects of H2S on mitochondrial respiration chain 
complex and mitochondrial matrix enzymes in isolated 
rabbits aorta 
Oxidative phosphorylation is executed by the respiratory proteins, including 
mitochondrial complexes and matrix enzymes. The activities of these proteins 
enzymes reflect the status of mitochondrial respiration chain producing ATP and 
byproduct, ROS. After isolated aortic mitochondria exposed to H2O2, the activities of 
complex I, II/III and IV were significantly reduced (P＜0.05, vs. control), whereas 
activities of complex I, II/III and IV were rallied by the pretreatments of NaHS (P＜
0.05, vs. vehicle + H2O2) and more affected to lower levels by PAG (P＜0.05, vs. 
control). The effects of H2S on mitochondrial respiratory chain complexes were 
shown in Fig. 4.2-4. 
 
However, the same treatments did not show such strong effects on activities of PDHC 
and citrate synthase, but mild change in the activities of α-KGDHC by stimulation of 
H2O2 (P＜0.05, vs. control). Pretreatments of NaHS (300 μM) restored α-KGDHC 
activity (P＜0.05, vs. vehicle + H2O2) but failed to ameliorate impairments on 
activities of PDHC and citrate synthase. Pretreatments of PAG made the stronger 
reduced activities of α-KGDHC (P＜0.05, vs. control) and less sensitive effects on 
activities of PDHC and citrate synthase. The effects of H2S on mitochondrial matrix 
enzymes were shown in Fig. 4.2-5. 
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Fig.4.2- 4 Effects of H2S on activities of mitochondrial respiratory chain 
complexes. The values of enzymes activities of (A) complex I, (B) complex II/III and 
(C) complex IV in treated mitochondria were normalized against the values for controls 
and expressed as a percentage of control, which was set to 100%. The data shown are 
mean ± SEM (n=9). # p<0.05 vs control. * p<0.05 vs vehicle + H2O2 group. 
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Fig.4.2- 5 Effects of H2S on activities of mitochondrial matrix enzymes. The values 
of enzymes activities of (A) α-KGDHC, (B) citrate synthase and (C) PDHC in treated 
mitochondria were normalized against the values for controls and expressed as a 
percentage of control, which was set to 100%. The data shown are mean ± SEM (n=9). 
# p<0.05 vs control. * p<0.05 vs vehicle + H2O2 group. 
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4.2.5 Effects of H2S on mitochondrial membrane 
permeability in isolated rabbits aorta 
In the electron transport on the mitochondrial respiration chain, complexes I-IV pump 
H+ out from mitochondrial matrix to mitochondrial intermembrane and complex V 
pump H+ in, which establish an electrochemical potential (ΔΨm) resulting in a pH and 
a voltage gradient. Therefore, mitochondrial potential, ΔΨm, is a highly sensitive 
indicator of the status of mitochondrial respiration function. Addition of 1mM H2O2 
for 30 min, the ΔΨm dramatically decreased, compare to control group (P< 0.01). 
Pretreatments of NaHS (100 and 300 μM) for 1 hour, significantly prevented the 
H2O2–induced decrease of JC-1 fluorescence intensity ratio (P<0.01, vs. vehicle + 
H2O2). However, pre-incubation with PAG (10 mM) for 1 hour, caused a deeper 
decline in JC-1 fluorescence intensity ratio (P＜0.05, vs. control).  
 
Further, mitochondrial swelling was monitored by analyzing change of absorbance at 
540nm (A540), which also an indicator of mitochondrial membrane permeability. The 
absorbance significantly increased at H2O2 and PAG groups (P＜0.01, vs. control), 
but reduced at NaHS (100 and 300 μM) groups in dose dependence (P< 0.05, vs. 
vehicle + H2O2). The effects of H2S on JC-1 fluorescence intensity ratio and ΔA540 
were shown in Fig. 4.2-6. 
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Fig.4.2- 6 Effects of H2S on mitochondrial membrane permeability. After 
treatments, isolated rabbits aorta mitochondria reacted with (A) JC-1 to detect ΔΨm. (B) 
Mitochondrial swelling was detected by adding 5 mM sodium succinate and monitored 
at 540nm. The absorbance values of the mitochondria were normalized against the 
values of control and presented as a percentage of control, which was set as 100%. The 
data shown are mean ± SEM (n=9). ## p<0.01 vs control. * p<0.05, ** p<0.01 vs 
vehicle + H2O2 group.  
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4.3 Results of experiment III: Protective 
effects of Hydrogen sulfide on the 
development of atherosclerosis in 
hyperlipidemic rabbits 
4.3.1 Effects of H2S on the CSE/H2S pathway in the 
hyperlipidemic rabbit 
Fig. 4.3-1 shows the changes in the CSE/H2S pathway during the development of 
atherosclerosis. Compared with rabbits fed a normal diet (sham group), high 
cholesterol-fed rabbits (vehicle + HCD group) showed significantly lower serum H2S 
levels and thoracic aortic CSE activities, but higher aortic expressions of CSE mRNA 
(P< 0.05, vs. sham). In HCD-fed rabbits which were injected subcutaneously with 
sodium hydrosulfide (NaHS) 10 and 30 μmol/kg/d for 8 weeks, serum H2S levels 
showed dose-dependent increases (P< 0.05, vs. vehicle + HCD). Moreover, the aortic 
CSE activities and mRNA levels were decreased in a dose-dependent manner, and 
were significantly lower with 10 and 30 μmol/kg/d NaHS (P< 0.05, vs. vehicle + 
HCD). However, PAG + HCD rabbits had significantly lower serum H2S and aortic 
CSE activities, but higher aortic CSE mRNA (P< 0.05, vs. sham).  
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Fig.4.3- 1 Changes in CSE/H2S pathway in rabbits. (A) The changes of H2S levels in 
serum for each treatment group (expressed in μM). (B) CSE activities in HUVECs 
lysate of each group, presented as μmol/h/g. (C) CSE mRNA expression levels as 
determined by real-time PCR. The data shown are mean ± SEM (n=6). # p<0.05, ## 
p<0.01 vs sham. * p<0.05, ** p<0.01 vs vehicle + HCD group.  
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4.3.2 Effects of H2S on body weight and serum lipids in the 
New Zealand white (NZW) rabbits 
Fig. 4.3-2 showed the percentage increases in body weight in all rabbits. The body 
weight of rabbits fed a normal diet increased 15.94 ± 0.46 %, while the body weight 
of rabbits fed the HCD increased by 21.31 ± 2.67 % (P< 0.05, vs. sham). Injections of 
NaHS or PAG did not significantly affect the percentage increases in body weight.  
 
 
Fig.4.3- 2 Changes in body weight, serum lipid in rabbits of each group. The 
changes of percentage of increasing body weight for each treatment group, expressed in 
%. The data shown are mean ± SEM (n=6). # p<0.05, vs sham. group. 
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Fig. 4.3-3 shows the serum levels of LDL and total cholesterol (TC). Compared with 
sham rabbits, vehicle + HCD group showed increased serum levels of LDL and TC 
(P< 0.05, vs. sham). However, treatment with NaHS (30μmol/kg/d) suppressed the 
levels of LDL (P< 0.05, vs. vehicle + HCD); NaHS did not affect the levels of TC. 
The hyperlipidemic rabbits treated with PAG showed higher serum lipid levels, 
compared to sham rabbits (P< 0.05).  
 
 
Fig.4.3- 3 The cholesterol levels in serum of hyperlipidemic rabbits in each group. 
(A) LDL levels and (B) Total cholesterol levels were presented as mmol/L. The data 
shown are mean ± SEM (n=6). ## p<0.01 vs sham. * p<0.05 vs vehicle + HCD group. 
 
 
The oxysterols levels were also measured, seen in Fig. 4.3-4. Compared with sham 
group, other treatments rabbits all showed the high levels of oxysterols, including 
cholesteryl ester, 7-keto cholesterol, 7-OH, 24-OH, 25-OH, 27-OH cholesterols (P< 
0.05, vs. sham). Among them, NaHS (10 and 30μmol/kg/d) + HCD-fed rabbits showed 
significantly decreased sum of 24-OH, 25-OH, 27-OH cholesterols (P< 0.05, vs. 
vehicle + HCD), but did not present the lowering effects at other oxysterols. 
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Fig.4.3- 4 The oxysterols levels in serum of hyperlipidemic rabbits in each group. 
The levels of (A) cholesteryl ester, (B) 7-OH cholesterol, (C) 7-keto cholesterol and 
(D) sum of 24-OH, 25-OH, 27-OH cholesterols were presented as μg/ml. The data 
shown are mean ± SEM (n=6). # p<0.05 vs sham. * p<0.05, ** p<0.01 vs vehicle + 
HCD group. 
 
The full blood count was tested in the serum of hyperlipidemic rabbits in each group. 
Four main indices, white blood cell (WBC), monocytes, red blood cell (RBC) and 
hemoglobin (HGB), were shown in Fig 4.3-5. Compared with sham group, all 
treatments groups showed significant differences in these indices (P< 0.05, vs. sham). 
Although NaHS treatments showed an increase trend in the RBC levels compared to 
vehicle + HCD group, the differences have little significance. 
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Fig.4.3- 5 The levels of blood cells in serum of hyperlipidemic rabbits in each 
group. (A)WBC and (B) monocytes were presented as K/μL, (C) RBC levels were 
presented as M/μL, and (D) HGB were presented as g/dl. The data shown are mean ± 
SEM (n=6). # p<0.05 vs sham. * p<0.05 vs vehicle + HCD group. 
 
4.3.3 Effects of H2S on atherosclerotic plaques in the 
thoracic aorta and carotids of the NZW rabbits 
H & E staining was used to estimate plaque size and intima-media thickness (IMT) of 
thoracic aortas, which directly reflected the grade of the atherosclerotic lesions in 
aortas. It was shown that the atherosclerotic plaques were widely observed in vehicle 
+ HCD rabbits but not in sham rabbits (Fig. 4.3-6). Compared with vehicle + 
HCD-fed rabbits, IMT and plaque sizes were significantly diminished in NaHS (10 
and 30 μmol/kg/d) + HCD-fed rabbits and increased in PAG +HCD-fed rabbits (P< 
0.05). 
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Fig.4.3- 6 Aortic lesions by H&E staining in hyperlipidemic rabbits in each group. 
(A-F) The changes of aortic lesions for each treatment group, determined by H&E 
staning. Scale bar is shown at 100μm. (G) Itima-media thickness in impaired aorta of 
each group, presented as mm. (H) Plaque area in impaired aorta of each group, 
presented as mm2. The data shown are mean ± SEM (n=3). # p<0.05, ## p<0.01 vs 
sham. *p<0.05vs vehicle + HCD group. 
 
Similar results were determined from HRUS of the carotids of HCD-fed rabbits, using 
indices of IMT, Peak flow velocity (Vp) and Relative-Sectional change (RS) (Fig. 
4.3-7). Vp, a reflection of the hemodynamic status, is closely related to lumen stenosis 
RS is another important index of vascular elasticity. The atherosclerotic plaques were 
clearly evident in the carotid arteries of vehicle + HCD-fed rabbits (P< 0.05, vs. 
sham). These findings were greatly improved by injection of NaHS (10 and 30 
μmol/kg/d), which decreased IMT, Vp and RS in the carotid arterie of HCD-fed 
rabbits (P< 0.05, vs. vehicle + HCD). In the PAG + HCD-fed rabbits, the protective 
efforts caused by NaHS were reversed (P< 0.05, vs. sham). 
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Fig.4.3- 7 HRUS images of carotid artery lesions in hyperlipidemic rabbits in each 
group. (A1-2) The changes in carotid artery lesions for each treatment group, 
determined by HRUS images. (A1) showed the original images, while (A2) illustrated 
the plaques based on the protrudes at the intima. Scale bar is shown at 1mm. (B) 
Intima-media thickness in carotid artery of each group, presented as mm. (C) Peak flow 
velocity in impaired carotid artery of each group, presented as mm/s. (D) 
Relative-sectional changes in impaired carotid artery of each group.  
# p<0.05 vs sham. * p<0.05 vs vehicle + HCD group. 
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Echocardiogram is the test to accurately assess heart function and strength. Owing to 
early atherosclerotic lesions, the echocardiogram did not show any significant 
difference in each index of heart functions among all the groups (Table 4.3-1). 
 
Table 4.3- 1 The heart function detected by echocardiogram in rabbits of each 
group 
 
Sham Vehicle 
HCD+NaHS 
1μmol/kg/d  
HCD+NaHS 
10μmol/kg/d  
HCD+NaHS 
30μmol/kg/d  
HCD + PAG 
10mg/kg/d  
LVDd AVE 1.071±0.006  1.089±0.015  1.07±0.008  1.053±0.002  1.058±0.003  1.061±0.003  
LVDs AVE 0.568±0.018  0.555±0.017  0.503±0.01  0.568±0.004  0.509±0.011  0.517±0.018  
R-R AVE 0.188±0.006  0.231±0.009  0.211±0.005  0.202±0.004  0.196±0.004  0.219±0.006  
FS (%) 46.9±1.683  49.067±0.839  53±0.069  46.16±0.392  51.92±0.958  51.4±1.67  
EF (ratio) 0.821±0.017  0.844±0.008  0.875±0.005  0.817±0.004  0.8664±0.007  0.858±0.014  
CO (L/min) 0.673±0.037  0.559±0.013  0.628±0.018  0.586±0.011  0.6386±0.006  0.578±0.023  
EDV (ml) 2.486±0.039  2.6±0.096  2.472±0.045  2.374±0.008  2.398±0.017  2.432±0.018  
ESV (ml) 0.4482±0.043  0.416±0.0305  0.311±0.017  0.432±0.009  0.321±0.018  0.343±0.034  
SV (ml) 2.038±0.056  2.185±0.061  2.162±0.034  1.936±0.011  2.076±0.017  2.088±0.037  
MMHR 327.4±10.459  265.667±7.747  290.4±6.554  301.6±5.017  308.2±5.257  396.4±7.106  
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4.3.4 Effects of H2S on ultrastructure of thoracic aorta of 
NZW rabbits 
Transmission electron microscopy (TEM) showed the ultrastructure of aorta in 
hyperlipidemic rabbits (Fig.4-3-8). The endothelial cells were found to be easily 
dislodged during sample processing. The focus was thus on the ultrastructure of the 
sub-endothelium and smooth muscle cells (SMCs). Sham rabbits showed clear tight 
intercellular junctions, uniformly distributed subendothelial tissues. SMCs were 
normal with intact nuclei and healthy looking organelles. Aorta from vehicle + 
HCD-fed rabbits showed ultrastructural disorders comprising thickened 
subendothelium, messy collagen, lipid droplets and vacuoles. SMCs displayed 
condensate chromatin, swollen mitochondria and expanding endoplasmic reticulum 
with cell debris and lipid droplets. The ultrastructure of aorta of rabbits treated with 
NaHS (1 μmol/kg/d) + HCD did not show significant difference from aorta from 
vehicle + HCD-fed rabbits. However, the ultrastructure of aorta of rabbits treated with 
NaHS (10 and 30 μmol/kg/d) +HCD was more similar to that of the sham group. It 
can also be seen that some SMCs showed vascular degeneration with slightly 
expanded mitochondria and endoplasmic reticulum; subendothelial tissues were 
thickened with vacuoles. Aorta from the PAG + HCD-fed rabbits showed more severe 
ultrastructural disorders compared to that of sham. The subendothelial layer was 
stacked with cell debris; the internal elastic membranes were uneven with messy 
collagen; SMCs were ultrastructural distorted with shrunken nuclei, unclear or 
corrupted organelles. 
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Fig.4.3- 8 Ultrastructures of thoracic aorta of rabbits. Subendothelium and smooth 
muscle cells of aorta in (A) the sham group; (B) vehicle + HCD group; (C) HCD + 
NaHS 1 μmol/kg/d group; (D) HCD + NaHS 10 μmol/kg/d group; (E) HCD + NaHS 30 
μmol/kg/d group; (F) HCD + PAG 10mg/kg/d group. Bold white “N” represented 
nucleus of smooth muscle cells. Scale bar is shown on individual images. 
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4.3.5 Effects of H2S on oxidative modification of LDL in the 
NZW rabbits 
Serum ox-LDL (analyzed by enzyme-linked immunosorbent assay [ELISA]), was 
significantly higher in vehicle + HCD-fed and PAG + HCD-fed rabbits (both P< 0.05, 
vs. sham), but significantly depressed in NaHS (30μmol/kg/d) + HCD-fed rabbits (P< 
0.05, vs. vehicle + HCD), seen in Fig.4.3-9.  
 
 
Fig.4.3- 9 Serum ox-LDL in hyperlipidemic rabbits in each group. ox-LDL levels 
in serum determined by ELISA, presented as μg/L.The data shown are mean ± SEM 
(n=6). # p<0.05, ## p<0.01 vs sham. * p<0.05 vs vehicle + HCD group. 
 
 
 
Hepatic levels of MDA, a product of lipid peroxidation, in all groups of rabbits are 
shown in Fig4.3-10. Vehicle + HCD-fed and PAG +HCD-fed rabbits showed higher 
levels of MDA while NaHS (10 and 30μmol/kg/d) +HCD-fed rabbits showed 
decreased levels of MDA (P< 0.05, vs. sham)  
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Fig.4.3- 10  MDA levels in livers of hyperlipidemic rabbits in each group.The data 
shown are presented as nmol/mg and mean ± SEM (n=6). ## p<0.01 vs sham. * p<0.05, 
** p<0.01vs vehicle + HCD group. 
 
Heme oxygenase-1 (HO-1), a cardioprotective and redox-sensitive protein, has a close 
relationship to lipid peroxidation. The protein and gene expressions of HO-1 in 
thoracic aortas of rabbits in each treatment group were shown in Fig.4-11 A and B. In 
the vehicle + HCD-fed rabbits, HO-1 protein and mRNA levels were slightly 
increased (P< 0.05, vs. sham); while in the NaHS (10 and 30μmol/kg/d) + HCD-fed 
rabbits, HO-1 protein and mRNA levels were significantly increased (P< 0.05, vs. 
vehicle + HCD). In the PAG + HCD-fed rabbits, HO-1 protein and mRNA levels were 
significantly decreased (P< 0.05, vs sham). 
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Fig.4.3- 11 HO-1 protein and gene levels in thoracic aortas of hyperlipidemic 
rabbits in each group. (A) HO-1 protein expressions in thoracic aorta of each group. 
(B) HO-1 mRNA expressions in thoracic aorta of each group. The data shown are 
presented as nmol/mg and mean ± SEM (n=6). # p<0.05 vs sham. * p<0.05, ** 
p<0.01vs vehicle + HCD group. 
 
4.3.6 Effects of H2S on oxidative stress in the NZW rabbits 
Fig. 4.3-12 shows the effects of different concentrations of NaHS on the redox state in 
the livers of hyperlipidemic rabbits. These are reflected in the activities of superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione 
S-transferase (GST), and levels of glutathione (GSH). Compared with sham rabbits, 
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vehicle + HCD-fed rabbits showed lower activities of these four antioxidant enzymes 
as well as levels of GSH (P< 0.05). NaHS (1 μmol/kg/d) increased the activities of 
SOD, CAT and GPx (P< 0.05, vs. vehicle + HCD), but did not significantly influence 
the activity of GST and levels of GSH. NaHS (10 and 30 μmol/kg/d) increased the 
activities of these four antioxidants and levels of GSH (P< 0.05, vs. vehicle + HCD). 
PAG reversed the effects of NaHS, showing the lesser activities of SOD, CAT, GPx, 
GST and lower levels of GSH (P< 0.05, vs. sham).   
 
Fig.4.3- 12 Effects of NaHS to the redox state analyzed in livers of hyperlipidemic 
rabbits in each group. (A) SOD-1 activities and (B) catalase activities were presented 
as U/mg; (C) GPx activities and (D) GST activities were presented as μmol/min/mg; 
(E) GSH activities were presented as μM/mg. The data shown are mean ± SEM (n=6). # 
p<0.05, ## p<0.01 vs sham. * p<0.05, ** p<0.01 vs vehicle + HCD group. 
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These results were consistent with protein expression levels of SOD-1, CAT, GPx and 
GST in the aorta of the hyperlipidemic rabbits (Fig. 4.3-13). The intensities of these 
proteins were lighter in vehicle + HCD-fed and PAG + HCD-fed rabbits than in the 
sham group. NaHS (1 μmol/kg/d) increased CAT expression in the aorta. NaHS (10 
and 30 μmol/kg/d) significantly increased the expressions of all four antioxidative 
enzymes.  
 
 
Fig.4.3- 13 Proteins expressions of antioxidants in aortas of hyperlipidemic 
rabbits in each group. (A)-(D) Western-blot analysis showing the intensities of 
SOD-1, Catalase, GST and GPx in each treatment group, were presented in bar charts 
indicating the different intensities of antioxidant proteins between groups. Values were 
normalized against the sham values. The data shown are mean ± SEM (n=6). # p<0.05 
vs sham. * p<0.05 vs vehicle + HCD group. 
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Gene expressions of SOD-1, CAT, GPx and GST in the aorta of the rabbits also 
support the protein findings, shown in Fig. 4.3-14. Lower gene expressions of these 
four enzymes were found in vehicle + HCD-fed and PAG + HCD-fed rabbits (P< 0.05, 
vs sham), while higher expressions were found in NaHS (10 and 30 
μmol/kg/d)-treated rabbits (P< 0.05, vs vehicle + HCD). 
 
 
Fig.4.3- 14 Gene expressions of antioxidants in aortas of hyperlipidemic rabbits in 
each group. (A) SOD-1, (B) catalase, (C) GST and (D) GPx mRNA expression tested 
by real-time PCR. The values in (A)-(D) were normalized against the sham values. The 
data shown are mean ± SEM (n=6). # p<0.05, ## p<0.01 vs sham. * p<0.05, ** p<0.01 
vs vehicle + HCD group. 
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4.3.7 Effects of H2S on cell adhesion in the NZW rabbits 
Mechanism of cell adhesion assists the ox-LDL to stimulate vascular endothelial cells 
to express various adhesive cytokines, such as VCAM-1, ICAM-1, MMP-9 and 
MCP-1, which lead to the attachment of leucocytes to the endothelium. To examine 
the abilities of anti-atherogenesis by H2S, firstly, we measured the soluble VCAM-1 
(sVCAM-1), soluble ICAM-1 (sICAM-1), MMP-9 and MCP-1 in plasma of NZW 
rabbits, seen in Fig.4.3-15. ELISA showed quite low levels of sVCAM-1, sICAM-1, 
MMP-9 and MCP-1, but significantly increased by HCD treatment (P< 0.05, vs. 
sham), NaHS (30 μmol/kg/d) significantly attenuated HCD-induced adhesion 
molecules expressions (P< 0.01, vs. vehicle + HCD), while NaHS (10 μmol/kg/d) 
suppressed HCD-induced sVCAM-1, MMP-9 and MCP-1 (P< 0.05, vs. vehicle + 
HCD). Treatment of PAG also elevated the levels of these adhesive cytokines in 
plasma (P< 0.05, vs. sham).  
 
Fig.4.3- 15 Cytokines of cell adhesions in serum of hyperlipidemic rabbits in each 
group. (A) sVCAM-1, (B) sICAM-1, (C) MCP-1 and (D) MMP-9 expressions in 
serum tested by ELISA. The values in (A)-(D) were presented μg/L. The data shown 
are mean ± SEM (n=6). # p<0.05, ## p<0.01 vs sham. * p<0.05, ** p<0.01 vs vehicle + 
HCD group. 
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The similar profile was observed by analyzing aorta protein and mRNA expressions 
of adhesion molecules (Fig.4.3-16). Protein expressions of MMP-9 and VCAM-1 
were augmented by vehicle +HCD treatment, compared to low expressions in sham 
(P< 0.05). Contrary, NaHS (10 and 30 μmol/kg/d) led to reduced expressions of 
MMP-9 and VCAM-1(P< 0.05, vs. vehicle + HCD). PAG abolished the anti-cell 
adhesion effects made by NaHS. Sham rabbits showed a low constitutive transcription 
of adhesion molecules, while intaking HCD 8 weeks caused a significant increase in 
mRNA levels of VCAM-1, ICAM-1, MMP-9 and MCP-1 (Fig.4.3-17). Injection of 
NaHS (10 and 30 μmol/kg/d) resulted in decreases of mRNA of above adhesion 
molecules (P< 0.05, vs. vehicle + HCD). PAG exhibited the amplified transcription of 
adhesion molecules (P< 0.05, vs. sham). 
 
 
Fig.4.3- 16 Aortic proteins expressions of cell adhesion in hyperlipidemic rabbits 
of each group. (A)-(B) Western-blot analysis showing the intensities of VCAM-1and 
MMP-9 in aortas of each treatment group, were presented in bar charts indicating the 
different intensities of antioxidant proteins between groups. Values were normalized 
against the sham values. The data shown are mean ± SEM (n=6). # p<0.05 vs sham. 
*p<0.05 vs vehicle + HCD group.
 Chapter 4 
136 
 
 
 
 
Fig.4.3- 17 Aortic genes expressions of cell adhesions in hyperlipidemic rabbits of 
each group. (A) VCAM-1, (B) ICAM-1, (C) MCP-1 and (D) MMP-9 mRNA 
expressions in aortas tested by real-time PCR. The values in (A)-(D) were normalized 
against the sham values. The data shown are mean ± SEM (n=6). ## p<0.01 vs sham. * 
p<0.05, ** p<0.01 vs vehicle + HCD group. 
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4.4 Results of experiment IV: Protective 
effects of S-Propargyl-cysteine on 
the development of atherosclerosis 
in hyperlipidemic rabbits 
4.4.1 Effects of SPRC on the CSE/H2S pathway in the 
hyperlipidemic rabbit 
Fig. 4.4-1 shows the changes in the CSE/H2S pathway during the development of 
atherosclerosis. Compared with rabbits fed a normal diet (sham group), high 
cholesterol-fed rabbits (vehicle + HCD group) showed significantly lower serum H2S 
levels and thoracic aortic CSE activities, but higher aortic expressions of CSE mRNA 
(P< 0.05, vs. sham). In HCD-fed rabbits which were injected subcutaneously with 
s-propargyl-cysteine (SPRC) (10 μmol/kg/d) for 8 weeks, serum H2S levels showed 
dose-dependent increases, which were significantly higher than in vehicle + HCD-fed 
rabbits (P< 0.05, vs. vehicle + HCD). Moreover, the aortic CSE activities and mRNA 
levels were significantly increased in SPRC 10 μmol/kg/d (P< 0.05, vs. vehicle + 
HCD). However, PAG + HCD rabbits had significantly lower serum H2S and aortic 
CSE activities, but higher aortic CSE mRNA (P< 0.05, vs. sham). 
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Fig.4.4- 1 Changes in CSE/H2S pathway in rabbits of each group. (A) The changes 
of H2S levels in serum for each treatment group (expressed in μM). (B) CSE activities 
in HUVECs lysate of each group, presented as μmol/h/g. (C) CSE mRNA expression 
levels as determined by real-time PCR. The data shown are mean ± SEM (n=6). # 
p<0.05, ## p<0.01 vs sham. * p<0.05 vs vehicle + HCD group.  
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4.4.2 Effects of SPRC on body weight and serum lipids in 
the New Zealand white (NZW) rabbits 
Fig. 4.4-2A showed the percentage increases in body weight in all rabbits. The 
percentage of increasing body weights of rabbits fed chow diet increased 13.18 ± 
0.67 %. Compared to sham group, the percentage of increasing body weights of 
rabbits fed HCD in all vehicle, SPRC and PAG groups significantly increased (P< 
0.01, vs. sham). Injections of SPRC or PAG did not significantly affect the percentage 
increases in body weight, compared to vehicle+ HCD group. 
 
Fig. 4.4-2 B-C shows the serum levels of LDL and total cholesterol (TC). Compared 
with sham rabbits, vehicle + HCD group showed dramatically increased serum levels 
of LDL and TC (P< 0.05, vs. sham). However, treatment with SPRC (10 μmol/kg/d) 
suppressed the levels of LDL (P< 0.05, vs. vehicle + HCD); SPRC did not affect the 
levels of TC. The hyperlipidemic rabbits treated with PAG showed higher serum lipid 
level, compared to sham rabbits (P< 0.05, vs. sham).  
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Fig.4.4- 2 Changes in body weight, serum lipid in rabbits of each group. (A) The 
changes of percentage of increasing body were expressed in %. (B) Total cholesterol 
and (C) LDL were expressed in mmol/L. The data shown are mean ± SEM (n=6). ## 
p<0.01 vs sham. * p<0.05 vs vehicle + HCD group. 
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4.4.3 Effects of SPRC on atherosclerotic plaques in the 
thoracic aorta and carotids of the NZW rabbits 
H & E staining was used to estimate plaque size and intima-media thickness (IMT) of 
thoracic aortas, which directly reflected the grade of the atherosclerotic lesions in 
aortas. It was shown that the atherosclerotic plaques were widely observed in vehicle 
+ HCD rabbits but not in sham rabbits (Fig. 4.4-3). Compared with vehicle + 
HCD-fed rabbits, IMT and plaque sizes were significantly diminished in SPRC (10 
μmol/kg/d) + HCD-fed rabbits and increased in PAG +HCD-fed rabbits (P< 0.05). 
  
Fig.4.4- 3 Thoracic aortic lesions by H&E staining in hyperlipidemic rabbits of 
each group.(A-E) The changes of aortic lesions for each treatment group, determined 
by H&E staning. (F) Itima-media thickness in impaired aorta of each group, presented 
as mm. (G) Plaque area in impaired aorta of each group, presented as mm2. The data 
shown are mean ± SEM (n=3). ## p<0.01 vs sham. *p<0.05 vs vehicle + HCD group. 
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Similar results were determined from HRUS of the carotids of HCD-fed rabbits, using 
indices of IMT, Peak flow velocity (Vp) and Relative-Sectional change (RS) (Fig. 
4.4-4). Vp, a reflection of the hemodynamic status, is closely related to lumen stenosis. 
RS is another important index of vascular elasticity. The atherosclerotic plaques were 
clearly evident in the carotid arteries of vehicle + HCD-fed rabbits (P< 0.05, vs. 
sham). These findings were greatly improved by injection of SPRC (10 μmol/kg/d), 
which decreased IMT, Vp and RS in the carotid arterie of HCD-fed rabbits (P< 0.05, 
vs. vehicle + HCD). In the PAG + HCD-fed rabbits, the protective efforts caused by 
SPRC were reversed (P< 0.05, vs. sham). 
 
 
Fig.4.4- 4 HRUS images of carotid artery lesions in hyperlipidemic rabbits of each 
group.(A1-2) (A1)showed the original images, while (A2) illustrated the plaques 
based on the protrudes at the intima. Scale bar is shown at 1mm. (B) Intima-media 
thickness in carotid artery of each group, presented as mm. (C) Peak flow velocity in 
impaired carotid artery of each group, presented as mm/s. (D) Relative-sectional 
changes in impaired carotid artery of each group. ## p<0.01 vs sham. * p<0.05 vs 
vehicle + HCD group. 
                                                                                                         
Chapter 4 
143 
 
Echocardiogram is the test to accurately assess heart function and strength. Owing to 
early atherosclerotic lesions, the echocardiogram did not show any significant 
difference in each index of heart functions among all the groups (Table 4.4-1). 
Table 4.4- 1 The heart function detected by echocardiogram among rabbits 
 
4.4.4 Effects of SPRC on ultrastructure of thoracic aorta of 
NZW rabbits 
Transmission electron microscopy (TEM) showed the ultrastructure of aorta in 
hyperlipidemic rabbits (Fig. 4.4-5). The endothelial cells were found to be easily 
dislodged during sample processing. The focus was thus on the ultrastructure of the 
sub-endothelium and smooth muscle cells (SMCs). Sham rabbits showed clear tight 
intercellular junctions, uniformly distributed subendothelial tissues. SMCs were 
 
Sham Vehicle 
HCD+SPRC 
1 μmol/kg/d 
HCD+SPRC 
10 
μmol/kg/d 
HCD + PAG 
10 mg/kg/d 
LVDd AVE 1.069±0.004 1.091±0.007 1.114±0.024 1.071±0.012 1.078±0.005 
LVDs AVE 0.571±0.013 0.562±0.014 0.640±0.020 0.503±0.006 0.544±0.015 
R-R AVE 0.189±0.007 0.228±0.009 0.219±0.009 0.210±0.009 0.211±0.008 
FS (%) 47.2±1.276 50.3±1.349 46.2±1.620 53.0±0.501 51.8±1.42 
EF (ratio) 0.856±0.009 0.869±0.008 0.807±0.011 0.875±0.004 0.866±0.012 
CO (L/min) 0.703±0.029 0.636±0.018 0.573±0.027 0.628±0.037 0.647±0.021 
EDV (ml) 2.526±0.045 2.718±0.075 2.784±0.158 2.472±0.072 2.798±0.086 
ESV (ml) 0.501±0.037 0.526±0.051 0.673±0.069 0.311±0.012 0.588±0.071 
SV (ml) 2.166±0.048 2.179±0.054 2.106±0.031 2.162±0.067 2.112±0.063 
MMHR 345.7±8.567 277.3±9.412 281.4±9.234 290.4±11.169 390.1±9.052 
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normal with intact nuclei and healthy looking organelles. Aorta from vehicle + 
HCD-fed rabbits showed ultrastructural disorders comprising thickened 
subendothelium, messy collagen, lipid droplets and vacuoles. SMCs displayed 
condensate chromatin, swollen mitochondria and expanding endoplasmic reticulum 
with cell debris and lipid droplets. The ultrastructure of aorta of rabbits treated with 
SPRC (1 μmol/kg/d) + HCD did not show significant difference from aorta from 
vehicle + HCD-fed rabbits. However, the ultrastructure of aorta of rabbits treated with 
SPRC (10 μmol/kg/d) +HCD was more similar to that of the sham group. It can also 
be seen that some SMCs showed vascular degeneration with slightly expanded 
mitochondria and endoplasmic reticulum; subendothelial tissues were thickened with 
vacuoles. Aorta from the PAG + HCD-fed rabbits showed more severe ultrastructural 
disorders compared to that of sham. The subendothelial layer was stacked with cell 
debris; the internal elastic membranes were uneven with messy collagen; SMCs were 
ultrastructural distorted with shrunken nuclei, unclear or corrupted organelles.   
 
Fig.4.4- 5 Ultrastructures of thoracic aorta of rabbits. Subendothelium and smooth 
muscle cells of aorta in (A) the sham group; (B) vehicle + HCD group; (C) HCD + 
SPRC 1 μmol /kg/d group; (D) HCD + SPRC 10 μmol/kg/d group; (E) HCD + PAG 
10mg/kg/d group. Bold white “N” represented nucleus of smooth muscle cells. Scale 
bar is shown on individual images. 
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4.4.5 Effects of SPRC on oxidative stress in the NZW 
rabbits 
Fig. 4.4-6 A-E shows the effects of different concentrations of NaHS on the redox 
state in the livers of hyperlipidemic rabbits. These are reflected in the activities of 
superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and 
glutathione S-transferase (GST), and levels of glutathione (GSH). Compared with 
sham rabbits, vehicle + HCD-fed rabbits showed lower activities of these four 
antioxidant enzymes as well as levels of GSH (P< 0.05). SPRC (1 μmol/kg/d) 
increased the activities of SOD, CAT and GPx (P< 0.05, vs. vehicle + HCD), but did 
not significantly influence the activity of GST and levels of GSH. SPRC (10 
μmol/kg/d) increased the activities of these four antioxidants and levels of GSH (P< 
0.05, vs. vehicle + HCD). PAG reversed the effects of NaHS, showing the lesser 
activities of SOD, CAT, GPx, GST and lower levels of GSH (P< 0.05, vs. sham).  
 
Hepatic levels of MDA, a product of lipid peroxidation, in all groups of rabbits are 
shown in Fig. 4.4-6 F. Vehicle + HCD-fed and PAG +HCD-fed rabbits showed higher 
levels of MDA (P< 0.05, vs. sham), while SPRC (10 μmol/kg/d) +HCD-fed rabbits 
showed decreased levels of MDA (P< 0.05, vs. vehicle + HCD)  
 
These results were consistent with protein expression levels of SOD-1, CAT, GPx and 
GST in the aorta of the hyperlipidemic rabbits (Fig. 4.4-7). The intensities of these 
proteins were lighter in vehicle + HCD-fed and PAG + HCD-fed rabbits than in the 
sham group (P< 0.05, vs. sham). SPRC (10 μmol/kg/d) significantly increased the 
expressions of all four antioxidative enzymes (P< 0.05, vs. vehicle + HCD).  
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Fig.4.4- 6 Effects of SPRC to the redox state analyzed in livers of hyperlipidemic 
rabbits of each group. (A) SOD-1 activities and (B) catalase activities were presented 
as U/mg; (C) GPx activities and (D) GST activities were presented as μmol/min/mg; 
(E) GSH activities were presented as μM/mg; (F) levels of MDA were shown are 
presented as nmol/mg The data shown are mean ± SEM (n=6). ## p<0.01 vs sham. * 
p<0.05, ** p<0.01 vs vehicle + HCD group. 
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Fig.4.4- 7 Proteins expressions of antioxidants in aortas of hyperlipidemic rabbits 
of each group. (A)-(D) Western-blot analysis showing the intensities of SOD-1, 
Catalase, GST and GPx in each treatment group, were presented in bar charts indicating 
the different intensities of antioxidant proteins between groups. Values were 
normalized against the sham values. The data shown are mean ± SEM (n=6). # p<0.05, 
## p<0.01 vs sham. * p<0.05, ** p<0.01 vs vehicle + HCD group. 
 
 
Gene expressions of SOD-1, CAT, GPx and GST in the aorta of the rabbits also 
support the protein findings, shown in Fig. 4.4-8. Lower gene expressions of these 
four enzymes were found in vehicle + HCD-fed and PAG + HCD-fed rabbits (P< 0.05, 
vs sham), while significantly higher expressions were found in SPRC (10 
μmol/kg/d)-treated rabbits (P< 0.05, vs vehicle + HCD). 
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Fig.4.4- 8 Gene expressions of antioxidants in aortas of hyperlipidemic rabbits of 
each group (A) SOD-1, (B) catalase, (C) GST and (D) GPx mRNA expression tested 
by real-time PCR. The values in (A)-(D) were normalized against the sham values. The 
data shown are mean ± SEM (n=6). # p<0.05, ## p<0.01 vs sham. * p<0.05, ** p<0.01 
vs vehicle + HCD group. 
 
 
4.4.6 Effects of SPRC on cell adhesion in the NZW rabbits 
Various adhesion cytokines, such as VCAM-1, ICAM-1, MMP-9 and MCP-1, induce 
leucocytes binding to endothelial cell. To examine the abilities of anti-atherogenesis 
by H2S, firstly, we measured the soluble VCAM-1 (sVCAM-1), soluble ICAM-1 
(sICAM-1), MMP-9 and MCP-1 in plasma of NZW rabbits, seen in Fig. 4.4-9. ELISA 
showed quite low levels of sVCAM-1, sICAM-1, MMP-9 and MCP-1, but 
significantly increased by HCD treatment (P< 0.05, vs. sham), SPRC (10 μmol/kg/d) 
significantly attenuated HCD-induced adhesion molecules expressions (P< 0.01, vs. 
vehicle + HCD). Treatment of PAG also elevated the levels of these adhesion 
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cytokines in plasma (P< 0.05, vs. sham).  
 
 
 
Fig.4.4- 9 Cytokines of cell adhesions in serum of hyperlipidemic rabbits of each 
group. (A) sVCAM-1, (B) sICAM-1, (C) MCP-1 and (D) MMP-9 expressions in 
serum tested by ELISA. The values in (A)-(D) were presented μg/L. The data shown 
are mean ± SEM (n=6). ## p<0.01 vs sham. * p<0.05 vs vehicle + HCD group. 
 
 
The similar profile was observed by analyzing aorta mRNA expressions of adhesion 
molecules (Fig.4.4-10). Sham rabbits showed a low constitutive transcription of 
adhesion molecules, while intaking HCD 8 weeks caused a significant increase in 
mRNA levels of VCAM-1, ICAM-1, MMP-9 and MCP-1. Injection of SPRC (10 
μmol/kg/d) resulted in decreases of mRNA of above adhesion molecules (P< 0.05, vs. 
vehicle + HCD). PAG exhibited the amplified transcription of adhesion molecules (P< 
0.05, vs. sham). 
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Fig.4.4- 10 Aortic genes expressions of cell adhesions in hyperlipidemic rabbits of 
each group. (A) VCAM-1, (B) ICAM-1, (C) MCP-1 and (D) MMP-9 mRNA 
expressions in aortas tested by real-time PCR. The values in (A)-(D) were normalized 
against the sham values. The data shown are mean ± SEM (n=6). ## p<0.01 vs sham. * 
p<0.05 vs vehicle + HCD group. 
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5.1 Discussion on experiment I: 
This part study explored the cardiovascular protective effects by H2S on H2O2 
induced injured in HUVECs as assessed by measurements of mitochondrial integrity 
and antioxidative systems. It is well known that oxidative stress is a potent 
atherogenic factor during the initiation of atherosclerotic lesions. Oxidized 
cholesterol particles promote inflammation, the formation of plaques and the 
migration of smooth muscle cells, which all contribute to the development of 
atherosclerotic lesions. Moreover, at the cellular level, these toxic free radicals can 
also damage mitochondria. Identifying chemical agents and drugs that can protect 
mitochondria is a rational means to prevent severe cellular damages. However, the 
current treatments for atherosclerosis are limited and with strong adverse drug 
reactions occurring in some patients. Previous studies on H2S, have found it to be a 
vasodilator in the cardiovascular system, yet few studies have determined the effects 
of H2S on the endothelium nor the mechanisms by which it can protect 
mitochondrial function and suppressing oxidative damage. To test our hypothesis 
that H2S has a protective effect on the endothelium against cell damage, we used 
HUVECs as a model system. Oxidative injury was induced by H2O2 treatment and 
the protective effects of H2S assessed using the donor compound, NaHS. 
Considering the important roles of mitochondria in cell energy production, free 
radical generation and cell survival, this research unveils for the first time the 
mechanisms involved in mitochondria protection by H2S in endothelial cells. 
 
We first evaluated the toxicity of H2S in HUVECs. Cell viability studies indicated 
that H2S was non-toxic at the μM levels. In addition, we also demonstrated a 
concentration dependent protective effect of H2S against H2O2 induced loss of cell 
viability. Moreover, the protective effect of H2S against H2O2 may be regulated by 
inhibition of early apoptosis. Interestingly, H2S is synthesized by the enzymes CSE 
and cystathionine β-synthase (CBS) [266]. CSE is expressed in the cardiovascular 
system, liver, kidney, stomach and uterus; while CBS is chiefly located in the 
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nervous system, liver, kidney, placenta and pancreatic islets [23]. In our study, we 
found that CSE gene and protein expression levels were suppressed by H2O2 
treatment. This observation has been further confirmed by the noted reduction in H2S 
levels in cell lysates following H2O2 treatment. Parallel studies also found that CBS 
gene and protein expression levels were not significantly influenced by H2O2, H2S or 
PAG treatments. The trends in H2S levels, CSE and CBS gene and protein 
expressions correspond well with our investigations on the changes of mitochondria 
functions and redox status. Furthermore, as an irreversible inhibitor of the H2S 
enzyme CSE, PAG is a key enzyme involved in glutathione synthesis [267]and the 
metabolic trans-sulfuration pathway which regulates homocysteine concentration 
and mediates cysteine synthesis[268]. NaHS and PAG on CSE showed increasing 
and decreasing effects, respectively, which may resulted from the weaker or stronger 
lesions in endothelial cells, with tender feedbacks induced by the acute damage 
(within 4 hours) to this sulfide-producing enzyme, CSE. In a study design, necessity 
of an inhibitor (PAG) can help to observe the effects of imposed drug (H2S). The 
adverse effects of the targeted drug (H2S) induced by the inhibitor (PAG), may 
indicate that the results of an experiments may be due to influences of the drug (H2S). 
Therefore, in our experiments, PAG was introduced through all the studies. 
Consequently, our observations correspond with previous findings about the 
localization of H2S synthesis enzymes, suggesting the mitochondria protective 
effects by exogenous H2S are probably though CSE/H2S pathway. 
 
We further explored the mechanisms of action of H2S on H2O2 induced cells viability. 
Since mitochondrial function is linked to cell redox status, and that H2S is a known 
redox active molecule, we conducted a series of studies on mitochondria. The 
primary function of mitochondria is to generate ATP by the process of oxidative 
phosphorylation [269]. ATP synthesis is driven via the transfer of electrons through 
complex I to V generating a concentration gradient of protons across the inner 
mitochondrial membrane thus maintaining membrane potential [270]. During stress 
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induction electron transportation and ATP synthesis often fails leading to the 
accumulation of free radicals and mitochondrial dysfunction [271]. In our study, 
ATP synthesis was increased following pre-treatment with H2S. In contrast, H2O2 
abolished ATP synthesis. This result suggests that exogenous H2S stimulates 
efficient oxidative phosphorylation rates thus raising mitochondrial energy 
metabolism. This leads us to speculate that one of the mechanisms of H2S protection 
against oxidants may be directly through improved rates of ATP synthesis. 
 
An additional factor involved in mitochondrial functions is the integrity of the 
mitochondrial membrane structure, which is responsible for the transmembrane 
proton gradient and ATP energy production [243]. During a severe stress insult, 
mitochondrial membrane depolarization occurs leading to organelle swelling 
resulting in ROS production, ATP hydrolysis and apoptosis [272]. Several lines of 
evidence have demonstrated that atherosclerotic lesions are promoted by 
mitochondrial depolarization [273] and cytochrome c redistribution [274]. Under our 
experimental conditions, preconditioning with NaHS attenuated the discontinuity of 
the outer mitochondrial membrane, stabilized mitochondrial membrane 
permeabilization and controlled cytochrome c release from the mitochondria to the 
cytosol. According to our study, H2S significantly inhibited cytochrome c release and 
preserved endothelial ultrastructure. One possible mechanism may be directly 
through the preservation of mitochondrial inner and outer membranes, like the 
cristae, and indirectly through the inhibition of matrix remodeling. Our results also 
showed that mitochondria dysfunction occurred as early as 4 hours following H2O2 
treatment, and stimulated an increased production of ROS [205]. Therefore, 
protective intervention in these early stages may contribute to the amelioration of 
atherosclerosis damage.  
 
The second and most important factor that should be highlighted is the interplay 
between mitochondrial ROS production and antioxidants. Although oxidation 
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reactions are crucial for physiological functions, elevated levels of ROS can be 
damaging and toxic [275]. It has been widely acknowledged that ROS are involved 
in the initiation and progression stages of atherogenesis [276]. We observed that 
H2O2 (600μM) strongly reduced endothelial cell viability however, pretreatment with 
H2S (300 μM NaHS), preserved cell viability. This finding correlated with a 
significant decrease in MDA, DPPP and endogenous ROS. Interestingly, the 
protective effects of H2S could be reversed by PAG. One possible explanation for 
this observation is that H2S is a strong reducing agent and may readily react with 
labile molecules, particularly those derived from reactive oxygen and nitrogen 
species, like the superoxide radical anion [77], hydrogen peroxide [75], peroxynitrite 
[78] and hypochlorite [79]. All these compounds are highly reactive and their 
reactions with H2S may contribute to the protection of mitochondria in endothelial 
cells. Moreover, our results also found that pretreatment with NaHS elevated the 
protein expressions and activities of the antioxidant enzymes SOD, catalase and 
glutathione peroxidase. These findings further support an antioxidant role for H2S. 
Our observations agree with recent studies that found H2S was cardioprotective by 
virtue of its antioxidant properties [136]. In this case, our results suggest that the 
third underlying mechanism of mitochondrial protective by exogenous H2S is though 
decreasing the toxicity of ROS via increasing the expression levels of antioxidants 
enzymes. 
 
The third possible mechanism by which oxidative stress may trigger cellular toxicity 
in HUVECs may be the induction of the mitochondrial apoptotic pathway. It has 
reached a consensus that mitochondria do not merely supply cellular energy, are also 
involved in a range of other processes, such as cellular differentiation, program cell 
death (apoptosis), as well as the control of the cell cycle and cell growth [277]. In the 
mitochondrial pathway of apoptosis, mitochondrial outer membrane 
permeabilization has a close relationship with release of cytochrome c, the 
dissipation of mitochondrial inner transmembrane potential (ΔΨm) and regulation of 
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Bcl-2 family [278]. The break of inner and outer membranes of mitochondria will 
result in cellular apoptosis or even necrosis in several pathologies of neurological 
disorders, ischemic diseases and cardiac dysfunction, such as atherosclerosis, stroke, 
ischemia/reperfusion (I/R), cardiomyopathy, and congestive heart failure [279-281]. 
Members of the Bcl-2 family of proteins, including pro-apoptotic (e.g. Bax) and 
anti-apoptotic (e.g. Bcl-2 and Bcl-XL) members, are major regulators of 
mitochondrial cytochrome c release and down-stream caspase activation and as such 
play an important role in the regulation of cardiomyocyte apoptosis [62, 282]. Bcl-2 
is regarded as an important cellular component and it could guard against apoptotic 
cell death [283]. Bcl-2 prevents the release from mitochondria into the cytoplasm of 
apoptogenic factors, including cytochrome c and apoptosis inducing factor [251]. 
Meanwhile, its antagonists, such as Bax, caspase enzymes, are also involved in 
mitochondrion-dependent apoptosis. For example, it was recently investigated that 
lacking caspases 3 and 7 were highly resistant to mitochondrial apoptosis, delay of 
Bax translocation and cytochrome c release [284]. In our studies, NaHS increased 
expression levels of Bcl-2 and Bcl-XL and decreased levels of Bax and caspase-3, 
indicating that the mitochondrial protection by pharmacological preconditioning 
with exogenous H2S could be though enhancing cell anti-apoptotic effect.  
 
In a separate set of experiments, we also evaluated whether the exogenous H2S used 
in the current study activated the Akt signaling pathway. Akt, a serine/threonine 
kinase, have been reported in a number of studies that the activity of this protein can 
be regulated through redox stress [285]. The Akt pathway is activated not only by 
various growth factors and cytokines but also by G protein–coupled receptor 
agonists, such as bradykinin, through transactivation of receptor tyrosine kinase or 
activation of non-receptor tyrosine kinase, such as Src, in a ROS-dependent manner 
[286]. It has also been reported that Akt antagonized mitochondrial apoptosis though 
inhibiting cytochrome c release [287], regulating mitochondrial hexokinases [288] 
and interacting with phosphorylates X-linked inhibitor of apoptosis protein [289]. In 
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our study, we found increased expression of phospho-Akt (activated) in 
NaHS–treated groups. PAG could abolish this redox-sensitive signaling. This 
suggested that exogenous H2S may negatively regulate mitochondrial apoptosis by 
stimulated growth factor though Akt pathway.  
 
In conclusion, this part study describes the cellular protective effects of H2S against 
H2O2-induced toxicity, as shown in Fig 5-1. This protection was associated with the 
preservation of mitochondria function and stimulation of cellular antioxidants and 
anti-apoptosis defenses. Collectively, the ability of the CSE/H2S pathway to alter 
oxidative conditions suggests that the modulation of CSE expression and H2S 
production may provide a novel therapeutic avenue for the treatment of 
atherosclerosis. This is the first attempt to link H2S treatment with mitochondria 
protection in endothelial cells and provides a new insight into the cellular protective 
mechanisms of H2S. The availability of H2S donors should facilitate further studies 
on its cardiovascular protective roles in tissue-, animal- and patient-specific studies. 
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Fig. 5-1 Conceptualization of the way in which H2S may influence on 
H2O2-induced cell damage by preserving mitochondrial functions and displaying 
antioxidative and anti-apoptosis abilities though CSE/H2S pathway. 
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5.2 Discussion on experiment II: 
Atherosclerosis is a chronic inflammatory disease, which is initially induced by high 
level of serum lipid and oxidative stress [1]. ROS is mainly produced by 
mitochondria in the cells [111]. Once mitochondria are been attacked and damaged, 
the respiration chain will lose biological function and generate extreme ROS, which 
is toxic to cell and contributed to cell death [290]. Therefore, mitochondrial 
dysfunction has very close relationship to the early stage of atherogenesis. Increased 
mitochondrial ROS generation and dysfunction play vital roles in most 
cardiovascular disease, such as ischemia–reperfusion [18], peripheral vascular 
disease [291], atherosclerosis [205] and myocardial infarction [292]. Aortic samples 
collected from atherosclerotic patients were observed stronger mtDNA damage than 
that of nonatherosclerotic patients in age-matched transplant donors [293]. 
Meanwhile, NO, another gasotransmitter, has been found that NO releaser - 
bradykinin, modulate the canine myocardial mitochondrial respiration [294]. 
However, the effects of H2S on aortic mitochondrial functions are still unknown. 
Therefore, in this part of study, we hypothesized that H2S may protect thoracic aortic 
mitochondria of NZW rabbits and reserve the aortic mitochondrial function against 
the damage by H2O2. To test our hypothesis, we examined that respiration chain 
function and enzymes activities, mitochondrial matrix enzymes activities, ATP 
production, ROS generation and mitochondrial membrane permeability as the major 
indice of mitochondrial function. Importantly, this is the first time revealing the 
protective effects by H2S on rabbit aortic mitochondria from the several main 
mitochondrial function directions. 
 
Considering oxidative stress is highly related with atherogenesis, free radical and 
related agents is the first factor we interest. In tranquil status, mitochondria produce 
ROS as the natural byproduct of the normal metabolism of oxygen. The cellular 
internal antioxidant defense system can maintain the cellular inner environment 
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redox homeostasis by scavenging the toxic free radicals. However, various 
pathological conditions can break this balance and raise the formation of ROS [208]. 
The diseases influenced by oxidative stress can be divided into 2 groups. The first 
group is characterized by prooxidants altering the thiol/disulfide redox state and 
deteriorating glucose tolerance, including cancer and diabetes mellitus. The other 
group is characterized by inflammatory oxidative condition and increased activity of 
either NAD(P)H oxidase (such as atherosclerosis and chronic inflammation) or 
xanthine oxidase-induced formation of ROS (such as ischemia and reperfusion 
injury) [295]. The outcomes of excessive ROS stimuli were observed at two favorite 
atherosclerotic cell lines, human aortic smooth muscle cells (HASMCs) and 
HUVECs, that increase of mtDNA mutation, decrease of steady-state levels of 
mtDNA encoded mRNA transcription, suppression of mitochondrial enzymes 
synthesis, reduction of membrane potential and diminution of ATP pools[296]. Due 
to the antioxidative effects of H2S on our previous study, in this part of thesis we also 
detected the effects of H2S on H2O2-induced mitochondrial ROS generation in 
isolated rabbit aortic mitochondria. Our results showed that exogenous H2S 
significantly reduced the generation of oxygen free radicals in isolated rabbit aortic 
mitochondria injured by H2O2, indicating that the ability of H2S to prevent oxidative 
stress probably involves protection of mitochondrial function. Moreover, this effects 
likely to stem from a restoration of the oxidative-antioxidative balance, according to 
our previous part study that H2S can antagonist the damage of H2O2 and elevate the 
expressions of SOD, catalase, GPx and GST.  
 
The main function of mitochondria is ATP production by a process of oxidative 
phosphorylation. In this process, electrons are delivered from NADH/FAD(2H) via 
complexes on the electron transport chain (respiration chain) [205]. At the end of this 
chain, the final electron acceptor is oxygen and ultimately forms H2O. The energy 
from the reduction of O2 to H2O is utilized to synthesize ATP by ATP synthase [217]. 
During electron transportation, the complex I, III and IV push protons from 
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mitochondrial matrix out to the mitochondrial intermembrane space and complex V 
pumps protons back to matrix[206]. This creates a concentration gradient of protons 
that ATP synthase utilize the power to produce the energy carrier molecular ATP. 
Therefore, to study the above mentioned mitochondrial events, ATP synthesis rate 
and respiratory control ratio were analyzed. We found that the H2O2 can significantly 
ameliorate the ATP synthesis rate, ATP/O and mitochondrial active respiration. This 
result indicates that the negative effects of excessive ROS on mitochondria will in 
turn inhibit oxidative phosphorylation and may mainly related to the impairment of 
the electron transportation process. In agreement with our cellular study in previous 
part, exogenous H2S significantly attenuated mitochondrial toxicity induced by H2O2. 
H2S treatments were found significantly inhibited the reduction of the ATP synthesis 
rate, ATP/O and caused by H2O2. The mitochondrial protective effects of H2S on 
mitochondrial active respiration may be partly owing to the direct promotion of the 
ATP synthesis rate, which help to control the rate of electron flow and regulate the 
consumption of oxygen. Therefore, our results suggest that H2S may directly 
enhance the efficiency of oxidative phosphorylation and improve mitochondrial 
energy metabolism.  
 
Mitochondrial respiration chain is considered as the main site of the ROS production. 
In order to produce ATP, complex I transfer the electrons from NADH to ubiquinol, 
delivering O2
.- to mitochondrial matrix[216]. Complex III accept electrons from 
ubiquinol and cytochrome c, deliver O2
.- to mitochondrial matrix and 
intermembranous space[217]. Although ROS is the byproduct of ATP generation, 
under oxidative stress the impairment of mitochondrial respiration chain will release 
excessive ROS, which may directly decrease the efficiency of oxidative 
phosphorylation and aggravate ROS toxicity. On this respiration chain, there is a 
series of concurrent protein complexes located at the mitochondrial inner membrane 
and matrix. In order to ascertain the degree of impairment of these enzymes, we 
measured the activities of mitochondrial respiration chain complexes and matrix 
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enzymes. Our results showed that exogenous H2S significantly attenuated damage of 
mitochondrial complex and matrix enzymes activities induced by H2O2, implying 
that the development of the activities of these key enzymes probably attributes to the 
preservation of mitochondrial active respiration by H2S. 
 
The forth important factor for the oxidative phosphorylation is the integrity of the 
mitochondrial membrane structure, whose impairment not only demolishes 
transmembrane proton gradient and interferes the ATP synthesis, also indirectly 
induced an augmentation of ROS generation and deprivation of antioxidants 
activities, finally may release cytochrome c and trigger apoptosis process[297]. 
Excessive ROS can devastate mitochondrial membrane lipids and mitochondrial 
proteins, open mitochondrial permeability transition (MPT) pores, even lead to the 
release of apoptotic proteins, like cytochrome c, etc [230, 231]. Our studies found 
that exogenous H2S significantly attenuated H2O2–induced mitochondrial swelling 
and abatement of mitochondrial membrane potential. Generally, it is accepted that 
mitochondrial swelling is because the growth of inner membrane permeability and 
opening of MPT pores, a high conductance channel with multiple macromolecular 
components including ATP/ADP translocase [272]. The induction of MPT, abolish 
the mitochondrial membrane potential leading to mitochondria further depolarized, 
and hydrolyzing ATP synthase leading to the decline of ATP production [243]. 
Therefore, the beneficial action of H2S on the mitochondrial membrane permeability 
should be through the inhibition of opening of MPT pores, which is also supported 
by the recovery effects of H2S on ATP synthesis rate and ATP/O values.  
 
In this study, we have several innovations. First, we have demonstrated for the first 
time that, in aortic mitochondria of NZW rabbit, H2S can attenuate mitochondrial 
dysfunction induced by H2O2. Importantly, it is also the first attempt to link H2S 
mitochondrial protection with its antioxidative effects and mitochondrial function 
reservation. Our study highlights the mechanism of H2S modulate the oxidative 
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phosphorylation through the conservation of membrane integrity and amelioration of 
energy metabolism. Our findings draw attention to a novel mitochondrial therapeutic 
target for the treatment of atherosclerosis in the organelle level. 
 
In conclusion, this study demonstrated the protective effects of H2S on the isolated 
mitochondria from thoracic aortas of NZW rabbit. The protection of H2S was 
associated with inhibition of H2O2–induced the growth of ROS generation, decline 
of ATP production, loss of respiration chain function, mitochondrial swelling and 
recession of mitochondrial membrane potential. This new attempt may provide a 
potential template for the development of anti-atherosclerosis drugs. The 
conceptualization of the way in which H2S may influence on H2O2-induced rabbits 
aortic mitochondrial damage by preserving mitochondrial membrane permeability, 
protecting respiration chain and matrix enzymes, displaying antioxidation and 
reserving ATP production abilities is shown in Fig. 5.2.  
 
Fig. 5- 2 Conceptualization of the way in which H2S may influence on 
H2O2-induced rabbits aortic mitochondrial damage by preserving mitochondrial 
membrane permeability, protecting respiration chain and matrix enzymes, 
displaying antioxidation and reserving ATP production abilities.  
OM= mitochondrial outer membrane, IM= mitochondrial inner membrane 
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5.3 Discussion on experiment III: 
 
Atherosclerosis is a chronic inflammatory disease ascribed to high fat diet, lipid 
oxidation, oxidative stress and inflammation in the early phrase of atherogenesis. 
Prior work has documented the cardiovascular protective effects of H2S on several 
types of hypertension, myocardial injury and vascular structural remodeling. 
However, the studies were mainly in vitro studies or focused on a single factor, like 
intercellular adhesion molecule-1 (ICAM-1) [15, 16]. In this study we examined the 
anti-atherosclerotic effects of H2S (with respect to inhibition of oxidative 
modification of LDL, vascular protective effects by diminishing atherosclerotic 
plaques and antioxidative ability) in NZW rabbits rendered hypercholesterolemia by 
HCD. To test our hypothesis that H2S may attenuate the early atherosclerotic lesions, 
we investigated the effects of NaHS - the donor of H2S, and of PAG - the potent and 
irreversible inhibitor of CSE (an H2S-producing enzyme), in this rabbit model. 
Importantly, our study for the first time reveals the effects by H2S on inhibition of 
ox-LDL, rebalance of redox status, suppression of cell adhesion and prevention of 
atherosclerotic plaque development in hyperlipidemic rabbits. 
 
To demonstrate the CSE/H2S pathway involved in manipulation of atherosclerotic 
progression, we determined serum H2S levels, serum CSE activities and aortic CSE 
mRNA in all groups. H2S is produced from L-cysteine and synthesized by CSE and 
cystathionine β-synthase (CBS) [266]. The concentrations of these enzymes have 
different ratios in different parts of the human system. For example, in the 
cardiovascular system, CSE is the main H2S synthesis enzyme; while in the nervous 
system, CBS is the dominant enzyme that produces H2S. In our studies, HCD-fed 
rabbits showed significantly decreased H2S levels in serum and CSE activities in 
thoracic aorta, which may lead to a positive feedback, resulting in a compensatory 
growth of CSE gene expression. Due to the CSE distribution in each system, the 
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reduced H2S levels in serum may be attributed to the decline of CSE activity not by 
CBS. Additionally, 3-MST together with AAT, present as the third H2S synthesis 
enzymes in brain and vascular cells. In mitochondria, L-cysteine and α-ketoglutarate 
as substrates, can be converted to 3-mercaptopyruvate by AAT; then the intermediate 
product is converted to H2S by 3-MST [42]. However, endothelial cells exist the two 
enzymes, 3-MST and AAT, while smooth muscle cells only 3-MST. Therefore, 
3-MST concentration may not directly indicate H2S producing rate, which will be 
related to AAT and enzymes locations. These interesting works will be investigated 
in future studies. Abve discussion indicates that the CSE/H2S pathway may 
participate in early atherosclerotic development, which is in agreement with peer 
studies. Moreover, the HCD-fed rabbits treated with NaHS showed dose-dependent 
increases in serum H2S levels and decreased CSE activities and CSE mRNA in aorta. 
This can be explained by the fact that exogenous H2S administration raised serum 
levels, causing a positive feedback, lowering CSE gene expression. Conversely, 
treatment with PAG + HCD led to significant decrease in serum H2S levels and 
aortic CSE activities thus up-regulation in CSE mRNA expression in aorta. This is 
explained by PAG inhibition of CSE activities, resulting in much lower H2S levels in 
serum and a positive feedback to augment CSE gene expression. However, although 
high levels of homocysteine in the serums is considered as an biomarker of 
cardiovascular disease, the debate was ongoing over does this biomarker can really 
suggest any cardiac events or not. Especially, a multicenter, randomized, controlled 
trial and a vitamin study for vascular disease showed that homocystine levels was 
reduced by vitamin treatments without any improvement of cardiovascular morbidity 
and mortality[298, 299]. Due to this issue, homocystine was not measured in our 
studies. These effects of exogenous H2S (from NaHS) and the CSE inhibitor, PAG, 
provide more evidence that the CSE/H2S pathway is probably involved in early 
atherosclerotic progression, and are demonstrated for the first time in the 
hyperlipidemic rabbit model. 
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The lipoproteins play essential physiological roles as vehicles for the delivery of 
cholesterol between livers and peripheral tissues. The lipid abnormalities, especially 
LDL, are closely associated with atherogenesis [300]. The exaggerated levels of this 
lipoprotein increase the risk of atherosclerotic vascular disease as well as progressive 
and cumulative complications. Rabbits fed HCD showed higher percentage increases 
in body weight, serum levels of TC and LDL than rabbits on chow diet. This is in 
accord with previous studies [301]. Hyperlipidemic rabbits treated with NaHS and 
PAG had decreased serum LDL or highly increased lipids in serum, respectively. 
Additionally, although blood cells, especially monocytes are involved in 
atherogenesis, the blood panel did not show significant changed by treatments of 
H2S. This can be interpreted that stimulation pathway of aggregation of monocytes 
may not be influenced by H2S. However, sustained high level of monocytes may be a 
healing mechanism of scavenging toxic and redundant ox-LDL. 
 
Many lines of evidence suggest that oxidative modifications of LDL drive the initial 
formation of fatty streaks [300]. We found that the highly induced serum ox-LDL in 
HCD-fed rabbits was inhibited by exposure to H2S. Meanwhile, the atherosclerotic 
plaques detected in aorta and carotids were both shown to be smaller with H2S 
treatment, indicating that H2S may retard the development of atherosclerotic lesions, 
likely via an antioxidative effect.  
 
A number of antioxidants, which can inhibit LDL oxidation, have been tested for 
their ability to attenuate atherosclerotic lesions in animal models of the disease. 
2,3-dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran  (BO-653),  a  
synthetic antioxidant  with  structural  components  of  vitamin  E [302], 
inhibited the serum lipid peroxidation in rat [303] and reduced atherosclerotic lesions 
in hyperlipidemic mice [304].  Similarly, N,N -diphenyl-phenylenediamine (DPPD) 
attenuated atherosclerosis in the aorta of cholesterol-fed rabbits and ApoE-deficient 
mice [142]. In addition, 3,3’,5,5’-tetrabutyl-1,1’-biphenyl-4,4’-diol, a lipophilic 
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bisphenol, inhibited atherosclerosis in mice deﬁcient in apolipoprotein E and the 
LDL receptor [305].  These findings indicate a common feature of inhibiting 
oxidation of LDL in reducing atherosclerosis, and are in line with our findings. 
Furthermore, we also found that H2S decreased MDA, which was stimulated by 
HCD. The findings of decreased ox-LDL and MDA suggest that the oxidative lipids 
can be degraded by H2S. H2S, as a strong reducing agent, may readily react with 
labile and highly reactive molecules, particularly those derived from reactive oxygen 
and nitrogen species, like superoxide radical anion [77], hydrogen peroxide [75], 
peroxynitrite [78] and hypochlorite [79], and thus contribute to vascular protection. 
Moreover, we found that the levels of 24-OH, 25-OH, 27-OH cholesterols, 
indicating biomarker of lipid oxidation, were decreased by treatments of H2S. 
Cholesterol oxidation products induced by iron and LDL modified by macrophages 
may be inhibited by H2S, possibly owing to binding of S
- anion or HS- anion with 
iron from negatively charged binding sites in lipids and proteins. These data 
indicated that H2S may act as an indirect antioxidant by competing with prooxidant 
metals such as iron and cooper for strategic binding sites and prohibiting the 
formation of reactive oxygen species, then in turn reducing oxidative damage and 
delaying progress of atherosclerosis. However, unstable S- anion or HS- anion lead to 
weak bingdings of metal ion, which in turn decreased one biomarker of lipid 
oxidation not all. 
 
Oxidative modification of lipoprotein has also been found to be catalyzed by 
hemoglobin-derived heme [306]. To further elucidate how H2S regulates oxidative 
modification of LDL, we investigated the changes in the level and expression of the 
cardioprotective protein, heme oxygenase (HO)-1. We found that H2S increased the 
protein expression of HO-1 in hyperlipidemic rabbits. Hemin (Fe3+-protoporphyrin 
IX) has been shown to bind to LDL thereby inducing lipid peroxidation, like LDL 
oxidation [307-309].  HO, the first rate-limiting enzyme, degrades the hemin analog 
- heme (Fe2+-), to generate equimolar amounts of carbon monoxide (CO), free 
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ferrous iron, and biliverdin (BV) [310, 311]. Induction of HO-1 (inducible HO) or 
HO over-expression also exerts protective effects via attenuation of ROS-mediated 
endothelial damage [312], a reduction of neointimal formation [313, 314], and 
inhibition of plaque lesions [315, 316]. In our study, the regulatory effect on 
oxidative modification of LDL by H2S may be mediated by elevated levels of HO-1, 
leading to increased degradation of hemin, and in turn, suppression of 
hemin-mediated oxidation of LDL. This is the first time that lipidomic and 
proteomic evidence from in vivo studies indicate that H2S can ameliorate 
atherogenesis through inhibiting oxidative modification of LDL. 
 
It is important to highlight the role of oxygen radicals and antioxidative agents. 
Oxidative stress is associated with increased formation of ROS that modifies lipids 
and proteins leading to peroxidation and oxidation of thiol groups [317]. The assaults 
by ROS lead to changes in LDL, the oxidizing forms of which are the potent 
inducers in the initiation and progress of atherogenesis [276]. The action of H2S on 
redox status observed in our study was a direct activation of the antioxidant enzymes 
(SOD, CAT, GPx, GST) and the non-enzyme (GSH). These findings indicate that the 
antioxidative effects of H2S are not only from the reactions with highly reactive free 
radicals, but also the elevation of both enzymatic and non-enzymatic antioxidants. 
Taken with the effects on MDA, the finding of antioxidative abilities of H2S is in 
agreement with that in our previous studies on acute myocardial ischemia [136]. This 
effect, in combination with a large increase in HO-1 expression, results in the 
protection of the vasculature and is important in preventing atherogenesis. 
 
The inflammatory process mediated by cell adhesive molecules plays roles in all 
phases of atherosclerosis [195]. VCAM-1 and ICAM-1 are endothelial adhesion 
molecules belonging to Ig superfamily that participate in the progress of 
atherosclerosis by promoting the accumulation of monocytes to endothelial cells in 
arterial intima [318]. Some studies showed the dominant role of VCAM-1 in the 
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initiation of atherosclerosis[179]. ICAM-1 was also found upregulation in serum and 
atherosclerotic aortas of apo E-/- mice and human atherosclerotic plaques [15, 319]. 
Matrix metalloproteinases (MMPs) are zinc-dependent proteases, which are secreted 
in a latent proform and require activation for proteolytic activity, and play functions 
as degradation of extracellular matrix components at neutral PH [320]. The activities 
of MMPs are increased in the process of intimal lesion formation and overall 
geometrical remodeling[199]. Monocyte chemotactic protein-1 (MCP-1) is a 
chemokine involved in atherogenesis due to its chemotactic activity for monocytes 
[321]. It has been reported that NO can modulates the MCP-1 expression in 
endothelial cells [322]. Although H2S and NO are all the gasotransmitter, whether 
H2S exerts the regulatory effects on expressions of these cellular adhesion molecules 
in the development of atherosclerosis is unknown. Therefore, we tested sVCAM-1, 
sICAM-1, MMP-9 and MCP-1 in serum and relative molecules proteins and gene 
expressions in thoracic aortas. Exogenous H2S attenuated the levels of these cell 
adhesion molecules, which is consistent with the results that NaHS diminished the 
size of atherosclerotic plaques in thoracic aortas and carotids. These data indicate 
that H2S inhibited secretion and proteins and genes expressions of adhesive 
molecules in H2S-induced reduction of atherosclerotic lesions. Thereafter, this may 
provide a mechanism of H2S anti-atherogenesis effects that may through suppression 
of cell adhesion. 
 
In this study, we have several innovations. First, we have demonstrated for the first 
time that, in hyperlipidemic rabbits, H2S can attenuate atherosclerotic lesions at the 
early developmental stage. Importantly, it is also the first attempt to link H2S 
cardioprotection with its antioxidative effects and ox-LDL-modulating effects. Our 
study highlights the molecular mechanism of how H2S activates HO-1 to regulate the 
oxidative modification of LDL. Interestingly, these H2S actions are mediated via the 
CSE/ H2S pathway. Our findings draw attention to a novel therapeutic target for the 
treatment of atherosclerosis. 
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In conclusion, this study demonstrated the anti-atherosclerotic effects of H2S in the 
hyperlipidemic NZW rabbit. The protection was associated with inhibition of 
oxidative modification of lipoprotein and antioxidation. The involvement of the 
CSE/H2S pathway in regulating ox-LDL and oxidative stress indicate that the 
modulation of CSE expression and H2S production may be a novel therapeutic target 
for the treatment of atherosclerosis. This is the first attempt to link H2S treatment 
with oxidative modification of LDL and antioxidation in hyperlipidemic rabbits, 
providing a new insight into the cardiovascular protective roles of H2S. The 
availability of H2S donors should facilitate further studies on the mechanism(s) of its 
cardiovascular protection. The conceptualization of the way in which H2S may 
attenuate atherosclerotic lesions in hyperlipidemic rabbits by inhibiting lipid 
oxidation and displaying antioxidative abilities through the CSE/H2S pathway is 
shown in Fig. 5.3. 
 
Fig. 5-3. Conceptualization of the way in which H2S may attenuate 
atherosclerotic lesions in hyperlipidemic rabbits by inhibiting lipid oxidation, 
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displaying antioxidative abilities and suppression inflammatory cell adhesion 
through the CSE/H2S pathway. 
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5.4 Discussion on experiment IV: 
Garlic, also called Allium sativum, has been consumed by human over 7,000 years 
[107]. It is widely used as a seasoning, as well as traditional medicine and a functional 
food to maintain physical health[56] [9]. The beneficial effects of garlic have been 
found to prevent cancer and cardiovascular disease, such as atherosclerosis, high 
serum cholesterol and hypertension[323]. A variety of studies on garlic used aged 
garlic extract (AGE) as the effective extracted compound [324-326]. S-Allylcysteine 
(SAC), the water-souble chemical, is the major composition in AGE, showing its 
cardioprotection in ischemic rat heart and antioxidative effects in endothelial cells and 
rat brain ischemia [10, 63], [327]. S-Propargyl-cysteine (SPRC), a structural analog of 
SAC, presents its cardioprotective roles in both in vitro and in vivo studies, and 
showed as a novel pharmacological agent modulating H2S level [64, 65, 328, 329]. 
Although some investigations showed SAC or AGE can prevent atherogenesis, the 
analog SPRC did not exhibit its role on the development of atherosclerosis. To verify 
our hypothesis that SPRC may attenuate the early stage development of 
atherosclerosis, we tested the serum cholesterol, aorta and carotid atherosclerotic 
lesions, free radicals, antioxidants and inflammatory adhesive molecules in rabbit 
models. Importantly, this part study for the first time discovers the effects by SPRC on 
inhibition of atherosclerotic plaque development, rebalance of redox status and 
suppression of inflammatory adhesive molecules in hyperlipidemic rabbits. 
 
SPRC shares a common cysteine-containing structure with SAC, which has been 
found its cardioprotection and anti-cancer effects [64, 330]. SAC, a substrate of CSE, 
induce CSE expression that lead to an increase of H2S production[10]. As a structural 
analog of SAC, SPRC is also shown as a slow H2S-releasing compound that provides 
cysteine. L-cysteine is the source of producing H2S that is synthesized by CSE and 
cystathionine β-synthase (CBS) [266]. CSE and CBS express differently in the organs 
and systems of human being. In the cardiovascular system, CSE is the main H2S 
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synthesis enzyme; while in the nervous system, CBS is the dominant H2S-producing 
enzyme [32-34]. To demonstrate the CSE/H2S pathway involved in vascular 
protection of SPRC in atherosclerotic progression, we determined serum H2S levels, 
CSE activities and aortic CSE mRNA in all groups. First, in our studies, HCD-fed 
rabbits showed significantly decreased H2S levels in serum and CSE activities. Due to 
the CSE distribution in each system, the reduced H2S levels in serum may be 
attributed to the decline of CSE activity. The CSE mRNA expression in thoracic aorta 
of HCD-fed group was significantly increased, due to the positive feedback between 
circulating H2S levels and CSE gene expression. This indicates that the CSE/H2S 
pathway may participate in early atherosclerotic development, which is in agreement 
with peer studies. Moreover, the HCD-fed rabbits treated with SPRC showed 
dose-dependent increases in H2S serum levels, CSE activities and aortic CSE mRNA. 
This can be explained by the fact that SPRC is an endogenous H2S donor, which can 
produce cysteine and in turn to raise CSE expression and activity, finally may reflect 
the increased H2S serum levels. Interestingly, the changes of CSE activity and gene 
expression influenced by endogenous H2S donor, SPRC, is quite different from 
exogenous H2S donor, like NaHS. This may be caused that SPRC supply cysteine, the 
source of H2S production, not like NaHS which transfer to H2S directly. This 
characteristic of SPRC may result in the growth of CSE not the compensatory 
suppression by NaHS. Lastly, HCD-fed rabbits treated with PAG, the inhibitor of CSE, 
showed significant decrease in H2S serum levels and CSE activities, and up-regulation 
of CSE mRNA expression in aorta. There is a limitation that current CSE antibody in 
Western Blot protein detecting experiment cannot be attached to rabbit tissue. 
Fortunately, the CSE protein expression in aorta can be speculated by aortic CSE 
activities. Therefore, much lower H2S levels by the suppression of CSE by PAG may 
lead to a positive feedback to augment CSE gene expression. These effects of 
endogenous H2S – SPRC and the CSE inhibitor – PAG on the change of H2S levels 
and CSE expressions, provide the evidence that the CSE/H2S pathway is probably 
involved in cardioprotection of SPRC in early atherosclerotic progression, and are 
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demonstrated for the first time in the hyperlipidemic rabbit model. 
 
The inhibition of atherosclerotic aggression by SPRC is further verified by H&E 
staining of aortas and HURS in carotids. As the result shown, the plaque sizes and 
IMT were diminished in SPRC treated hyperlipidemic rabbits. Moreover, the index of 
Vp and RS in carotids are also shown the positive results supporting the 
cardioprotection of SPRC. Vp is the velocity of peak blood flow. If there is a plaque 
leading to the narrow of the vessel, the Vp will increase. RS, Relative-Sectional 
change is calculated as: RS = (Dd2-Ds2) / Dd2 [aortic end-diastole diameter (Dd) and 
end-systolic diameter (Ds)]. RS is considered as an index of vascular elasticity in 
HRUS analysis. The arteries with plaques have higher pressure to the vascular wall, 
so the elasticity of the vessels becomes worse. Vp and RS were found an increase in 
HCD-fed rabbits and drops in SPRC treated rabbits, indicates that SPRC may improve 
the arterial elasticity and inhibit the plaque formation. These solid evidences from 
aortas and carotids indicate that the vascular protection and prohibition of plaque 
lesions may be caused by intaking the endogenous H2S. These changes is in line with 
the previous results regarding H2S effect on hyperlipidemic rabbits and peer studies of 
H2S effect on apo-E KO mice. However, little change was found in echocardiogram 
showing the heart function and strength. This may be due to the early stage of 
atherosclerotic lesions, which usually deposit the lipids in big arteries, like aorta. The 
complications of atherosclerosis, such as stroke or heart attack, happen at the late 
stage that influent the small arteries. The little change of echocardiogram indicated the 
coronary arteries were not eroded by lipid plaques. The effects on heart function by 
SPRC could be investigated in another animal model presenting late atherosclerosis or 
the ischemia of heart. 
 
An important role in atherogenesis is oxidative stress, which generates toxic free 
radicals to induce lipids oxidation and initiate atherosclerotic progress. To investigate 
the effects on oxidative stress by SPRC, we first tested hepatic levels of MDA (a 
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product of lipid peroxidation), hepatic activities of non-enzyme antioxidant (GSH) 
and antioxidant enzymes (SOD, catalase, GST, GPx), and aortic protein and gene 
expression of antioxidant enzymes. Our positive results indicated that SPRC may 
inhibit the oxidative stress in atherogenesis. This effect by SPRC may be through two 
mechanisms: 1. H2S produced by SPRC have the ability to react with labile and highly 
reactive molecules, particularly those derived from reactive oxygen and nitrogen 
species, like superoxide radical anion [77], hydrogen peroxide [75], peroxynitrite [78] 
and hypochlorite [79], and thus contribute to vascular protection. 2. SPRC, itself can 
be easily oxidized and inevitably react with active radicals to produce new transient 
species, which may alleviate atherosclerotic aggression[331]. 
 
It is highlight that the inflammatory cell adhesion plays vital roles in all phases of 
atherosclerosis [195]. Endothelial adhesion molecules, like VCAM-1 and ICAM-1, 
stimulating the adhesion of monocytes to endothelial cells in arterial intima, 
participate in the process of intimal atherosclerotic lesion formation [318]. Peer 
studies have found that the dominant role of VCAM-1 and ICAM-1 in the early 
atherosclerosis [15, 179, 319]. MMPs and MCP-1, due to chemotactic activity, were 
found in early lesion formation and overall geometrical remodeling[199] [321]. Our 
results showed that SPRC decreased the protein and gene expressions of inflammatory 
cell adhesive molecules which can be abolished by the inhibitor PAG, indicating the 
SPRC may suppress the atherosclerotic progression by inhibition of inflammation 
mediated by cell adhesive molecules. The similar results were found in some 
investigations that SAC decreased breast tumor cell adhesion[332]. As the structural 
analog of SAC, SPRC having the stronger chemical bonds, may through such 
mechanism to show its anti-atherosclerosis. 
 
In conclusion, this study demonstrated in first time that SPRC attenuated 
atherosclerotic lesions in the hyperlipidemic NZW rabbit. The vascular protective 
effects were associated with inhibition of oxidative stress and inflammatory cell 
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adhesion. As the structural analog of SAC and endogenous H2S, SPRC shows the 
cardiovascular protection through the CSE/H2S pathway, indicating that the 
modulation of CSE expression and H2S production may be a novel therapeutic target 
for the treatment of atherosclerosis. The contribution and innovations of this part 
study are: the first attempt to link endogenous H2S with anti-oxidation and 
anti-inflammation; first time to discover SPRC having the ability of inhibition of 
atherosclerotic lesions at the early developmental stage in hyperlipidemic rabbits, 
providing a new insight into the cardiovascular protective roles of H2S. The 
conceptualization of the way in which SPRC may attenuate atherosclerotic lesions in 
hyperlipidemic rabbits by inhibiting oxidative stress and inflammatory cell adesionqaa 
through the CSE/H2S pathway is shown in Fig. 5.4. 
 
 
Fig. 5-4. Conceptualization of the way in which SPRC may attenuate 
atherosclerotic lesions in hyperlipidemic rabbits by inhibiting aortic plaques, 
displaying antioxidative abilities and suppression inflammatory cell adhesion 
through the CSE/H2S pathway. 
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Chapter 6 
Conclusion and 
Future Perspective 
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6.1 Conclusion 
Due to long term high lipid diet, formation of multiple plaques leads to arteries 
narrow and harden, called atherosclerosis, which is initiated by oxidative stress and 
inflammatory processes. Under oxidative stress, circulating lipids are oxidized, such 
as ox-LDL, which become the potent inducer of atherosclerosis. From the cellular 
level, reactive free radicals will lead to mitochondrial dysfunction, which may cause 
severe oxidative stress. Meanwhile, inflammation is thought to link hyperlipidemia 
with atherosclerosis, which process mediated by cell adhesion leads to the attachment 
of leucocytes to endothelium. Therefore, the mitochondrial protection and 
intervention of oxidative stress and inflammation could be the approach of the 
atherosclerotic therapy. Previous studies have been found H2S has the 
cardioprotection and antioxidative ability. These encouraging results prompt us to 
further our studies on the effects of H2S and SPRC in vitro and in vivo. 
 
First, the pilot study in experiment I have achieved the first objective in this thesis that 
to verify the possible therapeutic potential of exogenous H2S on HUVECs against 
H2O2-induced mitochondrial dysfunction, oxidative stress and apoptosis. This part 
study shows that the cellular protective effects of H2S act through CSE/ H2S pathway 
by observation of modulation of H2S level and CSE protein and gene expressions. 
Exogenous H2S showed no toxic to HUVECs in μM level, as well as the growth of 
cell viability reduced by H2O2. The mitochondrial protection of H2S could be 
observed from the mitochondrial function by increase of ATP production and 
mitochondrial integrity by growth of ΔΨm and inhibition of cytochrome C release. 
The anti-oxidation of H2S was obtained by reduction of ROS production, MDA and 
enhancement of antioxidative enzymes, such as SOD, catalase, GST and GPx. 
Moreover, the cell viability survived by H2S, observed by Annexin V/PI staining and 
counted by flow cytometry, may be through its anti-apoptosis from inhibition of 
pro-apoptotic related proteins expressions, like Bax and caspase-3, and augmentation 
of anti- apoptotic related proteins expressions, like Bcl-2 and Bcl-xl, and modulation 
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of Akt pathway. These findings are the first time to demonstrate in endothelial cells 
that H2S presents its cellular and mitochondrial protection by and suppression of 
oxidative stress and apoptosis.  
 
Then, in experiment II, the rabbit aortic mitochondria were isolated for investigating 
the mitochondrial function protected by H2S in the largest artery with atherosclerotic 
high-risk area. The findings of a greater extent of ROS production and less ATP 
biosynthesis in H2O2 treated mitochondria are in line with the phenomenon that 
mitochondria are the both of contributors and targets of toxic free radicals in stressful 
condition. Under oxidative stress stimulated by H2O2, an augmentation of ROS in 
aortic mitochondria was prohibited by exogenous H2S in a dose dependent manner. 
Major mitochondrial function is ATP synthesis, which decreased by oxidative stress 
and recovered by treatment of H2S. This finding suggests that H2S may have the effect 
of metabolic arrest to the aortic mitochondria, resulting in the cytoprotective barrier to 
the stressful mitochondria. As the location of ATP generation, mitochondrial 
respiration chain was evaluated that reduced oxygen consumption was ascended by 
H2S, showing the mild uncoupling effect to the mitochondrial respiration. Meanwhile, 
the activities of mitochondrial respiration chain complex and matrix enzymes were 
partially increased by H2S, reflecting another mechanism of mitochondrial protection 
by H2S may stabilize mitochondrial respiration chain to achieve the mitochondrial 
function. Moreover, the detection of ΔΨm and mitochondrial swelling revealed 
mitochondrial protection by H2S may be through the maintenance of mitochondrial 
integrity. It is the first attempt, in rabbit aortic mitochondria, to link H2S 
mitochondrial protection with its antioxidative effects and mitochondrial function 
reservation. The findings of H2S conferring the modulation of the oxidative 
phosphorylation through the conservation of membrane integrity and amelioration of 
energy metabolism, provide a novel mitochondrial therapeutic target for the treatment 
of atherosclerosis.  
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Next, in vivo experiment III achieved the 3rd objective in this project that the 
inhibition of atherogenesis in New Zealand White rabbit by H2S. 8 weeks high 
cholesterol feeding was applied to induce hyperlipidemic model, which showed 
severe plaques in aortas. The injection of exogenous H2S may diminish the plaques 
sized and eroded IMT, indicating the potential therapeutic application of H2S on 
atherosclerosis. For the mechanism investigation, firstly, these findings of mild 
inhibition of serum cholesterol, suppressed oxysterols levels and reduced ox-LDL 
indicated that the inhibited effect of lipid oxidation of H2S. Moreover, augmented 
HO-1 protein and gene expression, prohibited ROS and increased antioxidants 
suggested that anti-oxidative lipid effect of H2S acts through activating HO-1 
expression and antioxidative ability. Furthermore, inflammation mediated by cell 
adhesion was observed by several important proteins expressions, such as VCAM-1, 
ICAM-1, MCP-1 and MMP-9, reflecting the anti-inflammatory effect of H2S. It is the 
first time to demonstrate, in hyperlipidemic rabbits, H2S may attenuate atherosclerotic 
lesions at the early developmental stage, through its antioxidative effects and 
inhibition of lipid oxidation and inflammation, and provide encouraging evidences to 
atherosclerotic therapeutic applications. 
 
Last, the 4th objective was achieved in experiment IV. To higher degree of similarity, 
SPRC, as the analog of garlic extraction (SAC) and sulfide-containing chemical, 
showed profound protective effect on atherosclerotic aortas. NZW rabbits were also 
applied to set up the hyperlipidemia model by feeding 1% cholesterol diet 8 weeks, 
which profound atherosclerotic lesions can be observed in rabbit aortas. Injection of 
SPRC 8 weeks with high cholesterol diet lead to diminished plaques size, decreased 
IMT and improved ultrastructure by, reflecting the effect of anti-atherogenesis by 
SPRC. The protein and gene expressions of antioxidant enzymes and inflammatory 
cell adhesive molecules were inhibited by SPRC, which revealed the undergoing 
mechanisms of anti-atherogenesis of SPRC. These encouraging findings suggest that 
the therapeutic effects of SPRC act through anti-oxidative and anti-inflammatory 
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targets. It is the first time to link garlic extraction analog with the therapeutic target of 
atherosclerosis that SPRC may inhibit atherogenesis, which serves a novel treatment 
of atherosclerosis.  
 
All in all, this project demonstrates H2S and sulfide-containing chemical (SPRC) may 
confer the anti-atherosclerotic effect in both in vitro and in vivo experiments. Our 
studies is the first time to elucidate the inhibited effect of H2S and (or) SPRC on 
atherosclerotic related cells or animal model. This is a good attempt to associate the 
anti-atherosclerotic effect of H2S and SPRC with their abilities of improving 
mitochondrial function, challenging undergoing apoptosis, balancing redox status and 
prohibiting inflammation. These evidences prompt researchers to further their studies 
on drug development of atherosclerosis.  
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6.2 Limitation of study 
Study on human disease-atherosclerosis is not an easy job, because this disease is the 
outcome of long tern effects, which is influenced by multiple factors, such as, 
oxidative stress, inflammation, program cell death and cell migration. Our in vitro 
study focused on endothelial cells and in vivo study used NZW rabbit to set up the 
hyperlipidemic model, due to the investigation on early atherosclerosis. Nonetheless, 
none of these models fully reflects all human atherosclerotic phenomena. This 
limitation contributes to countless abortions of drug development on therapeutic 
agents which have showed their anti-atherosclerotic effect, owing to the strong drug 
adverse reaction or narrow therapeutic dosage range. For these reasons, deeper 
understanding on pathophysiology of atherosclerosis and more evidences for 
supporting the therapeutic effect will be helpful for peer studies and clinical trials. 
However, it cannot undermine the value and importance of current studies that 
provide useful information of a new identified gasotransmitter, H2S on treatment of 
this tough cardiovascular disease. 
 
Although H2S is a hot issue in recent years, the pharmacological effects on every 
human system are still under investigation. Some of these findings even are 
conflicting, ascribed to the different study models, different H2S form or donors, etc. 
Nonetheless, as a gasotransmitter sharing several characteristics with NO, H2S may 
present its pharmacological effect on human public health. 
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6.3 Future perspective 
The current therapies of atherosclerosis mainly focusing on the lowering the serum 
lipid with strong adverse drug reaction and low patients tolerance remain a 
challenging task. Experimental models of atherosclerosis have provided us treasure 
insights that atherosclerosis is a chronic inflammatory process involving a series of 
complex signaling interacting the atherogenesis. Therefore, in long term research, 
multifaceted molecular pathways are needed to investigate that can help to deeply 
understand atherogenesis and identify the drug development target. 
 
As one of the mechanism in pathophysiology of atherosclerosis, oxidative stress 
interplay with other factors among different signaling pathways. Considering 
oxidative stress initial this chronic disease, its effects on activating other molecules 
and cells become very important. Therefore, researches on this field could be an 
interesting issue that inspires peers to pay more passions on drug development of 
antioxidant strategy.  
 
Research on H2S is a hot issue with abundant unknown characteristics. For example, it 
is still debating that the effects of H2S on inflammation, cancer and Alzheimer’s 
disease are prohibition or promotion. Considering atherosclerosis is a chronic 
inflammatory disease, future perspective can deeply investigate the effects of H2S on 
inflammation and immune system. Hence, the studies on pharmacology of H2S on 
human system could further the knowledge of this gasotransmitter that may present 
excellent performances as its brother, NO. 
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